*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG A 44 ARG.? 19.54 O ACT C 301 A 219 LYS C 19 LYS~? 19.44 O ACT C 301 A 376 GLY A 45 GLY.? 16.26 OXT ACT C 301 A 399 GLY A 40 GLY.? 8.88 O ACT C 301 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -9.80 41.84 63.03 -12.20 41.46 64.90 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -8.10 55.24 54.21 -11.72 57.88 57.10 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -4.76 42.35 60.16 -5.04 41.69 60.54 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -9.41 44.65 53.52 -9.78 44.04 53.98 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c00 naa= 4 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG A 44 ARG.? 19.54 O ACT C 301 B 219 LYS C 19 LYS~? 19.44 O ACT C 301 B 376 GLY A 45 GLY.? 16.26 OXT ACT C 301 B 399 GLY A 40 GLY.? 8.88 O ACT C 301 coo -2.66 39.94 47.71 -4.08 39.67 44.99 -9.80 41.84 63.03 -12.20 41.46 64.90 coo -12.62 42.34 36.27 -8.73 43.54 40.31 -8.10 55.24 54.21 -11.72 57.88 57.10 coo -6.85 37.45 46.42 -7.20 36.92 45.92 -4.76 42.35 60.16 -5.04 41.69 60.54 coo -4.26 38.64 36.66 -3.61 38.69 37.17 -9.41 44.65 53.52 -9.78 44.04 53.98 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c01 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG A 44 ARG.? 19.54 O ACT C 301 C 219 LYS C 19 LYS~? 19.44 O ACT C 301 C 376 GLY A 45 GLY.? 16.26 OXT ACT C 301 C 399 GLY A 40 GLY.? 8.88 O ACT C 301 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 5.22 26.79 80.32 0.48 26.84 77.06 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 1.35 28.76 68.50 2.09 28.66 68.61 -4.76 42.35 60.16 -5.04 41.69 60.54 coo 2.85 20.10 73.72 2.25 20.01 73.15 -9.41 44.65 53.52 -9.78 44.04 53.98 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 44 ARG.? 19.54 O ACT C 301 D 219 LYS C 19 LYS~? 19.44 O ACT C 301 D 376 GLY A 45 GLY.? 16.26 OXT ACT C 301 D 399 GLY A 40 GLY.? 8.88 O ACT C 301 coo 0.59 75.69 110.95 1.51 77.84 112.93 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 1.28 85.37 123.16 0.84 80.41 120.28 -8.10 55.24 54.21 -11.72 57.88 57.10 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -4.76 42.35 60.16 -5.04 41.69 60.54 coo 7.52 81.86 116.81 7.49 81.18 116.34 -9.41 44.65 53.52 -9.78 44.04 53.98 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c03 naa= 4 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1020 THR A 34 THR^? -4.67 OXT ACT A 303s A1034 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A1100 THR A 36 THR^? 9.99 OXT ACT A 303 B3294 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo 40.94 131.25 89.60 39.24 130.12 90.27 2.88 30.33 48.17 4.48 31.66 47.56 coo 35.38 132.08 89.27 36.78 129.74 88.76 1.04 26.01 48.23 1.29 24.82 50.73 coo 43.56 124.16 89.51 42.17 124.73 91.05 0.70 35.56 51.71 1.36 36.35 49.79 coo 33.89 125.64 85.55 35.54 126.95 85.33 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1020 THR B 34 THR^? -4.05 O ACT B 304s A1034 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A1100 THR B 36 THR^? 10.28 O ACT B 304 B3294 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo 40.94 131.25 89.60 39.24 130.12 90.27 8.80 45.53 47.76 6.89 46.40 47.31 coo 35.38 132.08 89.27 36.78 129.74 88.76 13.49 45.92 47.42 14.68 46.48 49.90 coo 43.56 124.16 89.51 42.17 124.73 91.05 5.70 40.75 51.53 3.79 40.81 50.49 coo 33.89 125.64 85.55 35.54 126.95 85.33 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1020 THR C 34 THR^? 4.17 OXT ACT C 301 A1034 TYR C 33 TYR.? -7.29 C ACT C 301s A1100 THR C 36 THR^? 10.76 OXT ACT C 301 B3294 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 40.94 131.25 89.60 39.24 130.12 90.27 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 35.38 132.08 89.27 36.78 129.74 88.76 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 43.56 124.16 89.51 42.17 124.73 91.05 -1.57 43.28 52.09 -0.86 42.09 50.37 coo 33.89 125.64 85.55 35.54 126.95 85.33 -5.97 51.16 54.03 -5.89 49.54 55.41 1djo_c00 source 1djo GLUTAMINASE-ASPARAGINASE : 3 hits 1djo_c00 naa= 4 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1294 GLU A 18 GLU~? 13.24 OXT ACT A 303 B3020 THR A 34 THR^? -4.67 OXT ACT A 303s B3034 TYR A 33 TYR.? -7.37 CH3 ACT A 303s B3100 THR A 36 THR^? 9.99 OXT ACT A 303 coo 42.18 93.40 84.96 40.44 92.19 85.03 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 35.69 87.89 89.88 37.41 89.09 90.33 2.88 30.33 48.17 4.48 31.66 47.56 coo 40.98 87.08 88.86 39.63 89.46 88.41 1.04 26.01 48.23 1.29 24.82 50.73 coo 33.09 94.86 90.18 34.63 94.22 91.55 0.70 35.56 51.71 1.36 36.35 49.79 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1294 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B3020 THR B 34 THR^? -4.05 O ACT B 304s B3034 TYR B 33 TYR.? -6.95 CH3 ACT B 304s B3100 THR B 36 THR^? 10.28 O ACT B 304 coo 42.18 93.40 84.96 40.44 92.19 85.03 15.35 40.93 52.66 14.20 41.89 54.18 coo 35.69 87.89 89.88 37.41 89.09 90.33 8.80 45.53 47.76 6.89 46.40 47.31 coo 40.98 87.08 88.86 39.63 89.46 88.41 13.49 45.92 47.42 14.68 46.48 49.90 coo 33.09 94.86 90.18 34.63 94.22 91.55 5.70 40.75 51.53 3.79 40.81 50.49 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1294 GLU C 18 GLU~? 13.25 OXT ACT C 301 B3020 THR C 34 THR^? 4.17 OXT ACT C 301 B3034 TYR C 33 TYR.? -7.29 C ACT C 301s B3100 THR C 36 THR^? 10.76 OXT ACT C 301 coo 42.18 93.40 84.96 40.44 92.19 85.03 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 35.69 87.89 89.88 37.41 89.09 90.33 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 40.98 87.08 88.86 39.63 89.46 88.41 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 33.09 94.86 90.18 34.63 94.22 91.55 -1.57 43.28 52.09 -0.86 42.09 50.37 1djo_c01 source 1djo GLUTAMINASE-ASPARAGINASE : 3 hits 1djo_c01 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 42 ARG A 47 ARG.? 21.65 CH3 ACT B 304 A 197 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 203 ARG C 57 ARG^? 6.12 O ACT B 304 coo 23.24 19.51 21.94 24.57 16.76 21.61 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 16.08 17.48 28.78 19.09 16.85 28.49 1.93 40.93 64.24 4.88 41.80 64.42 coo 28.26 9.63 19.68 28.71 10.56 22.55 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 33.62 12.31 23.18 30.84 12.90 24.36 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 A 33 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 42 ARG A 47 ARG.? 21.65 CH3 ACT B 304 A 197 ARG C 57 ARG^? 6.12 O ACT B 304 A 203 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 23.24 19.51 21.94 24.57 16.76 21.61 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 16.08 17.48 28.78 19.09 16.85 28.49 1.93 40.93 64.24 4.88 41.80 64.42 coo 28.26 9.63 19.68 28.71 10.56 22.55 0.41 44.01 46.89 3.20 43.89 45.69 coo 33.62 12.31 23.18 30.84 12.90 24.36 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 A 33 ARG C 39 ARG.? 12.72 CH3 ACT B 304 A 42 ARG A 47 ARG.? 21.65 CH3 ACT B 304 A 197 ARG B 57 ARG^? 10.43 O ACT B 304 A 203 ARG C 57 ARG^? 6.12 O ACT B 304 coo 23.24 19.51 21.94 24.57 16.76 21.61 9.00 43.74 55.65 11.90 42.76 55.27 coo 16.08 17.48 28.78 19.09 16.85 28.49 1.93 40.93 64.24 4.88 41.80 64.42 coo 28.26 9.63 19.68 28.71 10.56 22.55 4.68 37.56 46.31 2.06 39.11 46.79 coo 33.62 12.31 23.18 30.84 12.90 24.36 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 A 33 ARG C 39 ARG.? 12.72 CH3 ACT B 304 A 42 ARG A 47 ARG.? 21.65 CH3 ACT B 304 A 197 ARG C 57 ARG^? 6.12 O ACT B 304 A 203 ARG B 57 ARG^? 10.43 O ACT B 304 coo 23.24 19.51 21.94 24.57 16.76 21.61 9.00 43.74 55.65 11.90 42.76 55.27 coo 16.08 17.48 28.78 19.09 16.85 28.49 1.93 40.93 64.24 4.88 41.80 64.42 coo 28.26 9.63 19.68 28.71 10.56 22.55 0.41 44.01 46.89 3.20 43.89 45.69 coo 33.62 12.31 23.18 30.84 12.90 24.36 4.68 37.56 46.31 2.06 39.11 46.79 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 4 hits 1f75_c00 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 15 SER.? 17.30 O ACT C 301 A 159 GLU A 23 GLU~? 17.46 O ACT A 303 A 184 ARG A 20 ARG~? 20.10 O ACT A 303 A 189 GLU A 14 GLU^? 15.87 O ACT C 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 52.64 14.17 18.05 51.99 14.09 16.04 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 45.78 18.05 21.49 44.51 17.88 18.72 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 49.07 22.26 28.01 48.95 23.27 26.11 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER A 15 SER.? 17.30 O ACT C 301 A 159 GLU A 24 GLU~? 16.57 O ACT A 303 A 184 ARG A 20 ARG~? 20.10 O ACT A 303 A 189 GLU A 14 GLU^? 15.87 O ACT C 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 52.64 14.17 18.05 51.99 14.09 16.04 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 45.78 18.05 21.49 44.51 17.88 18.72 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 49.07 22.26 28.01 48.95 23.27 26.11 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 3 4 # 3 A 147 SER A 15 SER.? 17.30 O ACT C 301 A 159 GLU A 24 GLU~? 16.57 O ACT A 303 A 184 ARG A 20 ARG~? 20.10 O ACT A 303 A 189 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo 53.09 24.63 27.00 51.51 25.19 25.28 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 52.64 14.17 18.05 51.99 14.09 16.04 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 45.78 18.05 21.49 44.51 17.88 18.72 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 49.07 22.26 28.01 48.95 23.27 26.11 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 4 4 # 4 A 147 SER C 15 SER.? 16.03 CH3 ACT B 304 A 159 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 184 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 189 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 -0.02 52.59 55.50 0.94 52.38 57.70 coo 52.64 14.17 18.05 51.99 14.09 16.04 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 45.78 18.05 21.49 44.51 17.88 18.72 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 49.07 22.26 28.01 48.95 23.27 26.11 -5.97 51.16 54.03 -5.89 49.54 55.41 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 4 hits 1og1_c00 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS B 19 LYS~? 19.93 CH3 ACT B 304 A 11 GLY C 40 GLY.? 7.10 CH3 ACT B 304 A 45 GLY C 42 GLY.? 12.37 CH3 ACT B 304 A 217 LYS B 26 LYS~? 10.63 CH3 ACT B 304 coo 23.95 20.41 42.64 25.99 15.22 44.13 19.96 40.93 52.37 24.88 43.37 55.52 coo 21.78 10.35 42.81 21.85 10.58 42.04 10.77 48.31 51.36 10.92 48.35 52.19 coo 27.49 8.11 39.28 26.75 8.17 38.90 14.74 50.71 55.40 14.32 50.00 55.21 coo 29.45 15.15 50.79 25.80 14.13 47.92 20.18 46.61 43.20 19.00 49.55 48.67 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 2 4 # 2 A 8 LYS B 19 LYS~? 19.93 CH3 ACT B 304 A 11 GLY C 42 GLY.? 12.37 CH3 ACT B 304 A 45 GLY C 40 GLY.? 7.10 CH3 ACT B 304 A 217 LYS B 26 LYS~? 10.63 CH3 ACT B 304 coo 23.95 20.41 42.64 25.99 15.22 44.13 19.96 40.93 52.37 24.88 43.37 55.52 coo 21.78 10.35 42.81 21.85 10.58 42.04 14.74 50.71 55.40 14.32 50.00 55.21 coo 27.49 8.11 39.28 26.75 8.17 38.90 10.77 48.31 51.36 10.92 48.35 52.19 coo 29.45 15.15 50.79 25.80 14.13 47.92 20.18 46.61 43.20 19.00 49.55 48.67 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 3 4 # 3 A 8 LYS C 19 LYS~? 19.44 O ACT C 301 A 11 GLY A 40 GLY.? 8.88 O ACT C 301 A 45 GLY A 42 GLY.? 12.48 O ACT C 301 A 217 LYS C 26 LYS~? 10.00 O ACT C 301 coo 23.95 20.41 42.64 25.99 15.22 44.13 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 21.78 10.35 42.81 21.85 10.58 42.04 -9.41 44.65 53.52 -9.78 44.04 53.98 coo 27.49 8.11 39.28 26.75 8.17 38.90 -13.24 44.86 57.56 -12.65 44.58 57.16 coo 29.45 15.15 50.79 25.80 14.13 47.92 -14.41 53.18 45.44 -15.58 50.04 50.81 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 3 hits 1oh9_c00 naa= 4 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 1 4 # 1 A 31 THR A 36 THR^? 9.99 OXT ACT A 303 A 64 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 114 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 996 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 0.70 35.56 51.71 1.36 36.35 49.79 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 -3.59 27.39 54.08 -2.09 28.32 55.24 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 2 4 # 2 A 31 THR B 36 THR^? 10.28 O ACT B 304 A 64 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 114 ARG B 57 ARG^? 10.43 O ACT B 304 A 996 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 5.70 40.75 51.53 3.79 40.81 50.49 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 15.35 40.93 52.66 14.20 41.89 54.18 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 4.68 37.56 46.31 2.06 39.11 46.79 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 4 2pda_c02 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 3 4 # 3 A 31 THR C 36 THR^? 10.76 OXT ACT C 301 A 64 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 114 ARG C 57 ARG^? 6.12 O ACT B 304 A 996 ASN A 55 ASN^? 10.27 O ACT C 301 coo -31.93 -70.88 26.26 -31.36 -72.64 25.07 -1.57 43.28 52.09 -0.86 42.09 50.37 coo -28.83 -60.40 27.93 -28.59 -62.02 26.61 -5.97 51.16 54.03 -5.89 49.54 55.41 coo -28.60 -70.98 30.66 -27.00 -70.27 28.18 0.41 44.01 46.89 3.20 43.89 45.69 coo -27.31 -71.61 17.96 -26.98 -72.71 19.76 -8.33 37.03 53.83 -10.36 37.52 54.24 2pda_c02 source 2pda PYRUVATE-FERREDOXIN OXIDOREDUCTASE : 3 hits 2pda_c02 naa= 4 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 1 4 # 1 B 31 THR A 36 THR^? 9.99 OXT ACT A 303 B 64 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 114 ARG A 57 ARG^? 9.16 OXT ACT C 301 B 996 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 0.70 35.56 51.71 1.36 36.35 49.79 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 -3.59 27.39 54.08 -2.09 28.32 55.24 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 2 4 # 2 B 31 THR B 36 THR^? 10.28 O ACT B 304 B 64 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 114 ARG B 57 ARG^? 10.43 O ACT B 304 B 996 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 5.70 40.75 51.53 3.79 40.81 50.49 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 15.35 40.93 52.66 14.20 41.89 54.18 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 4.68 37.56 46.31 2.06 39.11 46.79 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 4 2pda_c03 PYRUVATE-FERREDOXIN OXIDOREDUCTASE user 3 4 # 3 B 31 THR C 36 THR^? 10.76 OXT ACT C 301 B 64 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 114 ARG C 57 ARG^? 6.12 O ACT B 304 B 996 ASN A 55 ASN^? 10.27 O ACT C 301 coo -13.02 -42.92 38.04 -13.54 -40.80 38.29 -1.57 43.28 52.09 -0.86 42.09 50.37 coo -15.92 -51.72 32.00 -16.09 -49.62 32.08 -5.97 51.16 54.03 -5.89 49.54 55.41 coo -16.73 -45.67 41.07 -18.08 -44.48 38.62 0.41 44.01 46.89 3.20 43.89 45.69 coo -16.90 -36.67 32.00 -17.42 -37.04 34.03 -8.33 37.03 53.83 -10.36 37.52 54.24 2pda_c03 source 2pda PYRUVATE-FERREDOXIN OXIDOREDUCTASE : 3 hits 2pda_c03 naa= 4 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 1 4 # 1 A 283 GLU A 41 GLU.? 4.97 O ACT C 301 C 12 THR C 34 THR^? 4.17 OXT ACT C 301 C 25 TYR C 33 TYR.? -7.29 C ACT C 301s C 89 THR C 36 THR^? 10.76 OXT ACT C 301 coo 60.56 18.92 0.90 61.14 20.52 2.16 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 55.95 25.18 2.21 55.69 23.16 3.11 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 59.81 26.53 8.25 58.00 25.30 8.32 -1.57 43.28 52.09 -0.86 42.09 50.37 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 2 4 # 2 A 283 GLU A 89 GLU^? 9.05 CL CL A 201 C 12 THR A 10 THR^? 10.03 OXT ACT A 303 C 25 TYR A 87 TYR^? 7.71 OXT ACT C 301 C 89 THR A 60 THR^? -4.49 O ACT A 303s coo 60.56 18.92 0.90 61.14 20.52 2.16 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 55.95 25.18 2.21 55.69 23.16 3.11 -4.20 33.48 42.66 -3.27 35.43 42.96 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 59.81 26.53 8.25 58.00 25.30 8.32 0.42 28.72 42.47 -0.75 26.89 42.18 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 3 4 # 3 A 283 GLU B 89 GLU^? 9.16 CL CL B 202 C 12 THR B 10 THR^? 9.22 O ACT B 304 C 25 TYR B 87 TYR^? 7.07 OXT ACT A 303 C 89 THR B 60 THR^? -4.90 OXT ACT B 304s coo 60.56 18.92 0.90 61.14 20.52 2.16 3.69 38.42 36.29 2.58 38.79 38.06 coo 55.95 25.18 2.21 55.69 23.16 3.11 8.97 38.22 41.63 6.87 37.99 42.14 coo 55.67 19.31 -0.41 56.70 20.51 1.90 6.95 34.35 38.83 5.26 35.08 40.94 coo 59.81 26.53 8.25 58.00 25.30 8.32 10.88 44.65 41.79 13.01 44.54 41.32 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 4 4 # 4 A 283 GLU C 89 GLU^? 9.21 CL CL C 203 C 12 THR C 10 THR^? 8.48 O ACT B 304 C 25 TYR C 87 TYR^? 6.46 O ACT B 304 C 89 THR C 60 THR^? 4.85 CH3 ACT C 301 coo 60.56 18.92 0.90 61.14 20.52 2.16 0.03 43.20 36.88 0.18 41.91 38.57 coo 55.95 25.18 2.21 55.69 23.16 3.11 -1.75 47.62 42.43 -0.43 45.91 42.71 coo 55.67 19.31 -0.41 56.70 20.51 1.90 2.28 47.86 39.06 2.71 45.79 40.92 coo 59.81 26.53 8.25 58.00 25.30 8.32 -8.30 46.13 43.05 -9.25 48.08 42.71 3eca_c04 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c04 naa= 4 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 1 4 # 1 B 283 GLU A 41 GLU.? 4.97 O ACT C 301 D 12 THR C 34 THR^? 4.17 OXT ACT C 301 D 25 TYR C 33 TYR.? -7.29 C ACT C 301s D 89 THR C 36 THR^? 10.76 OXT ACT C 301 coo 30.23 27.31 19.48 30.08 25.34 19.98 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 32.19 21.46 15.06 33.45 23.05 16.00 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 31.17 27.34 14.84 32.70 26.15 16.86 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 35.78 18.11 20.94 36.76 19.54 19.61 -1.57 43.28 52.09 -0.86 42.09 50.37 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 2 4 # 2 B 283 GLU A 89 GLU^? 9.05 CL CL A 201 D 12 THR A 10 THR^? 10.03 OXT ACT A 303 D 25 TYR A 87 TYR^? 7.71 OXT ACT C 301 D 89 THR A 60 THR^? -4.49 O ACT A 303s coo 30.23 27.31 19.48 30.08 25.34 19.98 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 32.19 21.46 15.06 33.45 23.05 16.00 -4.20 33.48 42.66 -3.27 35.43 42.96 coo 31.17 27.34 14.84 32.70 26.15 16.86 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 35.78 18.11 20.94 36.76 19.54 19.61 0.42 28.72 42.47 -0.75 26.89 42.18 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 3 4 # 3 B 283 GLU B 89 GLU^? 9.16 CL CL B 202 D 12 THR B 10 THR^? 9.22 O ACT B 304 D 25 TYR B 87 TYR^? 7.07 OXT ACT A 303 D 89 THR B 60 THR^? -4.90 OXT ACT B 304s coo 30.23 27.31 19.48 30.08 25.34 19.98 3.69 38.42 36.29 2.58 38.79 38.06 coo 32.19 21.46 15.06 33.45 23.05 16.00 8.97 38.22 41.63 6.87 37.99 42.14 coo 31.17 27.34 14.84 32.70 26.15 16.86 6.95 34.35 38.83 5.26 35.08 40.94 coo 35.78 18.11 20.94 36.76 19.54 19.61 10.88 44.65 41.79 13.01 44.54 41.32 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 4 4 # 4 B 283 GLU C 89 GLU^? 9.21 CL CL C 203 D 12 THR C 10 THR^? 8.48 O ACT B 304 D 25 TYR C 87 TYR^? 6.46 O ACT B 304 D 89 THR C 60 THR^? 4.85 CH3 ACT C 301 coo 30.23 27.31 19.48 30.08 25.34 19.98 0.03 43.20 36.88 0.18 41.91 38.57 coo 32.19 21.46 15.06 33.45 23.05 16.00 -1.75 47.62 42.43 -0.43 45.91 42.71 coo 31.17 27.34 14.84 32.70 26.15 16.86 2.28 47.86 39.06 2.71 45.79 40.92 coo 35.78 18.11 20.94 36.76 19.54 19.61 -8.30 46.13 43.05 -9.25 48.08 42.71 3eca_c05 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c05 naa= 4 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 1 4 # 1 A 12 THR A 10 THR^? 10.03 OXT ACT A 303 A 25 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 89 THR A 60 THR^? -4.49 O ACT A 303s C 283 GLU A 89 GLU^? 9.05 CL CL A 201 coo 76.53 15.20 38.92 75.75 17.07 38.27 -4.20 33.48 42.66 -3.27 35.43 42.96 coo 78.55 20.90 39.91 77.09 20.09 37.68 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 72.66 13.38 32.85 71.79 14.81 34.24 0.42 28.72 42.47 -0.75 26.89 42.18 coo 79.85 20.73 35.44 79.36 18.97 34.45 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 2 4 # 2 A 12 THR B 10 THR^? 9.22 O ACT B 304 A 25 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 89 THR B 60 THR^? -4.90 OXT ACT B 304s C 283 GLU B 89 GLU^? 9.16 CL CL B 202 coo 76.53 15.20 38.92 75.75 17.07 38.27 8.97 38.22 41.63 6.87 37.99 42.14 coo 78.55 20.90 39.91 77.09 20.09 37.68 6.95 34.35 38.83 5.26 35.08 40.94 coo 72.66 13.38 32.85 71.79 14.81 34.24 10.88 44.65 41.79 13.01 44.54 41.32 coo 79.85 20.73 35.44 79.36 18.97 34.45 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 3 4 # 3 A 12 THR C 10 THR^? 8.48 O ACT B 304 A 25 TYR C 87 TYR^? 6.46 O ACT B 304 A 89 THR C 60 THR^? 4.85 CH3 ACT C 301 C 283 GLU C 89 GLU^? 9.21 CL CL C 203 coo 76.53 15.20 38.92 75.75 17.07 38.27 -1.75 47.62 42.43 -0.43 45.91 42.71 coo 78.55 20.90 39.91 77.09 20.09 37.68 2.28 47.86 39.06 2.71 45.79 40.92 coo 72.66 13.38 32.85 71.79 14.81 34.24 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 79.85 20.73 35.44 79.36 18.97 34.45 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 4 4 # 4 A 12 THR C 34 THR^? 4.17 OXT ACT C 301 A 25 TYR C 33 TYR.? -7.29 C ACT C 301s A 89 THR C 36 THR^? 10.76 OXT ACT C 301 C 283 GLU A 41 GLU.? 4.97 O ACT C 301 coo 76.53 15.20 38.92 75.75 17.07 38.27 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 78.55 20.90 39.91 77.09 20.09 37.68 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 72.66 13.38 32.85 71.79 14.81 34.24 -1.57 43.28 52.09 -0.86 42.09 50.37 coo 79.85 20.73 35.44 79.36 18.97 34.45 -13.23 45.29 51.30 -13.91 44.10 49.69 3eca_c06 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c06 naa= 4 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 1 4 # 1 B 12 THR A 10 THR^? 10.03 OXT ACT A 303 B 25 TYR A 87 TYR^? 7.71 OXT ACT C 301 B 89 THR A 60 THR^? -4.49 O ACT A 303s D 283 GLU A 89 GLU^? 9.05 CL CL A 201 coo 53.77 21.59 52.52 53.72 19.81 51.24 -4.20 33.48 42.66 -3.27 35.43 42.96 coo 52.81 15.60 53.32 51.72 16.94 51.12 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 50.67 24.88 46.55 52.16 23.30 46.40 0.42 28.72 42.47 -0.75 26.89 42.18 coo 48.21 16.39 52.49 47.84 18.39 51.92 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 2 4 # 2 B 12 THR B 10 THR^? 9.22 O ACT B 304 B 25 TYR B 87 TYR^? 7.07 OXT ACT A 303 B 89 THR B 60 THR^? -4.90 OXT ACT B 304s D 283 GLU B 89 GLU^? 9.16 CL CL B 202 coo 53.77 21.59 52.52 53.72 19.81 51.24 8.97 38.22 41.63 6.87 37.99 42.14 coo 52.81 15.60 53.32 51.72 16.94 51.12 6.95 34.35 38.83 5.26 35.08 40.94 coo 50.67 24.88 46.55 52.16 23.30 46.40 10.88 44.65 41.79 13.01 44.54 41.32 coo 48.21 16.39 52.49 47.84 18.39 51.92 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 3 4 # 3 B 12 THR C 10 THR^? 8.48 O ACT B 304 B 25 TYR C 87 TYR^? 6.46 O ACT B 304 B 89 THR C 60 THR^? 4.85 CH3 ACT C 301 D 283 GLU C 89 GLU^? 9.21 CL CL C 203 coo 53.77 21.59 52.52 53.72 19.81 51.24 -1.75 47.62 42.43 -0.43 45.91 42.71 coo 52.81 15.60 53.32 51.72 16.94 51.12 2.28 47.86 39.06 2.71 45.79 40.92 coo 50.67 24.88 46.55 52.16 23.30 46.40 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 48.21 16.39 52.49 47.84 18.39 51.92 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 4 4 # 4 B 12 THR C 34 THR^? 4.17 OXT ACT C 301 B 25 TYR C 33 TYR.? -7.29 C ACT C 301s B 89 THR C 36 THR^? 10.76 OXT ACT C 301 D 283 GLU A 41 GLU.? 4.97 O ACT C 301 coo 53.77 21.59 52.52 53.72 19.81 51.24 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 52.81 15.60 53.32 51.72 16.94 51.12 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 50.67 24.88 46.55 52.16 23.30 46.40 -1.57 43.28 52.09 -0.86 42.09 50.37 coo 48.21 16.39 52.49 47.84 18.39 51.92 -13.23 45.29 51.30 -13.91 44.10 49.69 3eca_c07 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c07 naa= 4 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP B 50 ASP.? 15.85 OXT ACT A 303 B 100 ARG A 47 ARG.? 21.65 CH3 ACT B 304 B 116 GLN A 54 GLN.? 18.54 OXT ACT C 301 coo 32.18 48.37 12.48 33.96 49.46 12.97 2.98 31.06 60.86 4.11 29.82 59.55 coo 39.04 43.25 11.37 38.30 45.35 13.56 1.93 40.93 64.24 4.88 41.80 64.42 coo 37.43 42.63 19.41 36.76 44.08 17.97 -6.26 37.47 60.50 -4.43 36.85 61.43 12as_c01 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 60 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 175 TYR A 33 TYR.? -7.37 CH3 ACT A 303s coo 46.10 28.27 19.27 45.48 26.99 20.84 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 56.42 28.06 12.93 55.01 27.92 14.50 2.98 31.06 60.86 4.11 29.82 59.55 coo 45.02 22.04 15.38 46.16 24.00 13.76 1.04 26.01 48.23 1.29 24.82 50.73 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 60 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 175 TYR A 33 TYR.? -7.37 CH3 ACT A 303s coo 46.10 28.27 19.27 45.48 26.99 20.84 4.59 21.37 51.97 2.75 21.07 50.95 coo 56.42 28.06 12.93 55.01 27.92 14.50 2.98 31.06 60.86 4.11 29.82 59.55 coo 45.02 22.04 15.38 46.16 24.00 13.76 1.04 26.01 48.23 1.29 24.82 50.73 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 76 GLU~? 14.44 O ACT A 302 A 60 ASP A 2 ASP.? 6.75 OXT ACT A 302 A 175 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 46.10 28.27 19.27 45.48 26.99 20.84 25.35 31.50 37.53 26.42 33.21 36.85 coo 56.42 28.06 12.93 55.01 27.92 14.50 16.13 27.42 32.13 14.80 25.81 31.83 coo 45.02 22.04 15.38 46.16 24.00 13.76 20.54 33.17 44.58 21.91 35.42 45.49 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 55 ASN^? 10.27 O ACT C 301 63 ARG A 39 ARG.? 13.42 OXT ACT C 301 255 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 44.36 11.24 3.39 41.81 12.78 4.00 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 55 ASN^? 10.27 O ACT C 301 63 ARG A 57 ARG^? 9.16 OXT ACT C 301 255 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 44.36 11.24 3.39 41.81 12.78 4.00 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 38.40 3.83 10.26 40.02 6.30 9.25 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN B 55 ASN^? 9.91 CH3 ACT A 303 63 ARG B 39 ARG.? 13.46 OXT ACT A 303 255 ARG B 57 ARG^? 10.43 O ACT B 304 coo 42.10 13.02 11.14 41.85 11.12 10.23 9.14 32.38 52.24 9.69 30.32 52.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 2.53 31.11 56.62 -0.26 29.95 56.31 coo 38.40 3.83 10.26 40.02 6.30 9.25 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 55 ASN^? 9.91 CH3 ACT A 303 63 ARG B 57 ARG^? 10.43 O ACT B 304 255 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 42.10 13.02 11.14 41.85 11.12 10.23 9.14 32.38 52.24 9.69 30.32 52.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 4.68 37.56 46.31 2.06 39.11 46.79 coo 38.40 3.83 10.26 40.02 6.30 9.25 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 55 ASN^? 9.91 CH3 ACT A 303 63 ARG B 57 ARG^? 10.43 O ACT B 304 255 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 42.10 13.02 11.14 41.85 11.12 10.23 9.14 32.38 52.24 9.69 30.32 52.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 4.68 37.56 46.31 2.06 39.11 46.79 coo 38.40 3.83 10.26 40.02 6.30 9.25 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN C 55 ASN^? 9.16 CH3 ACT B 304 63 ARG C 39 ARG.? 12.72 CH3 ACT B 304 255 ARG C 57 ARG^? 6.12 O ACT B 304 coo 42.10 13.02 11.14 41.85 11.12 10.23 4.32 50.30 52.50 5.90 51.72 52.50 coo 44.36 11.24 3.39 41.81 12.78 4.00 9.00 43.74 55.65 11.90 42.76 55.27 coo 38.40 3.83 10.26 40.02 6.30 9.25 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN C 55 ASN^? 9.16 CH3 ACT B 304 63 ARG C 57 ARG^? 6.12 O ACT B 304 255 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 42.10 13.02 11.14 41.85 11.12 10.23 4.32 50.30 52.50 5.90 51.72 52.50 coo 44.36 11.24 3.39 41.81 12.78 4.00 0.41 44.01 46.89 3.20 43.89 45.69 coo 38.40 3.83 10.26 40.02 6.30 9.25 9.00 43.74 55.65 11.90 42.76 55.27 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 7 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP B 50 ASP.? 15.85 OXT ACT A 303 187 GLU A 18 GLU~? 13.24 OXT ACT A 303 229 LYS A 19 LYS~? 20.51 O ACT A 303 coo -52.57 56.60 47.75 -51.52 54.87 46.95 2.98 31.06 60.86 4.11 29.82 59.55 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -3.59 27.39 54.08 -2.09 28.32 55.24 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -5.86 23.51 54.21 -8.85 19.33 56.46 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 1 hits 1ald_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER C 15 SER.? 16.03 CH3 ACT B 304 A 292 ASP A 50 ASP.? 19.58 O ACT C 301 A 322 HIS C 81 HIS.? 20.24 CH3 ACT B 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -0.02 52.59 55.50 0.94 52.38 57.70 coo 19.73 19.18 41.39 21.50 18.65 40.34 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 41.69 45.14 46.60 41.78 47.19 46.18 1.30 66.32 47.25 0.46 68.04 46.40 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 1 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER C 15 SER.? 16.03 CH3 ACT B 304 B 292 ASP A 50 ASP.? 19.58 O ACT C 301 B 322 HIS C 81 HIS.? 20.24 CH3 ACT B 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -0.02 52.59 55.50 0.94 52.38 57.70 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 48.81 64.16 26.34 49.30 62.16 26.73 1.30 66.32 47.25 0.46 68.04 46.40 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 1 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 47 ARG.? 21.65 CH3 ACT B 304 B 342 ASP A 50 ASP.? 19.58 O ACT C 301 B 531 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.93 40.93 64.24 4.88 41.80 64.42 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 47 ARG.? 21.65 CH3 ACT B 304 B 342 ASP B 50 ASP.? 15.85 OXT ACT A 303 B 531 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.93 40.93 64.24 4.88 41.80 64.42 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.98 31.06 60.86 4.11 29.82 59.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 47 ARG.? 21.65 CH3 ACT B 304 B 342 ASP B 50 ASP.? 15.85 OXT ACT A 303 B 531 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.93 40.93 64.24 4.88 41.80 64.42 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.98 31.06 60.86 4.11 29.82 59.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 9.00 43.74 55.65 11.90 42.76 55.27 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 3 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 47 ARG.? 21.65 CH3 ACT B 304 A 342 ASP A 50 ASP.? 19.58 O ACT C 301 A 531 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 1.93 40.93 64.24 4.88 41.80 64.42 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG C 39 ARG.? 12.72 CH3 ACT B 304 A 342 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 531 ARG B 57 ARG^? 10.43 O ACT B 304 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 9.00 43.74 55.65 11.90 42.76 55.27 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 2.98 31.06 60.86 4.11 29.82 59.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 4.68 37.56 46.31 2.06 39.11 46.79 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c01 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG C 39 ARG.? 12.72 CH3 ACT B 304 A 141 THR B 34 THR^? -4.05 O ACT B 304s A 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo 6.21 93.81 36.58 4.58 96.33 37.17 9.00 43.74 55.65 11.90 42.76 55.27 coo 6.80 92.87 28.33 4.91 92.74 27.40 8.80 45.53 47.76 6.89 46.40 47.31 coo 12.98 90.36 47.57 11.26 89.62 46.62 2.98 31.06 60.86 4.11 29.82 59.55 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG C 39 ARG.? 12.72 CH3 ACT B 304 D 141 THR B 34 THR^? -4.05 O ACT B 304s D 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo -8.33 92.80 100.06 -7.71 95.33 98.44 9.00 43.74 55.65 11.90 42.76 55.27 coo -9.24 93.49 108.77 -7.37 94.21 109.61 8.80 45.53 47.76 6.89 46.40 47.31 coo -14.64 87.74 89.51 -12.89 87.43 90.65 2.98 31.06 60.86 4.11 29.82 59.55 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG C 39 ARG.? 12.72 CH3 ACT B 304 C 141 THR B 34 THR^? -4.05 O ACT B 304s C 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo -5.79 67.26 36.83 -4.57 64.58 37.74 9.00 43.74 55.65 11.90 42.76 55.27 coo -6.81 68.31 28.28 -4.82 68.47 27.57 8.80 45.53 47.76 6.89 46.40 47.31 coo -13.01 70.96 47.58 -11.44 71.65 46.34 2.98 31.06 60.86 4.11 29.82 59.55 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 39 ARG.? 13.42 OXT ACT C 301 B 141 THR C 34 THR^? 4.17 OXT ACT C 301 B 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 8.28 67.78 108.81 6.22 67.65 109.43 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 14.55 73.52 89.47 12.81 73.95 90.56 2.98 31.06 60.86 4.11 29.82 59.55 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 57 ARG^? 9.16 OXT ACT C 301 B 141 THR C 34 THR^? 4.17 OXT ACT C 301 B 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo 8.13 67.41 100.27 7.18 68.35 97.45 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 14.55 73.52 89.47 12.81 73.95 90.56 2.98 31.06 60.86 4.11 29.82 59.55 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG C 39 ARG.? 12.72 CH3 ACT B 304 B 141 THR B 34 THR^? -4.05 O ACT B 304s B 235 ASP B 50 ASP.? 15.85 OXT ACT A 303 coo 8.13 67.41 100.27 7.18 68.35 97.45 9.00 43.74 55.65 11.90 42.76 55.27 coo 8.28 67.78 108.81 6.22 67.65 109.43 8.80 45.53 47.76 6.89 46.40 47.31 coo 14.55 73.52 89.47 12.81 73.95 90.56 2.98 31.06 60.86 4.11 29.82 59.55 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c03 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 23 GLU~? 17.46 O ACT A 303 A 503 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 537 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo 24.06 146.21 11.09 22.89 146.18 9.36 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 15.91 140.69 8.32 15.71 143.39 9.13 1.04 26.01 48.23 1.29 24.82 50.73 coo 16.65 144.44 13.24 18.34 145.22 12.33 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 23 GLU~? 17.46 O ACT A 303 A 503 TYR A 78 TYR~? 17.62 O ACT C 301 A 537 GLU A 24 GLU~? 16.57 O ACT A 303 coo 24.06 146.21 11.09 22.89 146.18 9.36 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 15.91 140.69 8.32 15.71 143.39 9.13 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU A 52 GLU.? 20.44 O ACT C 301 A 503 TYR A 82 TYR.? 16.37 O ACT C 301 A 537 GLU A 14 GLU^? 15.87 O ACT C 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 15.91 140.69 8.32 15.71 143.39 9.13 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 16.65 144.44 13.24 18.34 145.22 12.33 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 503 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 537 GLU A 89 GLU^? 9.05 CL CL A 201 coo 24.06 146.21 11.09 22.89 146.18 9.36 -0.06 34.24 44.69 1.54 35.69 44.88 coo 15.91 140.69 8.32 15.71 143.39 9.13 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 16.65 144.44 13.24 18.34 145.22 12.33 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU A 76 GLU~? 20.19 CL CL A 201 A 503 TYR A 78 TYR~? 17.62 O ACT C 301 A 537 GLU A 77 GLU~? 21.92 O ACT C 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 15.91 140.69 8.32 15.71 143.39 9.13 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 -16.08 22.27 46.45 -17.89 21.29 46.96 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU A 89 GLU^? 9.05 CL CL A 201 A 503 TYR C 87 TYR^? 6.46 O ACT B 304 A 537 GLU C 89 GLU^? 9.21 CL CL C 203 coo 24.06 146.21 11.09 22.89 146.18 9.36 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 15.91 140.69 8.32 15.71 143.39 9.13 2.28 47.86 39.06 2.71 45.79 40.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 503 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 537 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo 24.06 146.21 11.09 22.89 146.18 9.36 23.16 43.48 49.34 24.66 42.52 50.51 coo 15.91 140.69 8.32 15.71 143.39 9.13 13.49 45.92 47.42 14.68 46.48 49.90 coo 16.65 144.44 13.24 18.34 145.22 12.33 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 503 TYR B 78 TYR~? 17.24 CH3 ACT A 303 A 537 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 24.06 146.21 11.09 22.89 146.18 9.36 23.16 43.48 49.34 24.66 42.52 50.51 coo 15.91 140.69 8.32 15.71 143.39 9.13 20.54 33.17 44.58 21.91 35.42 45.49 coo 16.65 144.44 13.24 18.34 145.22 12.33 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 9 3 # 9 A 461 GLU B 59 GLU^? -6.17 O ACT B 304s A 503 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 537 GLU B 89 GLU^? 9.16 CL CL B 202 coo 24.06 146.21 11.09 22.89 146.18 9.36 6.72 41.22 43.91 4.75 41.83 44.25 coo 15.91 140.69 8.32 15.71 143.39 9.13 6.95 34.35 38.83 5.26 35.08 40.94 coo 16.65 144.44 13.24 18.34 145.22 12.33 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 10 3 # 10 A 461 GLU B 89 GLU^? 9.16 CL CL B 202 A 503 TYR C 87 TYR^? 6.46 O ACT B 304 A 537 GLU C 89 GLU^? 9.21 CL CL C 203 coo 24.06 146.21 11.09 22.89 146.18 9.36 3.69 38.42 36.29 2.58 38.79 38.06 coo 15.91 140.69 8.32 15.71 143.39 9.13 2.28 47.86 39.06 2.71 45.79 40.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 11 3 # 11 A 461 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 503 TYR C 33 TYR.? -7.29 C ACT C 301s A 537 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 15.91 140.69 8.32 15.71 143.39 9.13 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 16.65 144.44 13.24 18.34 145.22 12.33 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 12 3 # 12 A 461 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 503 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 537 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 15.91 140.69 8.32 15.71 143.39 9.13 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 16.65 144.44 13.24 18.34 145.22 12.33 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 13 3 # 13 A 461 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 503 TYR C 87 TYR^? 6.46 O ACT B 304 A 537 GLU C 89 GLU^? 9.21 CL CL C 203 coo 24.06 146.21 11.09 22.89 146.18 9.36 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 15.91 140.69 8.32 15.71 143.39 9.13 2.28 47.86 39.06 2.71 45.79 40.92 coo 16.65 144.44 13.24 18.34 145.22 12.33 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 14 3 # 14 A 461 GLU C 76 GLU~? 20.08 CL CL C 203 A 503 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 537 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 24.06 146.21 11.09 22.89 146.18 9.36 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 15.91 140.69 8.32 15.71 143.39 9.13 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 16.65 144.44 13.24 18.34 145.22 12.33 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 15 3 # 15 A 461 GLU C 89 GLU^? 9.21 CL CL C 203 A 503 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 537 GLU A 89 GLU^? 9.05 CL CL A 201 coo 24.06 146.21 11.09 22.89 146.18 9.36 0.03 43.20 36.88 0.18 41.91 38.57 coo 15.91 140.69 8.32 15.71 143.39 9.13 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 16.65 144.44 13.24 18.34 145.22 12.33 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 16 3 # 16 A 461 GLU C 89 GLU^? 9.21 CL CL C 203 A 503 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 537 GLU B 89 GLU^? 9.16 CL CL B 202 coo 24.06 146.21 11.09 22.89 146.18 9.36 0.03 43.20 36.88 0.18 41.91 38.57 coo 15.91 140.69 8.32 15.71 143.39 9.13 6.95 34.35 38.83 5.26 35.08 40.94 coo 16.65 144.44 13.24 18.34 145.22 12.33 3.69 38.42 36.29 2.58 38.79 38.06 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 16 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 23 GLU~? 17.46 O ACT A 303 A 504 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 540 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo 81.34 87.29 87.22 82.36 86.09 88.61 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 80.85 81.34 94.77 81.70 80.16 92.41 1.04 26.01 48.23 1.29 24.82 50.73 coo 79.94 80.46 88.84 81.11 81.36 87.27 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU A 52 GLU.? 20.44 O ACT C 301 A 504 TYR A 82 TYR.? 16.37 O ACT C 301 A 540 GLU A 14 GLU^? 15.87 O ACT C 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 80.85 81.34 94.77 81.70 80.16 92.41 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 79.94 80.46 88.84 81.11 81.36 87.27 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 81.34 87.29 87.22 82.36 86.09 88.61 -0.06 34.24 44.69 1.54 35.69 44.88 coo 80.85 81.34 94.77 81.70 80.16 92.41 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU A 76 GLU~? 20.19 CL CL A 201 A 504 TYR A 78 TYR~? 17.62 O ACT C 301 A 540 GLU A 77 GLU~? 21.92 O ACT C 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 80.85 81.34 94.77 81.70 80.16 92.41 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 -16.08 22.27 46.45 -17.89 21.29 46.96 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU A 89 GLU^? 9.05 CL CL A 201 A 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 540 GLU B 89 GLU^? 9.16 CL CL B 202 coo 81.34 87.29 87.22 82.36 86.09 88.61 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 80.85 81.34 94.77 81.70 80.16 92.41 6.95 34.35 38.83 5.26 35.08 40.94 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 504 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 540 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo 81.34 87.29 87.22 82.36 86.09 88.61 23.16 43.48 49.34 24.66 42.52 50.51 coo 80.85 81.34 94.77 81.70 80.16 92.41 13.49 45.92 47.42 14.68 46.48 49.90 coo 79.94 80.46 88.84 81.11 81.36 87.27 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU B 59 GLU^? -6.17 O ACT B 304s A 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 540 GLU B 89 GLU^? 9.16 CL CL B 202 coo 81.34 87.29 87.22 82.36 86.09 88.61 6.72 41.22 43.91 4.75 41.83 44.25 coo 80.85 81.34 94.77 81.70 80.16 92.41 6.95 34.35 38.83 5.26 35.08 40.94 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU B 89 GLU^? 9.16 CL CL B 202 A 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 81.34 87.29 87.22 82.36 86.09 88.61 3.69 38.42 36.29 2.58 38.79 38.06 coo 80.85 81.34 94.77 81.70 80.16 92.41 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 9 3 # 9 A 451 GLU B 89 GLU^? 9.16 CL CL B 202 A 504 TYR C 87 TYR^? 6.46 O ACT B 304 A 540 GLU C 89 GLU^? 9.21 CL CL C 203 coo 81.34 87.29 87.22 82.36 86.09 88.61 3.69 38.42 36.29 2.58 38.79 38.06 coo 80.85 81.34 94.77 81.70 80.16 92.41 2.28 47.86 39.06 2.71 45.79 40.92 coo 79.94 80.46 88.84 81.11 81.36 87.27 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 10 3 # 10 A 451 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 504 TYR C 33 TYR.? -7.29 C ACT C 301s A 540 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 80.85 81.34 94.77 81.70 80.16 92.41 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 11 3 # 11 A 451 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 504 TYR C 87 TYR^? 6.46 O ACT B 304 A 540 GLU C 89 GLU^? 9.21 CL CL C 203 coo 81.34 87.29 87.22 82.36 86.09 88.61 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 80.85 81.34 94.77 81.70 80.16 92.41 2.28 47.86 39.06 2.71 45.79 40.92 coo 79.94 80.46 88.84 81.11 81.36 87.27 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 12 3 # 12 A 451 GLU C 76 GLU~? 20.08 CL CL C 203 A 504 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 540 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 81.34 87.29 87.22 82.36 86.09 88.61 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 80.85 81.34 94.77 81.70 80.16 92.41 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 13 3 # 13 A 451 GLU C 89 GLU^? 9.21 CL CL C 203 A 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 81.34 87.29 87.22 82.36 86.09 88.61 0.03 43.20 36.88 0.18 41.91 38.57 coo 80.85 81.34 94.77 81.70 80.16 92.41 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 14 3 # 14 A 451 GLU C 89 GLU^? 9.21 CL CL C 203 A 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 540 GLU B 89 GLU^? 9.16 CL CL B 202 coo 81.34 87.29 87.22 82.36 86.09 88.61 0.03 43.20 36.88 0.18 41.91 38.57 coo 80.85 81.34 94.77 81.70 80.16 92.41 6.95 34.35 38.83 5.26 35.08 40.94 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.69 38.42 36.29 2.58 38.79 38.06 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 14 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 52 GLU.? 20.44 O ACT C 301 B 504 TYR A 82 TYR.? 16.37 O ACT C 301 B 540 GLU A 14 GLU^? 15.87 O ACT C 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 84.93 40.21 105.31 85.72 41.45 107.72 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 83.38 41.19 112.55 85.47 40.59 112.72 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 B 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 86.52 35.28 112.74 87.08 36.38 110.99 -0.06 34.24 44.69 1.54 35.69 44.88 coo 84.93 40.21 105.31 85.72 41.45 107.72 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 83.38 41.19 112.55 85.47 40.59 112.72 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 B 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 86.52 35.28 112.74 87.08 36.38 110.99 -0.06 34.24 44.69 1.54 35.69 44.88 coo 84.93 40.21 105.31 85.72 41.45 107.72 6.95 34.35 38.83 5.26 35.08 40.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU A 89 GLU^? 9.05 CL CL A 201 B 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 B 540 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 86.52 35.28 112.74 87.08 36.38 110.99 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 84.93 40.21 105.31 85.72 41.45 107.72 6.95 34.35 38.83 5.26 35.08 40.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU A 89 GLU^? 9.05 CL CL A 201 B 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 B 540 GLU B 89 GLU^? 9.16 CL CL B 202 coo 86.52 35.28 112.74 87.08 36.38 110.99 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 84.93 40.21 105.31 85.72 41.45 107.72 6.95 34.35 38.83 5.26 35.08 40.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU B 59 GLU^? -6.17 O ACT B 304s B 504 TYR B 87 TYR^? 7.07 OXT ACT A 303 B 540 GLU B 89 GLU^? 9.16 CL CL B 202 coo 86.52 35.28 112.74 87.08 36.38 110.99 6.72 41.22 43.91 4.75 41.83 44.25 coo 84.93 40.21 105.31 85.72 41.45 107.72 6.95 34.35 38.83 5.26 35.08 40.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 7 3 # 7 B 451 GLU B 89 GLU^? 9.16 CL CL B 202 B 504 TYR C 87 TYR^? 6.46 O ACT B 304 B 540 GLU B 59 GLU^? -6.17 O ACT B 304s coo 86.52 35.28 112.74 87.08 36.38 110.99 3.69 38.42 36.29 2.58 38.79 38.06 coo 84.93 40.21 105.31 85.72 41.45 107.72 2.28 47.86 39.06 2.71 45.79 40.92 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 8 3 # 8 B 451 GLU B 89 GLU^? 9.16 CL CL B 202 B 504 TYR C 87 TYR^? 6.46 O ACT B 304 B 540 GLU C 89 GLU^? 9.21 CL CL C 203 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.69 38.42 36.29 2.58 38.79 38.06 coo 84.93 40.21 105.31 85.72 41.45 107.72 2.28 47.86 39.06 2.71 45.79 40.92 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 9 3 # 9 B 451 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 504 TYR C 87 TYR^? 6.46 O ACT B 304 B 540 GLU C 89 GLU^? 9.21 CL CL C 203 coo 86.52 35.28 112.74 87.08 36.38 110.99 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 84.93 40.21 105.31 85.72 41.45 107.72 2.28 47.86 39.06 2.71 45.79 40.92 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 10 3 # 10 B 451 GLU C 76 GLU~? 20.08 CL CL C 203 B 504 TYR C 78 TYR~? 17.53 CH3 ACT B 304 B 540 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 84.93 40.21 105.31 85.72 41.45 107.72 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 83.38 41.19 112.55 85.47 40.59 112.72 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 11 3 # 11 B 451 GLU C 89 GLU^? 9.21 CL CL C 203 B 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 B 540 GLU A 89 GLU^? 9.05 CL CL A 201 coo 86.52 35.28 112.74 87.08 36.38 110.99 0.03 43.20 36.88 0.18 41.91 38.57 coo 84.93 40.21 105.31 85.72 41.45 107.72 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 83.38 41.19 112.55 85.47 40.59 112.72 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 12 3 # 12 B 451 GLU C 89 GLU^? 9.21 CL CL C 203 B 504 TYR A 87 TYR^? 7.71 OXT ACT C 301 B 540 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 86.52 35.28 112.74 87.08 36.38 110.99 0.03 43.20 36.88 0.18 41.91 38.57 coo 84.93 40.21 105.31 85.72 41.45 107.72 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 83.38 41.19 112.55 85.47 40.59 112.72 -3.08 44.06 44.69 -2.35 42.14 45.23 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 12 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 20 ARG~? 20.10 O ACT A 303 A 451 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 540 GLU A 23 GLU~? 17.46 O ACT A 303 coo 79.04 80.20 80.81 79.58 81.40 83.63 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 81.34 87.29 87.22 82.36 86.09 88.61 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 20 ARG~? 20.10 O ACT A 303 A 451 GLU A 24 GLU~? 16.57 O ACT A 303 A 540 GLU A 23 GLU~? 17.46 O ACT A 303 coo 79.04 80.20 80.81 79.58 81.40 83.63 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 81.34 87.29 87.22 82.36 86.09 88.61 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 20 ARG~? 20.10 O ACT A 303 A 451 GLU A 24 GLU~? 16.57 O ACT A 303 A 540 GLU A 77 GLU~? 21.92 O ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 81.34 87.29 87.22 82.36 86.09 88.61 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 79.94 80.46 88.84 81.11 81.36 87.27 -16.08 22.27 46.45 -17.89 21.29 46.96 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 451 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 540 GLU B 23 GLU~? 17.74 CH3 ACT B 304 coo 79.04 80.20 80.81 79.58 81.40 83.63 23.59 35.51 49.80 23.38 33.40 52.03 coo 81.34 87.29 87.22 82.36 86.09 88.61 15.35 40.93 52.66 14.20 41.89 54.18 coo 79.94 80.46 88.84 81.11 81.36 87.27 23.16 43.48 49.34 24.66 42.52 50.51 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 451 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 540 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 79.04 80.20 80.81 79.58 81.40 83.63 23.59 35.51 49.80 23.38 33.40 52.03 coo 81.34 87.29 87.22 82.36 86.09 88.61 23.16 43.48 49.34 24.66 42.52 50.51 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 451 GLU B 77 GLU~? 17.82 O ACT A 302 A 540 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 79.04 80.20 80.81 79.58 81.40 83.63 23.59 35.51 49.80 23.38 33.40 52.03 coo 81.34 87.29 87.22 82.36 86.09 88.61 25.37 33.50 41.00 25.99 35.47 41.49 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 540 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 79.94 80.46 88.84 81.11 81.36 87.27 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 540 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 79.94 80.46 88.84 81.11 81.36 87.27 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 10 3 # 10 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 540 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 79.94 80.46 88.84 81.11 81.36 87.27 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 11 3 # 11 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 540 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 79.94 80.46 88.84 81.11 81.36 87.27 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 12 3 # 12 A 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 451 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 79.94 80.46 88.84 81.11 81.36 87.27 -8.82 58.42 44.81 -9.22 60.41 45.38 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 12 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 20 ARG~? 20.10 O ACT A 303 B 451 GLU A 24 GLU~? 16.57 O ACT A 303 B 540 GLU A 23 GLU~? 17.46 O ACT A 303 coo 82.21 41.07 119.14 83.95 40.66 116.59 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 86.52 35.28 112.74 87.08 36.38 110.99 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 83.38 41.19 112.55 85.47 40.59 112.72 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 20 ARG~? 20.10 O ACT A 303 B 451 GLU A 24 GLU~? 16.57 O ACT A 303 B 540 GLU A 77 GLU~? 21.92 O ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 86.52 35.28 112.74 87.08 36.38 110.99 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 83.38 41.19 112.55 85.47 40.59 112.72 -16.08 22.27 46.45 -17.89 21.29 46.96 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG A 27 ARG~? 17.50 O ACT A 303 B 451 GLU A 23 GLU~? 17.46 O ACT A 303 B 540 GLU A 24 GLU~? 16.57 O ACT A 303 coo 82.21 41.07 119.14 83.95 40.66 116.59 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 83.38 41.19 112.55 85.47 40.59 112.72 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG A 27 ARG~? 17.50 O ACT A 303 B 451 GLU A 77 GLU~? 21.92 O ACT C 301 B 540 GLU A 24 GLU~? 16.57 O ACT A 303 coo 82.21 41.07 119.14 83.95 40.66 116.59 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 83.38 41.19 112.55 85.47 40.59 112.72 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG B 20 ARG~? 20.55 CH3 ACT A 303 B 451 GLU B 23 GLU~? 17.74 CH3 ACT B 304 B 540 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 82.21 41.07 119.14 83.95 40.66 116.59 23.59 35.51 49.80 23.38 33.40 52.03 coo 86.52 35.28 112.74 87.08 36.38 110.99 23.16 43.48 49.34 24.66 42.52 50.51 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG B 20 ARG~? 20.55 CH3 ACT A 303 B 451 GLU B 77 GLU~? 17.82 O ACT A 302 B 540 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 82.21 41.07 119.14 83.95 40.66 116.59 23.59 35.51 49.80 23.38 33.40 52.03 coo 86.52 35.28 112.74 87.08 36.38 110.99 25.37 33.50 41.00 25.99 35.47 41.49 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG B 27 ARG~? 17.68 OXT ACT B 304 B 451 GLU B 77 GLU~? 17.82 O ACT A 302 B 540 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 82.21 41.07 119.14 83.95 40.66 116.59 26.02 42.58 42.38 25.84 41.49 45.27 coo 86.52 35.28 112.74 87.08 36.38 110.99 25.37 33.50 41.00 25.99 35.47 41.49 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG B 57 ARG^? 10.43 O ACT B 304 B 451 GLU A 89 GLU^? 9.05 CL CL A 201 B 540 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 82.21 41.07 119.14 83.95 40.66 116.59 4.68 37.56 46.31 2.06 39.11 46.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 9 3 # 9 B 382 ARG B 57 ARG^? 10.43 O ACT B 304 B 451 GLU B 89 GLU^? 9.16 CL CL B 202 B 540 GLU B 59 GLU^? -6.17 O ACT B 304s coo 82.21 41.07 119.14 83.95 40.66 116.59 4.68 37.56 46.31 2.06 39.11 46.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.69 38.42 36.29 2.58 38.79 38.06 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 10 3 # 10 B 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 B 451 GLU C 23 GLU~? 17.30 CH3 ACT C 301 B 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 86.52 35.28 112.74 87.08 36.38 110.99 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 11 3 # 11 B 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 B 451 GLU C 24 GLU~? 16.74 CH3 ACT C 301 B 540 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 86.52 35.28 112.74 87.08 36.38 110.99 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 83.38 41.19 112.55 85.47 40.59 112.72 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 12 3 # 12 B 382 ARG C 20 ARG~? 20.69 CH3 ACT B 304 B 451 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 86.52 35.28 112.74 87.08 36.38 110.99 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 13 3 # 13 B 382 ARG C 27 ARG~? 17.31 CH3 ACT C 301 B 451 GLU C 23 GLU~? 17.30 CH3 ACT C 301 B 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 86.52 35.28 112.74 87.08 36.38 110.99 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 14 3 # 14 B 382 ARG C 27 ARG~? 17.31 CH3 ACT C 301 B 451 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 540 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 86.52 35.28 112.74 87.08 36.38 110.99 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.82 58.42 44.81 -9.22 60.41 45.38 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 14 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 27 ARG~? 17.50 O ACT A 303 183 LYS A 31 LYS.? 10.36 O ACT A 303 317 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.36 21.23 42.37 3.31 17.75 38.68 coo 65.21 120.62 58.76 63.62 123.14 59.66 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 27 ARG~? 17.50 O ACT A 303 183 LYS A 31 LYS.? 10.36 O ACT A 303 317 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 76.57 109.19 73.41 73.86 110.26 72.16 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.36 21.23 42.37 3.31 17.75 38.68 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 57 ARG^? 9.16 OXT ACT C 301 183 LYS A 7 LYS^? -3.09 CL CL A 201s 317 ARG A 27 ARG~? 17.50 O ACT A 303 coo 76.57 109.19 73.41 73.86 110.26 72.16 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.17 30.56 34.55 -1.45 32.28 29.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 57 ARG^? 9.16 OXT ACT C 301 183 LYS A 7 LYS^? -3.09 CL CL A 201s 317 ARG A 73 ARG~? 20.11 O ACT A 303 coo 76.57 109.19 73.41 73.86 110.26 72.16 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.17 30.56 34.55 -1.45 32.28 29.77 coo 65.21 120.62 58.76 63.62 123.14 59.66 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG A 69 ARG~? 15.12 O ACT A 303 183 LYS A 31 LYS.? 10.36 O ACT A 303 317 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -7.70 19.34 36.48 -5.54 18.45 34.49 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.36 21.23 42.37 3.31 17.75 38.68 coo 65.21 120.62 58.76 63.62 123.14 59.66 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG A 73 ARG~? 20.11 O ACT A 303 183 LYS A 26 LYS~? 7.74 CH3 ACT A 303 317 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 82.09 117.51 66.37 80.60 114.32 71.44 -2.24 19.72 44.66 2.39 20.87 47.23 coo 65.21 120.62 58.76 63.62 123.14 59.66 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG A 73 ARG~? 20.11 O ACT A 303 183 LYS A 26 LYS~? 7.74 CH3 ACT A 303 317 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 76.57 109.19 73.41 73.86 110.26 72.16 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 82.09 117.51 66.37 80.60 114.32 71.44 -2.24 19.72 44.66 2.39 20.87 47.23 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG B 27 ARG~? 17.68 OXT ACT B 304 183 LYS B 31 LYS.? 11.57 OXT ACT B 304 317 ARG B 57 ARG^? 10.43 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 26.02 42.58 42.38 25.84 41.49 45.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.94 50.91 41.57 17.07 55.01 36.93 coo 65.21 120.62 58.76 63.62 123.14 59.66 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG B 27 ARG~? 17.68 OXT ACT B 304 183 LYS B 31 LYS.? 11.57 OXT ACT B 304 317 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 26.02 42.58 42.38 25.84 41.49 45.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.94 50.91 41.57 17.07 55.01 36.93 coo 65.21 120.62 58.76 63.62 123.14 59.66 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG B 69 ARG~? 14.94 O ACT A 302 183 LYS B 26 LYS~? 10.63 CH3 ACT B 304 317 ARG B 57 ARG^? 10.43 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 22.62 42.29 33.58 21.65 45.19 33.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 20.18 46.61 43.20 19.00 49.55 48.67 coo 65.21 120.62 58.76 63.62 123.14 59.66 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG B 69 ARG~? 14.94 O ACT A 302 183 LYS B 31 LYS.? 11.57 OXT ACT B 304 317 ARG B 57 ARG^? 10.43 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 22.62 42.29 33.58 21.65 45.19 33.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.94 50.91 41.57 17.07 55.01 36.93 coo 65.21 120.62 58.76 63.62 123.14 59.66 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG B 73 ARG~? 16.43 O ACT A 302 183 LYS B 26 LYS~? 10.63 CH3 ACT B 304 317 ARG B 57 ARG^? 10.43 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 24.09 36.62 39.81 25.66 39.04 38.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 20.18 46.61 43.20 19.00 49.55 48.67 coo 65.21 120.62 58.76 63.62 123.14 59.66 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG B 73 ARG~? 16.43 O ACT A 302 183 LYS B 26 LYS~? 10.63 CH3 ACT B 304 317 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 24.09 36.62 39.81 25.66 39.04 38.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 20.18 46.61 43.20 19.00 49.55 48.67 coo 65.21 120.62 58.76 63.62 123.14 59.66 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG C 27 ARG~? 17.31 CH3 ACT C 301 183 LYS C 31 LYS.? 9.88 CH3 ACT C 301 317 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 65.21 120.62 58.76 63.62 123.14 59.66 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 15 3 # 15 118 ARG C 27 ARG~? 17.31 CH3 ACT C 301 183 LYS C 31 LYS.? 9.88 CH3 ACT C 301 317 ARG C 57 ARG^? 6.12 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 65.21 120.62 58.76 63.62 123.14 59.66 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 16 3 # 16 118 ARG C 57 ARG^? 6.12 O ACT B 304 183 LYS C 7 LYS^? -3.09 CL CL C 203s 317 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 0.41 44.01 46.89 3.20 43.89 45.69 coo 82.09 117.51 66.37 80.60 114.32 71.44 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 5.02 60.48 36.40 3.75 63.08 35.35 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 17 3 # 17 118 ARG C 57 ARG^? 6.12 O ACT B 304 183 LYS C 7 LYS^? -3.09 CL CL C 203s 317 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 0.41 44.01 46.89 3.20 43.89 45.69 coo 82.09 117.51 66.37 80.60 114.32 71.44 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 18 3 # 18 118 ARG C 57 ARG^? 6.12 O ACT B 304 183 LYS C 7 LYS^? -3.09 CL CL C 203s 317 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 0.41 44.01 46.89 3.20 43.89 45.69 coo 82.09 117.51 66.37 80.60 114.32 71.44 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 19 3 # 19 118 ARG C 69 ARG~? 14.72 CH3 ACT C 301 183 LYS C 31 LYS.? 9.88 CH3 ACT C 301 317 ARG C 57 ARG^? 6.12 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 -12.96 57.05 36.96 -15.23 55.68 35.39 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 65.21 120.62 58.76 63.62 123.14 59.66 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 20 3 # 20 118 ARG C 73 ARG~? 19.49 CH3 ACT C 301 183 LYS C 26 LYS~? 10.00 O ACT C 301 317 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 65.21 120.62 58.76 63.62 123.14 59.66 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 21 3 # 21 118 ARG C 73 ARG~? 19.49 CH3 ACT C 301 183 LYS C 26 LYS~? 10.00 O ACT C 301 317 ARG C 57 ARG^? 6.12 O ACT B 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 65.21 120.62 58.76 63.62 123.14 59.66 0.41 44.01 46.89 3.20 43.89 45.69 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 21 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 20 ARG~? 20.10 O ACT A 303 A 128 GLU A 24 GLU~? 16.57 O ACT A 303 A 225 GLU A 77 GLU~? 21.92 O ACT C 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 36.48 24.43 22.02 36.86 26.34 21.13 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 40.16 23.71 17.01 38.52 24.96 17.40 -16.08 22.27 46.45 -17.89 21.29 46.96 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 27 ARG~? 17.50 O ACT A 303 A 128 GLU A 23 GLU~? 17.46 O ACT A 303 A 225 GLU A 24 GLU~? 16.57 O ACT A 303 coo 38.56 19.11 14.83 37.12 21.00 16.76 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 36.48 24.43 22.02 36.86 26.34 21.13 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 40.16 23.71 17.01 38.52 24.96 17.40 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG A 27 ARG~? 17.50 O ACT A 303 A 128 GLU A 77 GLU~? 21.92 O ACT C 301 A 225 GLU A 24 GLU~? 16.57 O ACT A 303 coo 38.56 19.11 14.83 37.12 21.00 16.76 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 36.48 24.43 22.02 36.86 26.34 21.13 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 40.16 23.71 17.01 38.52 24.96 17.40 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 128 GLU A 89 GLU^? 9.05 CL CL A 201 A 225 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 38.56 19.11 14.83 37.12 21.00 16.76 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 36.48 24.43 22.02 36.86 26.34 21.13 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 40.16 23.71 17.01 38.52 24.96 17.40 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 128 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 225 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 38.56 19.11 14.83 37.12 21.00 16.76 23.59 35.51 49.80 23.38 33.40 52.03 coo 36.48 24.43 22.02 36.86 26.34 21.13 23.16 43.48 49.34 24.66 42.52 50.51 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 128 GLU B 77 GLU~? 17.82 O ACT A 302 A 225 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 38.56 19.11 14.83 37.12 21.00 16.76 23.59 35.51 49.80 23.38 33.40 52.03 coo 36.48 24.43 22.02 36.86 26.34 21.13 25.37 33.50 41.00 25.99 35.47 41.49 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bqc_c01 BETA-MANNANASE user 7 3 # 7 A 50 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 128 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 225 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 38.56 19.11 14.83 37.12 21.00 16.76 26.02 42.58 42.38 25.84 41.49 45.27 coo 36.48 24.43 22.02 36.86 26.34 21.13 23.16 43.48 49.34 24.66 42.52 50.51 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bqc_c01 BETA-MANNANASE user 8 3 # 8 A 50 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 128 GLU B 77 GLU~? 17.82 O ACT A 302 A 225 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 38.56 19.11 14.83 37.12 21.00 16.76 26.02 42.58 42.38 25.84 41.49 45.27 coo 36.48 24.43 22.02 36.86 26.34 21.13 25.37 33.50 41.00 25.99 35.47 41.49 coo 40.16 23.71 17.01 38.52 24.96 17.40 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1bqc_c01 BETA-MANNANASE user 9 3 # 9 A 50 ARG B 57 ARG^? 10.43 O ACT B 304 A 128 GLU A 89 GLU^? 9.05 CL CL A 201 A 225 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 38.56 19.11 14.83 37.12 21.00 16.76 4.68 37.56 46.31 2.06 39.11 46.79 coo 36.48 24.43 22.02 36.86 26.34 21.13 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 40.16 23.71 17.01 38.52 24.96 17.40 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1bqc_c01 BETA-MANNANASE user 10 3 # 10 A 50 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 128 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 225 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 36.48 24.43 22.02 36.86 26.34 21.13 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 40.16 23.71 17.01 38.52 24.96 17.40 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1bqc_c01 BETA-MANNANASE user 11 3 # 11 A 50 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 128 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 225 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 36.48 24.43 22.02 36.86 26.34 21.13 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 40.16 23.71 17.01 38.52 24.96 17.40 -8.82 58.42 44.81 -9.22 60.41 45.38 1bqc_c01 source 1bqc BETA-MANNANASE : 11 hits 1bqc_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 21.85 34.47 33.37 22.73 35.25 31.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.52 35.79 35.35 13.45 36.35 35.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 21.85 34.47 33.37 22.73 35.25 31.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.52 35.79 35.35 13.45 36.35 35.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 74 LEU~? 14.12 O ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 21.85 34.47 33.37 22.73 35.25 31.58 coo 38.58 45.09 70.44 38.28 45.21 72.59 17.71 34.11 40.40 16.81 35.58 41.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 19.05 29.20 35.92 18.84 29.16 33.81 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.52 35.79 35.35 13.45 36.35 35.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 19.05 29.20 35.92 18.84 29.16 33.81 coo 38.58 45.09 70.44 38.28 45.21 72.59 15.52 35.79 35.35 13.45 36.35 35.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 74 LEU~? 14.12 O ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 43.58 43.67 66.73 42.32 42.78 68.15 19.05 29.20 35.92 18.84 29.16 33.81 coo 38.58 45.09 70.44 38.28 45.21 72.59 17.71 34.11 40.40 16.81 35.58 41.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN C 72 GLN~? 16.20 CL CL C 203 A 91 LEU C 74 LEU~? 14.40 O ACT B 304 A 133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 -5.94 60.87 35.09 -4.45 61.30 33.63 coo 38.58 45.09 70.44 38.28 45.21 72.59 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 75 GLN~? 16.24 CL CL C 203 A 91 LEU C 74 LEU~? 14.40 O ACT B 304 A 133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 0.56 61.05 37.01 0.50 60.83 34.89 coo 38.58 45.09 70.44 38.28 45.21 72.59 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 -5.84 64.35 43.42 -7.71 63.68 44.17 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 8 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 72 GLN~? 8.59 O ACT A 302 B 591 LEU B 71 LEU~? 9.02 CH3 ACT A 302 B 633 GLU B 76 GLU~? 14.44 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 21.85 34.47 33.37 22.73 35.25 31.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.52 35.79 35.35 13.45 36.35 35.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 72 GLN~? 8.59 O ACT A 302 B 591 LEU B 71 LEU~? 9.02 CH3 ACT A 302 B 633 GLU B 77 GLU~? 17.82 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 21.85 34.47 33.37 22.73 35.25 31.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.52 35.79 35.35 13.45 36.35 35.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 72 GLN~? 8.59 O ACT A 302 B 591 LEU B 74 LEU~? 14.12 O ACT A 302 B 633 GLU B 76 GLU~? 14.44 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 21.85 34.47 33.37 22.73 35.25 31.58 coo 86.70 48.66 52.61 87.15 48.69 50.51 17.71 34.11 40.40 16.81 35.58 41.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 75 GLN~? 7.58 OXT ACT A 302 B 591 LEU B 71 LEU~? 9.02 CH3 ACT A 302 B 633 GLU B 76 GLU~? 14.44 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 19.05 29.20 35.92 18.84 29.16 33.81 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.52 35.79 35.35 13.45 36.35 35.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 75 GLN~? 7.58 OXT ACT A 302 B 591 LEU B 71 LEU~? 9.02 CH3 ACT A 302 B 633 GLU B 77 GLU~? 17.82 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 19.05 29.20 35.92 18.84 29.16 33.81 coo 86.70 48.66 52.61 87.15 48.69 50.51 15.52 35.79 35.35 13.45 36.35 35.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 75 GLN~? 7.58 OXT ACT A 302 B 591 LEU B 74 LEU~? 14.12 O ACT A 302 B 633 GLU B 76 GLU~? 14.44 O ACT A 302 coo 88.06 44.34 57.19 89.06 45.53 55.74 19.05 29.20 35.92 18.84 29.16 33.81 coo 86.70 48.66 52.61 87.15 48.69 50.51 17.71 34.11 40.40 16.81 35.58 41.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN C 72 GLN~? 16.20 CL CL C 203 B 591 LEU C 74 LEU~? 14.40 O ACT B 304 B 633 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 -5.94 60.87 35.09 -4.45 61.30 33.63 coo 86.70 48.66 52.61 87.15 48.69 50.51 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN C 75 GLN~? 16.24 CL CL C 203 B 591 LEU C 74 LEU~? 14.40 O ACT B 304 B 633 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 0.56 61.05 37.01 0.50 60.83 34.89 coo 86.70 48.66 52.61 87.15 48.69 50.51 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 -5.84 64.35 43.42 -7.71 63.68 44.17 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 8 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN B 72 GLN~? 8.59 O ACT A 302 C1091 LEU B 71 LEU~? 9.02 CH3 ACT A 302 C1133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 21.85 34.47 33.37 22.73 35.25 31.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.52 35.79 35.35 13.45 36.35 35.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 72 GLN~? 8.59 O ACT A 302 C1091 LEU B 71 LEU~? 9.02 CH3 ACT A 302 C1133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 21.85 34.47 33.37 22.73 35.25 31.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.52 35.79 35.35 13.45 36.35 35.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 72 GLN~? 8.59 O ACT A 302 C1091 LEU B 74 LEU~? 14.12 O ACT A 302 C1133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 21.85 34.47 33.37 22.73 35.25 31.58 coo 65.83 38.95 47.05 65.46 38.90 49.20 17.71 34.11 40.40 16.81 35.58 41.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 75 GLN~? 7.58 OXT ACT A 302 C1091 LEU B 71 LEU~? 9.02 CH3 ACT A 302 C1133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 19.05 29.20 35.92 18.84 29.16 33.81 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.52 35.79 35.35 13.45 36.35 35.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 75 GLN~? 7.58 OXT ACT A 302 C1091 LEU B 71 LEU~? 9.02 CH3 ACT A 302 C1133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 19.05 29.20 35.92 18.84 29.16 33.81 coo 65.83 38.95 47.05 65.46 38.90 49.20 15.52 35.79 35.35 13.45 36.35 35.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 75 GLN~? 7.58 OXT ACT A 302 C1091 LEU B 74 LEU~? 14.12 O ACT A 302 C1133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 68.29 34.44 43.03 66.67 34.74 44.37 19.05 29.20 35.92 18.84 29.16 33.81 coo 65.83 38.95 47.05 65.46 38.90 49.20 17.71 34.11 40.40 16.81 35.58 41.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN C 72 GLN~? 16.20 CL CL C 203 C1091 LEU C 71 LEU~? 10.30 CL CL C 203 C1133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 -5.94 60.87 35.09 -4.45 61.30 33.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.53 54.72 36.68 -2.83 52.69 36.89 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN C 72 GLN~? 16.20 CL CL C 203 C1091 LEU C 74 LEU~? 14.40 O ACT B 304 C1133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 -5.94 60.87 35.09 -4.45 61.30 33.63 coo 65.83 38.95 47.05 65.46 38.90 49.20 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN C 75 GLN~? 16.24 CL CL C 203 C1091 LEU C 71 LEU~? 10.30 CL CL C 203 C1133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 0.56 61.05 37.01 0.50 60.83 34.89 coo 65.83 38.95 47.05 65.46 38.90 49.20 -3.53 54.72 36.68 -2.83 52.69 36.89 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN C 75 GLN~? 16.24 CL CL C 203 C1091 LEU C 74 LEU~? 14.40 O ACT B 304 C1133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 0.56 61.05 37.01 0.50 60.83 34.89 coo 65.83 38.95 47.05 65.46 38.90 49.20 -2.51 57.28 41.48 -3.24 55.67 42.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.84 64.35 43.42 -7.71 63.68 44.17 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 10 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 21.85 34.47 33.37 22.73 35.25 31.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.52 35.79 35.35 13.45 36.35 35.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 21.85 34.47 33.37 22.73 35.25 31.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.52 35.79 35.35 13.45 36.35 35.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 72 GLN~? 8.59 O ACT A 302 A 91 LEU B 74 LEU~? 14.12 O ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 21.85 34.47 33.37 22.73 35.25 31.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 17.71 34.11 40.40 16.81 35.58 41.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 19.05 29.20 35.92 18.84 29.16 33.81 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.52 35.79 35.35 13.45 36.35 35.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 71 LEU~? 9.02 CH3 ACT A 302 A 133 GLU B 77 GLU~? 17.82 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 19.05 29.20 35.92 18.84 29.16 33.81 coo 35.40 53.22 73.30 35.37 54.87 74.74 15.52 35.79 35.35 13.45 36.35 35.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.37 33.50 41.00 25.99 35.47 41.49 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 91 LEU B 74 LEU~? 14.12 O ACT A 302 A 133 GLU B 76 GLU~? 14.44 O ACT A 302 coo 38.23 53.34 67.59 38.84 53.87 69.56 19.05 29.20 35.92 18.84 29.16 33.81 coo 35.40 53.22 73.30 35.37 54.87 74.74 17.71 34.11 40.40 16.81 35.58 41.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 25.35 31.50 37.53 26.42 33.21 36.85 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN C 72 GLN~? 16.20 CL CL C 203 A 91 LEU C 71 LEU~? 10.30 CL CL C 203 A 133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 -5.94 60.87 35.09 -4.45 61.30 33.63 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.53 54.72 36.68 -2.83 52.69 36.89 coo 45.08 56.04 70.60 43.15 55.19 70.77 -5.84 64.35 43.42 -7.71 63.68 44.17 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 75 GLN~? 16.24 CL CL C 203 A 91 LEU C 71 LEU~? 10.30 CL CL C 203 A 133 GLU C 77 GLU~? 20.13 CH3 ACT C 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 0.56 61.05 37.01 0.50 60.83 34.89 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.53 54.72 36.68 -2.83 52.69 36.89 coo 45.08 56.04 70.60 43.15 55.19 70.77 -5.84 64.35 43.42 -7.71 63.68 44.17 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 8 hits 1bsj_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 14 GLU^? 15.87 O ACT C 301 A 65 ARG A 20 ARG~? 20.10 O ACT A 303 A 85 HIS A 81 HIS.? 19.43 O ACT C 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -12.43 31.41 55.22 -14.25 31.05 56.29 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -12.34 22.00 52.71 -13.61 20.80 50.18 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -20.82 26.38 49.60 -21.72 24.86 48.45 1c54_c00 source 1c54 RIBONUCLEASE SA : 1 hits 1c54_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 81 HIS.? 19.43 O ACT C 301 A 408 TYR A 78 TYR~? 17.62 O ACT C 301 A 480 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -13.80 26.13 47.19 -12.59 23.74 48.01 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 81 HIS.? 19.43 O ACT C 301 A 408 TYR A 78 TYR~? 17.62 O ACT C 301 A 480 ARG A 69 ARG~? 15.12 O ACT A 303 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -13.80 26.13 47.19 -12.59 23.74 48.01 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS A 81 HIS.? 19.43 O ACT C 301 A 408 TYR A 82 TYR.? 16.37 O ACT C 301 A 480 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -16.19 29.33 51.63 -16.36 27.05 53.19 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS B 81 HIS.? 19.26 CH3 ACT A 303 A 408 TYR B 78 TYR~? 17.24 CH3 ACT A 303 A 480 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 24.07 26.52 45.84 25.63 26.47 44.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 20.54 33.17 44.58 21.91 35.42 45.49 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1c82_c02 HYALURONATE LYASE user 5 3 # 5 A 399 HIS B 81 HIS.? 19.26 CH3 ACT A 303 A 408 TYR B 78 TYR~? 17.24 CH3 ACT A 303 A 480 ARG B 69 ARG~? 14.94 O ACT A 302 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 24.07 26.52 45.84 25.63 26.47 44.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 20.54 33.17 44.58 21.91 35.42 45.49 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1c82_c02 HYALURONATE LYASE user 6 3 # 6 A 399 HIS B 81 HIS.? 19.26 CH3 ACT A 303 A 408 TYR B 82 TYR.? 16.39 CH3 ACT A 303 A 480 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 24.07 26.52 45.84 25.63 26.47 44.45 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 19.70 29.01 48.72 22.05 29.62 50.09 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1c82_c02 HYALURONATE LYASE user 7 3 # 7 A 399 HIS C 81 HIS.? 20.24 CH3 ACT B 304 A 408 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 480 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 1.30 66.32 47.25 0.46 68.04 46.40 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -2.76 60.08 45.99 -5.32 60.21 47.12 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1c82_c02 HYALURONATE LYASE user 8 3 # 8 A 399 HIS C 81 HIS.? 20.24 CH3 ACT B 304 A 408 TYR C 82 TYR.? 16.78 CH3 ACT B 304 A 480 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 1.30 66.32 47.25 0.46 68.04 46.40 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 1.46 61.13 49.70 -0.36 62.80 51.06 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 0.41 44.01 46.89 3.20 43.89 45.69 1c82_c02 source 1c82 HYALURONATE LYASE : 8 hits 1c82_c02 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 57 ARG^? 9.16 OXT ACT C 301 127 ARG B 57 ARG^? 10.43 O ACT B 304 270 GLU C 89 GLU^? 9.21 CL CL C 203 coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 4.68 37.56 46.31 2.06 39.11 46.79 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 57 ARG^? 9.16 OXT ACT C 301 127 ARG C 57 ARG^? 6.12 O ACT B 304 270 GLU A 41 GLU.? 4.97 O ACT C 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 0.41 44.01 46.89 3.20 43.89 45.69 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -13.23 45.29 51.30 -13.91 44.10 49.69 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 57 ARG^? 9.16 OXT ACT C 301 127 ARG C 57 ARG^? 6.12 O ACT B 304 270 GLU B 89 GLU^? 9.16 CL CL B 202 coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 0.41 44.01 46.89 3.20 43.89 45.69 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG B 57 ARG^? 10.43 O ACT B 304 127 ARG A 57 ARG^? 9.16 OXT ACT C 301 270 GLU C 89 GLU^? 9.21 CL CL C 203 coo -0.83 25.63 1.57 0.97 28.05 0.90 4.68 37.56 46.31 2.06 39.11 46.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG C 57 ARG^? 6.12 O ACT B 304 127 ARG A 57 ARG^? 9.16 OXT ACT C 301 270 GLU B 89 GLU^? 9.16 CL CL B 202 coo -0.83 25.63 1.57 0.97 28.05 0.90 0.41 44.01 46.89 3.20 43.89 45.69 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 3.69 38.42 36.29 2.58 38.79 38.06 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 5 hits 1cbx_c01 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS C 81 HIS.? 20.24 CH3 ACT B 304 A 262 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 358 GLU C 76 GLU~? 20.08 CL CL C 203 coo 26.19 60.87 43.98 27.48 59.27 43.30 1.30 66.32 47.25 0.46 68.04 46.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 27.06 50.43 44.36 27.99 52.27 44.74 -3.98 63.92 37.70 -6.01 64.18 37.13 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS B 81 HIS.? 19.26 CH3 ACT A 303 B 262 GLU B 77 GLU~? 17.82 O ACT A 302 B 358 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 44.98 77.01 48.39 44.42 78.67 47.18 24.07 26.52 45.84 25.63 26.47 44.45 coo 41.60 83.57 54.16 42.46 83.24 52.25 25.37 33.50 41.00 25.99 35.47 41.49 coo 44.05 87.61 48.73 43.15 85.67 48.52 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS C 81 HIS.? 20.24 CH3 ACT B 304 B 262 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 358 GLU C 76 GLU~? 20.08 CL CL C 203 coo 44.98 77.01 48.39 44.42 78.67 47.18 1.30 66.32 47.25 0.46 68.04 46.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 44.05 87.61 48.73 43.15 85.67 48.52 -3.98 63.92 37.70 -6.01 64.18 37.13 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 45 GLY.? 16.26 OXT ACT C 301 A 228 SER A 48 SER.? 20.26 O ACT C 301 A 549 ASP A 50 ASP.? 19.58 O ACT C 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -4.76 42.35 60.16 -5.04 41.69 60.54 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -4.83 40.14 65.16 -7.27 40.24 64.93 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -9.90 37.94 65.42 -11.50 37.20 64.25 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 1 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 45 GLY.? 16.26 OXT ACT C 301 B1228 SER A 48 SER.? 20.26 O ACT C 301 B1549 ASP A 50 ASP.? 19.58 O ACT C 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -4.76 42.35 60.16 -5.04 41.69 60.54 coo 131.65 74.68 129.41 130.31 72.73 128.82 -4.83 40.14 65.16 -7.27 40.24 64.93 coo 134.72 69.43 130.42 133.03 70.65 130.08 -9.90 37.94 65.42 -11.50 37.20 64.25 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 1 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 89 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 120 SER C 43 SER.? 11.78 CH3 ACT B 304 coo -24.35 9.53 67.64 -25.07 11.29 68.60 15.35 40.93 52.66 14.20 41.89 54.18 coo -31.18 6.91 75.60 -32.39 8.51 74.91 16.43 50.94 51.34 17.50 52.11 49.94 coo -34.73 8.57 68.21 -33.63 9.08 70.28 12.90 47.82 57.02 10.85 48.75 56.12 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 89 GLU A 41 GLU.? 4.97 O ACT C 301 A 120 SER A 43 SER.? 10.34 O ACT C 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -5.97 51.16 54.03 -5.89 49.54 55.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -13.23 45.29 51.30 -13.91 44.10 49.69 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.91 41.82 57.59 -11.21 40.61 55.53 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU B 52 GLU.? 22.83 CH3 ACT B 304 B 89 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 120 SER C 43 SER.? 11.78 CH3 ACT B 304 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.66 37.44 62.50 7.81 38.11 64.51 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 15.35 40.93 52.66 14.20 41.89 54.18 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.90 47.82 57.02 10.85 48.75 56.12 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 89 GLU A 41 GLU.? 4.97 O ACT C 301 B 120 SER A 43 SER.? 10.34 O ACT C 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.91 41.82 57.59 -11.21 40.61 55.53 1cns_c01 source 1cns CHITINASE : 2 hits 1cns_c01 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA B 13 ALA^? 11.27 CH3 ACT A 303 A 74 ASN B 55 ASN^? 9.91 CH3 ACT A 303 A 75 GLY B 40 GLY.? 8.14 CH3 ACT A 303 coo -1.80 62.71 122.76 -1.88 63.70 123.92 12.76 32.40 49.06 14.10 32.82 48.50 coo 1.20 66.40 122.20 2.03 64.53 121.46 9.14 32.38 52.24 9.69 30.32 52.26 coo 4.68 65.84 125.52 4.11 65.60 126.05 4.87 27.57 51.92 4.89 27.45 52.77 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 38 ALA^? 9.48 OXT ACT A 303 A 74 ASN B 55 ASN^? 9.91 CH3 ACT A 303 A 75 GLY B 40 GLY.? 8.14 CH3 ACT A 303 coo -1.80 62.71 122.76 -1.88 63.70 123.92 5.14 34.55 52.80 5.58 34.51 51.35 coo 1.20 66.40 122.20 2.03 64.53 121.46 9.14 32.38 52.24 9.69 30.32 52.26 coo 4.68 65.84 125.52 4.11 65.60 126.05 4.87 27.57 51.92 4.89 27.45 52.77 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA B 38 ALA^? 9.48 OXT ACT A 303 B 74 ASN B 55 ASN^? 9.91 CH3 ACT A 303 B 75 GLY B 40 GLY.? 8.14 CH3 ACT A 303 coo 39.21 14.97 27.55 40.19 16.01 27.08 5.14 34.55 52.80 5.58 34.51 51.35 coo 43.06 12.94 25.74 42.26 11.81 27.44 9.14 32.38 52.24 9.69 30.32 52.26 coo 46.38 13.54 29.18 46.14 14.29 29.26 4.87 27.57 51.92 4.89 27.45 52.77 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA B 38 ALA^? 9.48 OXT ACT A 303 C 74 ASN B 55 ASN^? 9.91 CH3 ACT A 303 C 75 GLY B 40 GLY.? 8.14 CH3 ACT A 303 coo 16.14 15.08 36.63 15.28 14.65 37.81 5.14 34.55 52.80 5.58 34.51 51.35 coo 11.60 16.13 36.70 12.80 17.74 35.96 9.14 32.38 52.24 9.69 30.32 52.26 coo 10.99 19.23 40.32 11.50 18.77 40.74 4.87 27.57 51.92 4.89 27.45 52.77 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA B 38 ALA^? 9.48 OXT ACT A 303 D 74 ASN B 55 ASN^? 9.91 CH3 ACT A 303 D 75 GLY B 40 GLY.? 8.14 CH3 ACT A 303 coo -13.31 41.90 116.45 -13.05 40.39 116.25 5.14 34.55 52.80 5.58 34.51 51.35 coo -16.85 39.36 115.26 -17.55 40.58 116.90 9.14 32.38 52.24 9.69 30.32 52.26 coo -17.65 36.37 119.00 -16.85 36.22 119.00 4.87 27.57 51.92 4.89 27.45 52.77 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA C 38 ALA^? 8.62 O ACT B 304 D 74 ASN C 55 ASN^? 9.16 CH3 ACT B 304 D 75 GLY C 40 GLY.? 7.10 CH3 ACT B 304 coo -13.31 41.90 116.45 -13.05 40.39 116.25 4.45 45.58 52.38 4.04 46.24 51.10 coo -16.85 39.36 115.26 -17.55 40.58 116.90 4.32 50.30 52.50 5.90 51.72 52.50 coo -17.65 36.37 119.00 -16.85 36.22 119.00 10.77 48.31 51.36 10.92 48.35 52.19 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP B 2 ASP.? 15.66 OXT ACT B 304 315 GLU B 97 GLU~? 14.31 OXT ACT B 304 390 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 32.46 99.13 19.34 30.94 100.38 20.07 3.21 59.71 32.87 5.22 59.30 32.47 coo 32.04 94.22 18.23 30.57 94.75 16.88 9.46 57.70 31.80 7.43 57.99 32.35 coo 21.10 94.74 18.36 23.09 96.71 18.59 10.71 51.79 38.53 9.13 52.40 40.75 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 2 ASP.? 6.75 OXT ACT A 302 A 56 ILE B 85 ILE^? -4.63 OXT ACT A 303s A 82 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 16.13 27.42 32.13 14.80 25.81 31.83 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 9.47 30.63 43.46 8.18 30.09 43.64 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 6.28 25.07 38.68 7.82 26.15 40.75 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c00 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 243 ASP C 2 ASP.? 15.16 CH3 ACT C 301 A 272 LYS C 98 LYS~? 7.72 O ACT C 301 coo 2.03 68.31 21.46 0.66 68.36 23.90 1.04 26.01 48.23 1.29 24.82 50.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 243 ASP A 2 ASP.? 6.75 OXT ACT A 302 A 272 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 2.03 68.31 21.46 0.66 68.36 23.90 13.49 45.92 47.42 14.68 46.48 49.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.13 27.42 32.13 14.80 25.81 31.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR C 33 TYR.? -7.29 C ACT C 301s A 243 ASP B 2 ASP.? 15.66 OXT ACT B 304 A 272 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 2.03 68.31 21.46 0.66 68.36 23.90 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 16.93 55.67 9.65 17.16 54.23 11.19 3.21 59.71 32.87 5.22 59.30 32.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 12.25 56.30 36.89 8.12 57.51 41.12 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 3 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 7 LYS^? -3.09 CL CL A 201s A 177 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 201 LEU A 8 LEU^? 7.10 OXT ACT A 303 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.17 30.56 34.55 -1.45 32.28 29.77 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 0.69 33.35 38.41 1.48 33.79 40.37 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 19 LYS~? 20.51 O ACT A 303 A 177 GLU A 14 GLU^? 15.87 O ACT C 301 A 201 LEU A 17 LEU~? 15.80 O ACT C 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -10.45 28.47 52.81 -12.30 27.97 51.84 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 19 LYS~? 20.51 O ACT A 303 A 177 GLU A 24 GLU~? 16.57 O ACT A 303 A 201 LEU A 21 LEU~? 13.53 O ACT A 303 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -7.31 26.48 49.16 -8.96 27.84 48.73 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 7 LYS^? -3.05 CL CL B 202s A 177 GLU B 59 GLU^? -6.17 O ACT B 304s A 201 LEU B 8 LEU^? 6.38 O ACT B 304 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 8.57 44.02 33.90 7.44 42.15 29.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 6.28 42.91 37.89 5.54 43.26 39.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS B 7 LYS^? -3.05 CL CL B 202s A 177 GLU C 89 GLU^? 9.21 CL CL C 203 A 201 LEU B 8 LEU^? 6.38 O ACT B 304 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 8.57 44.02 33.90 7.44 42.15 29.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 0.03 43.20 36.88 0.18 41.91 38.57 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 6.28 42.91 37.89 5.54 43.26 39.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 19 LYS~? 19.93 CH3 ACT B 304 A 177 GLU B 14 GLU^? 14.83 CH3 ACT A 303 A 201 LEU B 17 LEU~? 15.90 CH3 ACT A 303 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 19.96 40.93 52.37 24.88 43.37 55.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 14.26 29.69 53.47 14.81 28.86 55.34 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 17.86 34.43 50.92 19.03 32.72 50.29 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS C 7 LYS^? -3.09 CL CL C 203s A 177 GLU A 89 GLU^? 9.05 CL CL A 201 A 201 LEU C 8 LEU^? 7.40 OXT ACT C 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -4.83 43.06 38.74 -4.44 42.19 40.69 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS C 7 LYS^? -3.09 CL CL C 203s A 177 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 201 LEU C 8 LEU^? 7.40 OXT ACT C 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -4.83 43.06 38.74 -4.44 42.19 40.69 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS C 19 LYS~? 19.44 O ACT C 301 A 177 GLU C 14 GLU^? 15.65 CH3 ACT B 304 A 201 LEU C 17 LEU~? 15.40 CH3 ACT B 304 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 3.23 56.16 55.11 3.39 58.23 55.56 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -1.80 56.52 51.96 -1.21 58.31 50.94 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS C 19 LYS~? 19.44 O ACT C 301 A 177 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 201 LEU C 21 LEU~? 13.70 OXT ACT C 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -5.55 54.45 48.75 -3.64 55.19 48.06 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 10 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 7 LYS^? -3.09 CL CL A 201s B 177 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 201 LEU A 8 LEU^? 7.10 OXT ACT A 303 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 0.17 30.56 34.55 -1.45 32.28 29.77 coo 27.00 6.35 51.01 26.30 4.53 50.18 -0.06 34.24 44.69 1.54 35.69 44.88 coo 23.74 1.68 49.50 22.87 -0.24 49.97 0.69 33.35 38.41 1.48 33.79 40.37 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 7 LYS^? -3.09 CL CL A 201s B 177 GLU B 89 GLU^? 9.16 CL CL B 202 B 201 LEU A 8 LEU^? 7.10 OXT ACT A 303 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 0.17 30.56 34.55 -1.45 32.28 29.77 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.69 38.42 36.29 2.58 38.79 38.06 coo 23.74 1.68 49.50 22.87 -0.24 49.97 0.69 33.35 38.41 1.48 33.79 40.37 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 19 LYS~? 20.51 O ACT A 303 B 177 GLU A 14 GLU^? 15.87 O ACT C 301 B 201 LEU A 17 LEU~? 15.80 O ACT C 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 27.00 6.35 51.01 26.30 4.53 50.18 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -10.45 28.47 52.81 -12.30 27.97 51.84 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS A 19 LYS~? 20.51 O ACT A 303 B 177 GLU A 24 GLU~? 16.57 O ACT A 303 B 201 LEU A 21 LEU~? 13.53 O ACT A 303 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 27.00 6.35 51.01 26.30 4.53 50.18 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -7.31 26.48 49.16 -8.96 27.84 48.73 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 7 LYS^? -3.05 CL CL B 202s B 177 GLU B 59 GLU^? -6.17 O ACT B 304s B 201 LEU B 8 LEU^? 6.38 O ACT B 304 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 8.57 44.02 33.90 7.44 42.15 29.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 6.72 41.22 43.91 4.75 41.83 44.25 coo 23.74 1.68 49.50 22.87 -0.24 49.97 6.28 42.91 37.89 5.54 43.26 39.89 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 7 LYS^? -3.05 CL CL B 202s B 177 GLU C 89 GLU^? 9.21 CL CL C 203 B 201 LEU B 8 LEU^? 6.38 O ACT B 304 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 8.57 44.02 33.90 7.44 42.15 29.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 0.03 43.20 36.88 0.18 41.91 38.57 coo 23.74 1.68 49.50 22.87 -0.24 49.97 6.28 42.91 37.89 5.54 43.26 39.89 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS B 19 LYS~? 19.93 CH3 ACT B 304 B 177 GLU B 14 GLU^? 14.83 CH3 ACT A 303 B 201 LEU B 17 LEU~? 15.90 CH3 ACT A 303 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 19.96 40.93 52.37 24.88 43.37 55.52 coo 27.00 6.35 51.01 26.30 4.53 50.18 14.26 29.69 53.47 14.81 28.86 55.34 coo 23.74 1.68 49.50 22.87 -0.24 49.97 17.86 34.43 50.92 19.03 32.72 50.29 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS B 19 LYS~? 19.93 CH3 ACT B 304 B 177 GLU B 24 GLU~? 17.02 OXT ACT B 304 B 201 LEU B 21 LEU~? 13.85 OXT ACT B 304 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 19.96 40.93 52.37 24.88 43.37 55.52 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.32 38.82 44.21 23.94 38.72 42.86 coo 23.74 1.68 49.50 22.87 -0.24 49.97 17.44 38.43 47.38 17.01 36.39 46.85 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS C 7 LYS^? -3.09 CL CL C 203s B 177 GLU A 89 GLU^? 9.05 CL CL A 201 B 201 LEU C 8 LEU^? 7.40 OXT ACT C 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -4.83 43.06 38.74 -4.44 42.19 40.69 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS C 7 LYS^? -3.09 CL CL C 203s B 177 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 201 LEU C 8 LEU^? 7.40 OXT ACT C 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -4.83 43.06 38.74 -4.44 42.19 40.69 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS C 19 LYS~? 19.44 O ACT C 301 B 177 GLU C 14 GLU^? 15.65 CH3 ACT B 304 B 201 LEU C 17 LEU~? 15.40 CH3 ACT B 304 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.23 56.16 55.11 3.39 58.23 55.56 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -1.80 56.52 51.96 -1.21 58.31 50.94 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 B 145 LYS C 19 LYS~? 19.44 O ACT C 301 B 177 GLU C 24 GLU~? 16.74 CH3 ACT C 301 B 201 LEU C 21 LEU~? 13.70 OXT ACT C 301 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 27.00 6.35 51.01 26.30 4.53 50.18 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -5.55 54.45 48.75 -3.64 55.19 48.06 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 12 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 60 THR^? -4.49 O ACT A 303s A 156 TYR A 99 TYR~? -4.58 CH3 ACT A 303s A 160 LYS A 31 LYS.? 10.36 O ACT A 303 coo 10.50 56.87 17.73 11.24 57.93 19.43 0.42 28.72 42.47 -0.75 26.89 42.18 coo 11.64 63.07 23.95 11.76 62.47 21.20 6.28 25.07 38.68 7.82 26.15 40.75 coo 5.78 61.30 21.65 8.04 62.89 17.54 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 60 THR^? -4.90 OXT ACT B 304s A 156 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 160 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 10.50 56.87 17.73 11.24 57.93 19.43 10.88 44.65 41.79 13.01 44.54 41.32 coo 11.64 63.07 23.95 11.76 62.47 21.20 10.71 51.79 38.53 9.13 52.40 40.75 coo 5.78 61.30 21.65 8.04 62.89 17.54 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR C 60 THR^? 4.85 CH3 ACT C 301 A 156 TYR C 99 TYR~? -4.22 CH3 ACT C 301s A 160 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 11.64 63.07 23.95 11.76 62.47 21.20 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 5.78 61.30 21.65 8.04 62.89 17.54 -16.24 47.41 43.58 -19.18 48.92 39.46 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 3 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 226 THR C 60 THR^? 4.85 CH3 ACT C 301 A 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 9.66 102.78 70.07 9.79 101.18 71.42 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 226 THR C 60 THR^? 4.85 CH3 ACT C 301 A 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 41 GLU.? 4.97 O ACT C 301 A 226 THR A 60 THR^? -4.49 O ACT A 303s A 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 9.66 102.78 70.07 9.79 101.18 71.42 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 226 THR A 60 THR^? -4.49 O ACT A 303s A 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 9.66 102.78 70.07 9.79 101.18 71.42 15.35 40.93 52.66 14.20 41.89 54.18 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 226 THR A 60 THR^? -4.49 O ACT A 303s A 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 9.66 102.78 70.07 9.79 101.18 71.42 15.35 40.93 52.66 14.20 41.89 54.18 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 A 226 THR A 60 THR^? -4.49 O ACT A 303s A 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.66 37.44 62.50 7.81 38.11 64.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 A 226 THR B 60 THR^? -4.90 OXT ACT B 304s A 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.66 37.44 62.50 7.81 38.11 64.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU C 14 GLU^? 15.65 CH3 ACT B 304 A 226 THR C 60 THR^? 4.85 CH3 ACT C 301 A 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 9.66 102.78 70.07 9.79 101.18 71.42 3.23 56.16 55.11 3.39 58.23 55.56 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 226 THR B 60 THR^? -4.90 OXT ACT B 304s A 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 226 THR B 60 THR^? -4.90 OXT ACT B 304s A 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 A 226 THR B 60 THR^? -4.90 OXT ACT B 304s A 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 9.66 102.78 70.07 9.79 101.18 71.42 2.90 48.54 61.44 4.21 46.86 61.22 coo 7.24 97.46 49.60 8.11 95.69 48.80 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 A 226 THR C 60 THR^? 4.85 CH3 ACT C 301 A 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 9.66 102.78 70.07 9.79 101.18 71.42 2.90 48.54 61.44 4.21 46.86 61.22 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 A 226 THR C 60 THR^? 4.85 CH3 ACT C 301 A 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 2.90 48.54 61.44 4.21 46.86 61.22 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.24 47.41 43.58 -19.18 48.92 39.46 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 13 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 226 THR C 60 THR^? 4.85 CH3 ACT C 301 B 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 15.90 87.61 49.61 13.92 86.96 49.36 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 226 THR C 60 THR^? 4.85 CH3 ACT C 301 B 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 41 GLU.? 4.97 O ACT C 301 B 226 THR A 60 THR^? -4.49 O ACT A 303s B 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 15.90 87.61 49.61 13.92 86.96 49.36 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.42 28.72 42.47 -0.75 26.89 42.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 226 THR A 60 THR^? -4.49 O ACT A 303s B 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 15.90 87.61 49.61 13.92 86.96 49.36 15.35 40.93 52.66 14.20 41.89 54.18 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.42 28.72 42.47 -0.75 26.89 42.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 226 THR A 60 THR^? -4.49 O ACT A 303s B 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 15.90 87.61 49.61 13.92 86.96 49.36 15.35 40.93 52.66 14.20 41.89 54.18 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.42 28.72 42.47 -0.75 26.89 42.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 B 226 THR A 60 THR^? -4.49 O ACT A 303s B 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.66 37.44 62.50 7.81 38.11 64.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 0.42 28.72 42.47 -0.75 26.89 42.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 B 226 THR B 60 THR^? -4.90 OXT ACT B 304s B 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.66 37.44 62.50 7.81 38.11 64.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 10.88 44.65 41.79 13.01 44.54 41.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU C 14 GLU^? 15.65 CH3 ACT B 304 B 226 THR C 60 THR^? 4.85 CH3 ACT C 301 B 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 15.90 87.61 49.61 13.92 86.96 49.36 3.23 56.16 55.11 3.39 58.23 55.56 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 226 THR B 60 THR^? -4.90 OXT ACT B 304s B 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 20.74 95.78 68.68 19.29 96.84 69.83 10.88 44.65 41.79 13.01 44.54 41.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 226 THR B 60 THR^? -4.90 OXT ACT B 304s B 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 20.74 95.78 68.68 19.29 96.84 69.83 10.88 44.65 41.79 13.01 44.54 41.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 B 226 THR B 60 THR^? -4.90 OXT ACT B 304s B 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 15.90 87.61 49.61 13.92 86.96 49.36 2.90 48.54 61.44 4.21 46.86 61.22 coo 20.74 95.78 68.68 19.29 96.84 69.83 10.88 44.65 41.79 13.01 44.54 41.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 B 226 THR C 60 THR^? 4.85 CH3 ACT C 301 B 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 15.90 87.61 49.61 13.92 86.96 49.36 2.90 48.54 61.44 4.21 46.86 61.22 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 B 226 THR C 60 THR^? 4.85 CH3 ACT C 301 B 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 2.90 48.54 61.44 4.21 46.86 61.22 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.24 47.41 43.58 -19.18 48.92 39.46 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 13 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 226 THR C 60 THR^? 4.85 CH3 ACT C 301 C 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 5.43 40.40 61.63 4.27 41.99 60.90 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 226 THR C 60 THR^? 4.85 CH3 ACT C 301 C 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 41 GLU.? 4.97 O ACT C 301 C 226 THR A 60 THR^? -4.49 O ACT A 303s C 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 5.43 40.40 61.63 4.27 41.99 60.90 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.42 28.72 42.47 -0.75 26.89 42.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 226 THR A 60 THR^? -4.49 O ACT A 303s C 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 5.43 40.40 61.63 4.27 41.99 60.90 15.35 40.93 52.66 14.20 41.89 54.18 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.42 28.72 42.47 -0.75 26.89 42.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 226 THR A 60 THR^? -4.49 O ACT A 303s C 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 5.43 40.40 61.63 4.27 41.99 60.90 15.35 40.93 52.66 14.20 41.89 54.18 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.42 28.72 42.47 -0.75 26.89 42.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 C 226 THR A 60 THR^? -4.49 O ACT A 303s C 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.66 37.44 62.50 7.81 38.11 64.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 0.42 28.72 42.47 -0.75 26.89 42.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 C 226 THR B 60 THR^? -4.90 OXT ACT B 304s C 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.66 37.44 62.50 7.81 38.11 64.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 10.88 44.65 41.79 13.01 44.54 41.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU C 14 GLU^? 15.65 CH3 ACT B 304 C 226 THR C 60 THR^? 4.85 CH3 ACT C 301 C 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 5.43 40.40 61.63 4.27 41.99 60.90 3.23 56.16 55.11 3.39 58.23 55.56 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 C 226 THR B 60 THR^? -4.90 OXT ACT B 304s C 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 22.16 45.88 73.63 23.23 47.70 73.25 10.88 44.65 41.79 13.01 44.54 41.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 C 226 THR B 60 THR^? -4.90 OXT ACT B 304s C 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 22.16 45.88 73.63 23.23 47.70 73.25 10.88 44.65 41.79 13.01 44.54 41.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 C 226 THR B 60 THR^? -4.90 OXT ACT B 304s C 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 5.43 40.40 61.63 4.27 41.99 60.90 2.90 48.54 61.44 4.21 46.86 61.22 coo 22.16 45.88 73.63 23.23 47.70 73.25 10.88 44.65 41.79 13.01 44.54 41.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 C 226 THR C 60 THR^? 4.85 CH3 ACT C 301 C 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 5.43 40.40 61.63 4.27 41.99 60.90 2.90 48.54 61.44 4.21 46.86 61.22 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 C 226 THR C 60 THR^? 4.85 CH3 ACT C 301 C 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 2.90 48.54 61.44 4.21 46.86 61.22 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.24 47.41 43.58 -19.18 48.92 39.46 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 13 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 D 226 THR C 60 THR^? 4.85 CH3 ACT C 301 D 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 26.07 55.89 66.14 25.33 56.50 68.01 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 18 GLU~? 13.24 OXT ACT A 303 D 226 THR C 60 THR^? 4.85 CH3 ACT C 301 D 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 41 GLU.? 4.97 O ACT C 301 D 226 THR A 60 THR^? -4.49 O ACT A 303s D 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 26.07 55.89 66.14 25.33 56.50 68.01 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 D 226 THR A 60 THR^? -4.49 O ACT A 303s D 229 LYS A 7 LYS^? -3.09 CL CL A 201s coo 26.07 55.89 66.14 25.33 56.50 68.01 15.35 40.93 52.66 14.20 41.89 54.18 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 18 GLU~? 12.98 CH3 ACT B 304 D 226 THR A 60 THR^? -4.49 O ACT A 303s D 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 26.07 55.89 66.14 25.33 56.50 68.01 15.35 40.93 52.66 14.20 41.89 54.18 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 D 226 THR A 60 THR^? -4.49 O ACT A 303s D 229 LYS A 31 LYS.? 10.36 O ACT A 303 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.66 37.44 62.50 7.81 38.11 64.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 0.42 28.72 42.47 -0.75 26.89 42.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 52 GLU.? 22.83 CH3 ACT B 304 D 226 THR B 60 THR^? -4.90 OXT ACT B 304s D 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.66 37.44 62.50 7.81 38.11 64.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU C 14 GLU^? 15.65 CH3 ACT B 304 D 226 THR C 60 THR^? 4.85 CH3 ACT C 301 D 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 26.07 55.89 66.14 25.33 56.50 68.01 3.23 56.16 55.11 3.39 58.23 55.56 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 D 226 THR B 60 THR^? -4.90 OXT ACT B 304s D 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 11.79 47.62 52.67 10.10 46.51 53.39 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU C 18 GLU~? 13.25 OXT ACT C 301 D 226 THR B 60 THR^? -4.90 OXT ACT B 304s D 229 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 11.79 47.62 52.67 10.10 46.51 53.39 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 D 226 THR B 60 THR^? -4.90 OXT ACT B 304s D 229 LYS B 7 LYS^? -3.05 CL CL B 202s coo 26.07 55.89 66.14 25.33 56.50 68.01 2.90 48.54 61.44 4.21 46.86 61.22 coo 11.79 47.62 52.67 10.10 46.51 53.39 10.88 44.65 41.79 13.01 44.54 41.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.57 44.02 33.90 7.44 42.15 29.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 D 226 THR C 60 THR^? 4.85 CH3 ACT C 301 D 229 LYS C 7 LYS^? -3.09 CL CL C 203s coo 26.07 55.89 66.14 25.33 56.50 68.01 2.90 48.54 61.44 4.21 46.86 61.22 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 -7.36 44.70 35.08 -5.66 44.82 30.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU C 52 GLU.? 17.63 CH3 ACT B 304 D 226 THR C 60 THR^? 4.85 CH3 ACT C 301 D 229 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 2.90 48.54 61.44 4.21 46.86 61.22 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.24 47.41 43.58 -19.18 48.92 39.46 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 13 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 99 TYR~? -4.58 CH3 ACT A 303s 150 LYS A 31 LYS.? 10.36 O ACT A 303 186 ASN A 90 ASN^? -5.08 CL CL A 201s coo 32.88 50.55 24.33 31.89 51.78 26.65 6.28 25.07 38.68 7.82 26.15 40.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 3.36 21.23 42.37 3.31 17.75 38.68 coo 36.98 50.30 37.29 35.85 50.29 35.50 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 99 TYR~? -4.58 CH3 ACT A 303s 150 LYS A 98 LYS~? 7.98 CH3 ACT A 303 186 ASN A 90 ASN^? -5.08 CL CL A 201s coo 32.88 50.55 24.33 31.89 51.78 26.65 6.28 25.07 38.68 7.82 26.15 40.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 9.24 21.45 37.02 12.73 25.01 40.79 coo 36.98 50.30 37.29 35.85 50.29 35.50 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 99 TYR~? 4.94 OXT ACT B 304 150 LYS B 31 LYS.? 11.57 OXT ACT B 304 186 ASN B 90 ASN^? -5.08 CL CL B 202s coo 32.88 50.55 24.33 31.89 51.78 26.65 10.71 51.79 38.53 9.13 52.40 40.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 15.94 50.91 41.57 17.07 55.01 36.93 coo 36.98 50.30 37.29 35.85 50.29 35.50 3.80 42.08 30.71 3.97 43.74 29.40 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 99 TYR~? 4.94 OXT ACT B 304 150 LYS B 98 LYS~? 9.29 CH3 ACT B 304 186 ASN B 90 ASN^? -5.08 CL CL B 202s coo 32.88 50.55 24.33 31.89 51.78 26.65 10.71 51.79 38.53 9.13 52.40 40.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 12.25 56.30 36.89 8.12 57.51 41.12 coo 36.98 50.30 37.29 35.85 50.29 35.50 3.80 42.08 30.71 3.97 43.74 29.40 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 99 TYR~? 4.94 OXT ACT B 304 150 LYS B 98 LYS~? 9.29 CH3 ACT B 304 186 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 32.88 50.55 24.33 31.89 51.78 26.65 10.71 51.79 38.53 9.13 52.40 40.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 12.25 56.30 36.89 8.12 57.51 41.12 coo 36.98 50.30 37.29 35.85 50.29 35.50 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR C 33 TYR.? -7.29 C ACT C 301s 150 LYS C 26 LYS~? 10.00 O ACT C 301 186 ASN A 55 ASN^? 10.27 O ACT C 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 27.04 52.42 22.30 26.88 49.99 27.00 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 36.98 50.30 37.29 35.85 50.29 35.50 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR C 33 TYR.? -7.29 C ACT C 301s 150 LYS C 31 LYS.? 9.88 CH3 ACT C 301 186 ASN A 55 ASN^? 10.27 O ACT C 301 coo 32.88 50.55 24.33 31.89 51.78 26.65 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 27.04 52.42 22.30 26.88 49.99 27.00 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 36.98 50.30 37.29 35.85 50.29 35.50 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR C 99 TYR~? -4.22 CH3 ACT C 301s 150 LYS C 31 LYS.? 9.88 CH3 ACT C 301 186 ASN C 90 ASN^? -5.08 CL CL C 203s coo 32.88 50.55 24.33 31.89 51.78 26.65 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 27.04 52.42 22.30 26.88 49.99 27.00 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 36.98 50.30 37.29 35.85 50.29 35.50 -3.57 41.72 31.30 -5.19 41.10 30.13 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR C 99 TYR~? -4.22 CH3 ACT C 301s 150 LYS C 98 LYS~? 7.72 O ACT C 301 186 ASN C 90 ASN^? -5.08 CL CL C 203s coo 32.88 50.55 24.33 31.89 51.78 26.65 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 27.04 52.42 22.30 26.88 49.99 27.00 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 36.98 50.30 37.29 35.85 50.29 35.50 -3.57 41.72 31.30 -5.19 41.10 30.13 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 9 hits 1dhr_c00 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 53 GLY.? 16.08 O ACT C 301 B 144 GLU A 52 GLU.? 20.44 O ACT C 301 B 164 GLU A 14 GLU^? 15.87 O ACT C 301 coo 88.87 114.43 152.30 88.45 115.15 152.32 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 85.20 111.99 152.05 86.60 110.89 150.91 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 88.14 113.46 145.73 86.79 113.92 147.30 -12.43 31.41 55.22 -14.25 31.05 56.29 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 53 GLY.? 16.08 O ACT C 301 C 144 GLU A 52 GLU.? 20.44 O ACT C 301 C 164 GLU A 14 GLU^? 15.87 O ACT C 301 coo 56.28 104.55 135.84 56.09 105.34 136.05 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 58.46 103.90 139.48 57.57 102.00 139.16 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 51.71 102.03 140.09 53.02 103.62 140.54 -12.43 31.41 55.22 -14.25 31.05 56.29 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 53 GLY.? 16.08 O ACT C 301 D 144 GLU A 52 GLU.? 20.44 O ACT C 301 D 164 GLU A 14 GLU^? 15.87 O ACT C 301 coo 86.19 80.64 132.77 86.38 79.85 132.93 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 84.75 81.24 136.88 85.62 83.14 136.43 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 91.47 83.05 136.24 90.35 81.38 136.84 -12.43 31.41 55.22 -14.25 31.05 56.29 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 53 GLY.? 16.08 O ACT C 301 E 144 GLU A 52 GLU.? 20.44 O ACT C 301 E 164 GLU A 14 GLU^? 15.87 O ACT C 301 coo 90.07 81.07 170.50 90.23 80.26 170.38 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 87.05 81.30 167.53 86.38 82.74 168.94 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 84.40 80.02 173.80 85.08 79.06 172.03 -12.43 31.41 55.22 -14.25 31.05 56.29 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 53 GLY.? 16.08 O ACT C 301 F 144 GLU A 52 GLU.? 20.44 O ACT C 301 F 164 GLU A 14 GLU^? 15.87 O ACT C 301 coo 57.12 70.68 155.10 57.52 69.95 155.02 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 60.62 73.13 154.21 59.05 74.26 153.35 -13.35 32.78 61.59 -14.92 31.80 62.64 coo 56.75 71.71 148.46 58.44 71.01 149.54 -12.43 31.41 55.22 -14.25 31.05 56.29 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c17 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 7 LYS^? -3.09 CL CL A 201s A 193 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 217 VAL A 9 VAL^? 8.80 O ACT A 303 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.17 30.56 34.55 -1.45 32.28 29.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -0.06 34.24 44.69 1.54 35.69 44.88 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -3.33 31.29 39.71 -4.75 29.67 39.44 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 19 LYS~? 20.51 O ACT A 303 A 193 GLU A 24 GLU~? 16.57 O ACT A 303 A 217 VAL A 22 VAL~? 10.70 O ACT A 303 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -5.86 23.51 54.21 -8.85 19.33 56.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -3.86 23.56 49.28 -2.07 23.78 50.49 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 193 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 217 VAL A 22 VAL~? 10.70 O ACT A 303 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -2.24 19.72 44.66 2.39 20.87 47.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -3.86 23.56 49.28 -2.07 23.78 50.49 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 7 LYS^? -3.05 CL CL B 202s A 193 GLU B 59 GLU^? -6.17 O ACT B 304s A 217 VAL B 9 VAL^? 8.91 OXT ACT B 304 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.57 44.02 33.90 7.44 42.15 29.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.72 41.22 43.91 4.75 41.83 44.25 coo 0.07 12.29 66.53 -0.24 11.95 64.38 10.15 40.29 38.68 12.23 39.93 38.14 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 193 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 217 VAL B 22 VAL~? 10.79 CH3 ACT B 304 coo 2.10 10.68 61.44 -2.14 13.16 60.61 20.18 46.61 43.20 19.00 49.55 48.67 coo -5.33 11.71 69.72 -4.62 11.92 67.73 15.35 40.93 52.66 14.20 41.89 54.18 coo 0.07 12.29 66.53 -0.24 11.95 64.38 18.14 42.82 47.77 17.21 44.18 49.23 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU A 89 GLU^? 9.05 CL CL A 201 A 217 VAL C 91 VAL^? 7.59 CL CL A 201 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -5.96 39.29 34.50 -5.93 40.19 36.52 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 217 VAL C 9 VAL^? 9.27 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -4.42 47.71 39.74 -5.17 49.68 39.28 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU C 65 GLU~? 12.15 CL CL C 203 A 217 VAL C 62 VAL^? 6.47 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -11.54 46.76 37.77 -10.43 48.42 38.67 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS C 19 LYS~? 19.44 O ACT C 301 A 193 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 217 VAL C 22 VAL~? 10.84 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -8.10 55.24 54.21 -11.72 57.88 57.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -9.68 52.97 49.56 -10.23 51.47 51.07 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS C 26 LYS~? 10.00 O ACT C 301 A 193 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 217 VAL C 22 VAL~? 10.84 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -9.68 52.97 49.56 -10.23 51.47 51.07 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 159 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 193 GLU C 65 GLU~? 12.15 CL CL C 203 A 217 VAL C 62 VAL^? 6.47 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -11.54 46.76 37.77 -10.43 48.42 38.67 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 159 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 193 GLU C 65 GLU~? 12.15 CL CL C 203 A 217 VAL C 100 VAL~? 10.38 CH3 ACT C 301 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -17.51 45.83 36.32 -18.16 45.20 34.33 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 12 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 10 THR^? 10.03 OXT ACT A 303 A 159 LYS A 7 LYS^? -3.09 CL CL A 201s A 193 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -4.20 33.48 42.66 -3.27 35.43 42.96 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.17 30.56 34.55 -1.45 32.28 29.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 34 THR^? -4.67 OXT ACT A 303s A 159 LYS A 31 LYS.? 10.36 O ACT A 303 A 193 GLU A 23 GLU~? 17.46 O ACT A 303 coo -2.58 16.31 54.79 -4.02 14.93 55.64 2.88 30.33 48.17 4.48 31.66 47.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.36 21.23 42.37 3.31 17.75 38.68 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 60 THR^? -4.49 O ACT A 303s A 159 LYS A 7 LYS^? -3.09 CL CL A 201s A 193 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 0.42 28.72 42.47 -0.75 26.89 42.18 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.17 30.56 34.55 -1.45 32.28 29.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 60 THR^? -4.49 O ACT A 303s A 159 LYS A 7 LYS^? -3.09 CL CL A 201s A 193 GLU C 89 GLU^? 9.21 CL CL C 203 coo -2.58 16.31 54.79 -4.02 14.93 55.64 0.42 28.72 42.47 -0.75 26.89 42.18 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.17 30.56 34.55 -1.45 32.28 29.77 coo -5.33 11.71 69.72 -4.62 11.92 67.73 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR A 60 THR^? -4.49 O ACT A 303s A 159 LYS A 31 LYS.? 10.36 O ACT A 303 A 193 GLU A 23 GLU~? 17.46 O ACT A 303 coo -2.58 16.31 54.79 -4.02 14.93 55.64 0.42 28.72 42.47 -0.75 26.89 42.18 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.36 21.23 42.37 3.31 17.75 38.68 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 10 THR^? 9.22 O ACT B 304 A 159 LYS B 7 LYS^? -3.05 CL CL B 202s A 193 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.58 16.31 54.79 -4.02 14.93 55.64 8.97 38.22 41.63 6.87 37.99 42.14 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.57 44.02 33.90 7.44 42.15 29.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 34 THR^? -4.05 O ACT B 304s A 159 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 193 GLU B 23 GLU~? 17.74 CH3 ACT B 304 coo -2.58 16.31 54.79 -4.02 14.93 55.64 8.80 45.53 47.76 6.89 46.40 47.31 coo 2.10 10.68 61.44 -2.14 13.16 60.61 15.94 50.91 41.57 17.07 55.01 36.93 coo -5.33 11.71 69.72 -4.62 11.92 67.73 23.16 43.48 49.34 24.66 42.52 50.51 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 60 THR^? -4.90 OXT ACT B 304s A 159 LYS B 7 LYS^? -3.05 CL CL B 202s A 193 GLU A 89 GLU^? 9.05 CL CL A 201 coo -2.58 16.31 54.79 -4.02 14.93 55.64 10.88 44.65 41.79 13.01 44.54 41.32 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.57 44.02 33.90 7.44 42.15 29.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR B 60 THR^? -4.90 OXT ACT B 304s A 159 LYS B 7 LYS^? -3.05 CL CL B 202s A 193 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.58 16.31 54.79 -4.02 14.93 55.64 10.88 44.65 41.79 13.01 44.54 41.32 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.57 44.02 33.90 7.44 42.15 29.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR B 60 THR^? -4.90 OXT ACT B 304s A 159 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 193 GLU B 23 GLU~? 17.74 CH3 ACT B 304 coo -2.58 16.31 54.79 -4.02 14.93 55.64 10.88 44.65 41.79 13.01 44.54 41.32 coo 2.10 10.68 61.44 -2.14 13.16 60.61 15.94 50.91 41.57 17.07 55.01 36.93 coo -5.33 11.71 69.72 -4.62 11.92 67.73 23.16 43.48 49.34 24.66 42.52 50.51 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR C 10 THR^? 8.48 O ACT B 304 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU C 65 GLU~? 12.15 CL CL C 203 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -1.75 47.62 42.43 -0.43 45.91 42.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR C 34 THR^? 4.17 OXT ACT C 301 A 159 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 193 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR C 60 THR^? 4.85 CH3 ACT C 301 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU B 89 GLU^? 9.16 CL CL B 202 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR C 60 THR^? 4.85 CH3 ACT C 301 A 159 LYS C 7 LYS^? -3.09 CL CL C 203s A 193 GLU C 65 GLU~? 12.15 CL CL C 203 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.36 44.70 35.08 -5.66 44.82 30.05 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 38 THR C 60 THR^? 4.85 CH3 ACT C 301 A 159 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 193 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 38 THR C 60 THR^? 4.85 CH3 ACT C 301 A 159 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 193 GLU C 65 GLU~? 12.15 CL CL C 203 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 16 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 14 GLU^? 15.87 O ACT C 301 A 260 ARG B 39 ARG.? 13.46 OXT ACT A 303 A 270 LYS A 19 LYS~? 20.51 O ACT A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 39.80 27.50 22.98 42.20 26.56 21.34 2.53 31.11 56.62 -0.26 29.95 56.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 -5.86 23.51 54.21 -8.85 19.33 56.46 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 260 ARG A 73 ARG~? 20.11 O ACT A 303 A 270 LYS A 26 LYS~? 7.74 CH3 ACT A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 39.80 27.50 22.98 42.20 26.56 21.34 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 48.83 21.70 19.50 47.44 24.99 15.25 -2.24 19.72 44.66 2.39 20.87 47.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 41 GLU.? 4.97 O ACT C 301 A 260 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 270 LYS C 19 LYS~? 19.44 O ACT C 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 39.80 27.50 22.98 42.20 26.56 21.34 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 -8.10 55.24 54.21 -11.72 57.88 57.10 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 41 GLU.? 4.97 O ACT C 301 A 260 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 270 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 39.80 27.50 22.98 42.20 26.56 21.34 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 260 ARG B 73 ARG~? 16.43 O ACT A 302 A 270 LYS B 26 LYS~? 10.63 CH3 ACT B 304 coo 50.99 29.43 12.86 52.11 29.45 14.65 15.35 40.93 52.66 14.20 41.89 54.18 coo 39.80 27.50 22.98 42.20 26.56 21.34 24.09 36.62 39.81 25.66 39.04 38.73 coo 48.83 21.70 19.50 47.44 24.99 15.25 20.18 46.61 43.20 19.00 49.55 48.67 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 260 ARG A 20 ARG~? 20.10 O ACT A 303 A 270 LYS A 26 LYS~? 7.74 CH3 ACT A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 4.59 21.37 51.97 2.75 21.07 50.95 coo 39.80 27.50 22.98 42.20 26.56 21.34 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 48.83 21.70 19.50 47.44 24.99 15.25 -2.24 19.72 44.66 2.39 20.87 47.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 260 ARG A 27 ARG~? 17.50 O ACT A 303 A 270 LYS A 19 LYS~? 20.51 O ACT A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 4.59 21.37 51.97 2.75 21.07 50.95 coo 39.80 27.50 22.98 42.20 26.56 21.34 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 48.83 21.70 19.50 47.44 24.99 15.25 -5.86 23.51 54.21 -8.85 19.33 56.46 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 260 ARG A 27 ARG~? 17.50 O ACT A 303 A 270 LYS A 31 LYS.? 10.36 O ACT A 303 coo 50.99 29.43 12.86 52.11 29.45 14.65 4.59 21.37 51.97 2.75 21.07 50.95 coo 39.80 27.50 22.98 42.20 26.56 21.34 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 48.83 21.70 19.50 47.44 24.99 15.25 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU C 14 GLU^? 15.65 CH3 ACT B 304 A 260 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 270 LYS C 19 LYS~? 19.44 O ACT C 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 3.23 56.16 55.11 3.39 58.23 55.56 coo 39.80 27.50 22.98 42.20 26.56 21.34 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 -8.10 55.24 54.21 -11.72 57.88 57.10 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 260 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 270 LYS C 26 LYS~? 10.00 O ACT C 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 39.80 27.50 22.98 42.20 26.56 21.34 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 48.83 21.70 19.50 47.44 24.99 15.25 -14.41 53.18 45.44 -15.58 50.04 50.81 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 11 3 # 11 A 34 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 260 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 270 LYS B 19 LYS~? 19.93 CH3 ACT B 304 coo 50.99 29.43 12.86 52.11 29.45 14.65 16.43 50.94 51.34 17.50 52.11 49.94 coo 39.80 27.50 22.98 42.20 26.56 21.34 26.02 42.58 42.38 25.84 41.49 45.27 coo 48.83 21.70 19.50 47.44 24.99 15.25 19.96 40.93 52.37 24.88 43.37 55.52 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 12 3 # 12 A 34 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 260 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 270 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 50.99 29.43 12.86 52.11 29.45 14.65 16.43 50.94 51.34 17.50 52.11 49.94 coo 39.80 27.50 22.98 42.20 26.56 21.34 26.02 42.58 42.38 25.84 41.49 45.27 coo 48.83 21.70 19.50 47.44 24.99 15.25 15.94 50.91 41.57 17.07 55.01 36.93 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 12 hits 1euy_c00 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s A 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 A 165 LYS A 31 LYS.? 10.36 O ACT A 303 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 6.28 25.07 38.68 7.82 26.15 40.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 0.69 33.35 38.41 1.48 33.79 40.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 142 LEU B 8 LEU^? 6.38 O ACT B 304 A 165 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 10.71 51.79 38.53 9.13 52.40 40.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 6.28 42.91 37.89 5.54 43.26 39.89 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 142 LEU B 8 LEU^? 6.38 O ACT B 304 A 165 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 10.71 51.79 38.53 9.13 52.40 40.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 6.28 42.91 37.89 5.54 43.26 39.89 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 12.25 56.30 36.89 8.12 57.51 41.12 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s A 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 A 165 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s A 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 A 165 LYS C 98 LYS~? 7.72 O ACT C 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -19.31 41.45 39.34 -17.64 37.26 43.62 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s B 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 B 165 LYS A 31 LYS.? 10.36 O ACT A 303 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.28 25.07 38.68 7.82 26.15 40.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 0.69 33.35 38.41 1.48 33.79 40.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s B 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 B 165 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 6.28 25.07 38.68 7.82 26.15 40.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 0.69 33.35 38.41 1.48 33.79 40.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 B 142 LEU B 8 LEU^? 6.38 O ACT B 304 B 165 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 10.71 51.79 38.53 9.13 52.40 40.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 6.28 42.91 37.89 5.54 43.26 39.89 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 B 142 LEU B 8 LEU^? 6.38 O ACT B 304 B 165 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 10.71 51.79 38.53 9.13 52.40 40.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 6.28 42.91 37.89 5.54 43.26 39.89 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 12.25 56.30 36.89 8.12 57.51 41.12 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s B 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 B 165 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -4.83 43.06 38.74 -4.44 42.19 40.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s B 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 B 165 LYS C 98 LYS~? 7.72 O ACT C 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -4.83 43.06 38.74 -4.44 42.19 40.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.31 41.45 39.34 -17.64 37.26 43.62 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s C 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 C 165 LYS A 31 LYS.? 10.36 O ACT A 303 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.28 25.07 38.68 7.82 26.15 40.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 0.69 33.35 38.41 1.48 33.79 40.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s C 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 C 165 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 6.28 25.07 38.68 7.82 26.15 40.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 0.69 33.35 38.41 1.48 33.79 40.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 C 142 LEU B 8 LEU^? 6.38 O ACT B 304 C 165 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 10.71 51.79 38.53 9.13 52.40 40.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 6.28 42.91 37.89 5.54 43.26 39.89 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 C 142 LEU B 8 LEU^? 6.38 O ACT B 304 C 165 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 10.71 51.79 38.53 9.13 52.40 40.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 6.28 42.91 37.89 5.54 43.26 39.89 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 12.25 56.30 36.89 8.12 57.51 41.12 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s C 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 C 165 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s C 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 C 165 LYS C 98 LYS~? 7.72 O ACT C 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.31 41.45 39.34 -17.64 37.26 43.62 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s D 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 D 165 LYS A 31 LYS.? 10.36 O ACT A 303 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.28 25.07 38.68 7.82 26.15 40.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 0.69 33.35 38.41 1.48 33.79 40.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 99 TYR~? -4.58 CH3 ACT A 303s D 142 LEU A 8 LEU^? 7.10 OXT ACT A 303 D 165 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 6.28 25.07 38.68 7.82 26.15 40.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 0.69 33.35 38.41 1.48 33.79 40.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 D 142 LEU B 8 LEU^? 6.38 O ACT B 304 D 165 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 10.71 51.79 38.53 9.13 52.40 40.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 6.28 42.91 37.89 5.54 43.26 39.89 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 99 TYR~? 4.94 OXT ACT B 304 D 142 LEU B 8 LEU^? 6.38 O ACT B 304 D 165 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 10.71 51.79 38.53 9.13 52.40 40.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 6.28 42.91 37.89 5.54 43.26 39.89 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 12.25 56.30 36.89 8.12 57.51 41.12 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s D 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 D 165 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -16.24 47.41 43.58 -19.18 48.92 39.46 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR C 99 TYR~? -4.22 CH3 ACT C 301s D 142 LEU C 8 LEU^? 7.40 OXT ACT C 301 D 165 LYS C 98 LYS~? 7.72 O ACT C 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -14.59 42.37 40.43 -14.19 40.56 42.54 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -4.83 43.06 38.74 -4.44 42.19 40.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.31 41.45 39.34 -17.64 37.26 43.62 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 27 ARG~? 17.50 O ACT A 303 A 136 GLU A 77 GLU~? 21.92 O ACT C 301 A 246 GLU A 24 GLU~? 16.57 O ACT A 303 coo 13.48 30.30 107.06 11.75 30.99 109.44 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 9.46 32.37 115.82 8.50 34.20 115.47 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 11.99 34.33 109.92 10.08 34.19 110.77 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 136 GLU A 89 GLU^? 9.05 CL CL A 201 A 246 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.48 30.30 107.06 11.75 30.99 109.44 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 9.46 32.37 115.82 8.50 34.20 115.47 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 11.99 34.33 109.92 10.08 34.19 110.77 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 73 ARG~? 20.11 O ACT A 303 A 136 GLU A 23 GLU~? 17.46 O ACT A 303 A 246 GLU A 24 GLU~? 16.57 O ACT A 303 coo 13.48 30.30 107.06 11.75 30.99 109.44 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 9.46 32.37 115.82 8.50 34.20 115.47 -5.54 19.06 51.41 -6.99 18.34 52.80 coo 11.99 34.33 109.92 10.08 34.19 110.77 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 136 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.48 30.30 107.06 11.75 30.99 109.44 23.59 35.51 49.80 23.38 33.40 52.03 coo 9.46 32.37 115.82 8.50 34.20 115.47 23.16 43.48 49.34 24.66 42.52 50.51 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 136 GLU B 77 GLU~? 17.82 O ACT A 302 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.48 30.30 107.06 11.75 30.99 109.44 23.59 35.51 49.80 23.38 33.40 52.03 coo 9.46 32.37 115.82 8.50 34.20 115.47 25.37 33.50 41.00 25.99 35.47 41.49 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 136 GLU B 77 GLU~? 17.82 O ACT A 302 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.48 30.30 107.06 11.75 30.99 109.44 26.02 42.58 42.38 25.84 41.49 45.27 coo 9.46 32.37 115.82 8.50 34.20 115.47 25.37 33.50 41.00 25.99 35.47 41.49 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG B 57 ARG^? 10.43 O ACT B 304 A 136 GLU A 89 GLU^? 9.05 CL CL A 201 A 246 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.48 30.30 107.06 11.75 30.99 109.44 4.68 37.56 46.31 2.06 39.11 46.79 coo 9.46 32.37 115.82 8.50 34.20 115.47 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 11.99 34.33 109.92 10.08 34.19 110.77 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG B 57 ARG^? 10.43 O ACT B 304 A 136 GLU B 89 GLU^? 9.16 CL CL B 202 A 246 GLU B 59 GLU^? -6.17 O ACT B 304s coo 13.48 30.30 107.06 11.75 30.99 109.44 4.68 37.56 46.31 2.06 39.11 46.79 coo 9.46 32.37 115.82 8.50 34.20 115.47 3.69 38.42 36.29 2.58 38.79 38.06 coo 11.99 34.33 109.92 10.08 34.19 110.77 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG B 73 ARG~? 16.43 O ACT A 302 A 136 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.48 30.30 107.06 11.75 30.99 109.44 24.09 36.62 39.81 25.66 39.04 38.73 coo 9.46 32.37 115.82 8.50 34.20 115.47 23.16 43.48 49.34 24.66 42.52 50.51 coo 11.99 34.33 109.92 10.08 34.19 110.77 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 10 3 # 10 A 45 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 136 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 246 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 9.46 32.37 115.82 8.50 34.20 115.47 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 11.99 34.33 109.92 10.08 34.19 110.77 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 11 3 # 11 A 45 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 136 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 246 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 9.46 32.37 115.82 8.50 34.20 115.47 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 11.99 34.33 109.92 10.08 34.19 110.77 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 12 3 # 12 A 45 ARG C 57 ARG^? 6.12 O ACT B 304 A 136 GLU C 89 GLU^? 9.21 CL CL C 203 A 246 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 0.41 44.01 46.89 3.20 43.89 45.69 coo 9.46 32.37 115.82 8.50 34.20 115.47 0.03 43.20 36.88 0.18 41.91 38.57 coo 11.99 34.33 109.92 10.08 34.19 110.77 -3.08 44.06 44.69 -2.35 42.14 45.23 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 12 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 27 ARG~? 17.50 O ACT A 303 A 136 GLU A 77 GLU~? 21.92 O ACT C 301 A 246 GLU A 24 GLU~? 16.57 O ACT A 303 coo 13.94 29.84 106.80 11.67 30.40 108.79 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 9.52 31.97 115.23 8.45 33.74 114.72 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 11.92 33.82 109.35 10.10 33.50 110.39 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 136 GLU A 89 GLU^? 9.05 CL CL A 201 A 246 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.94 29.84 106.80 11.67 30.40 108.79 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 9.52 31.97 115.23 8.45 33.74 114.72 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 11.92 33.82 109.35 10.10 33.50 110.39 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 136 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.94 29.84 106.80 11.67 30.40 108.79 23.59 35.51 49.80 23.38 33.40 52.03 coo 9.52 31.97 115.23 8.45 33.74 114.72 23.16 43.48 49.34 24.66 42.52 50.51 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 136 GLU B 77 GLU~? 17.82 O ACT A 302 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.94 29.84 106.80 11.67 30.40 108.79 23.59 35.51 49.80 23.38 33.40 52.03 coo 9.52 31.97 115.23 8.45 33.74 114.72 25.37 33.50 41.00 25.99 35.47 41.49 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 136 GLU B 77 GLU~? 17.82 O ACT A 302 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.94 29.84 106.80 11.67 30.40 108.79 26.02 42.58 42.38 25.84 41.49 45.27 coo 9.52 31.97 115.23 8.45 33.74 114.72 25.37 33.50 41.00 25.99 35.47 41.49 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 57 ARG^? 10.43 O ACT B 304 A 136 GLU A 89 GLU^? 9.05 CL CL A 201 A 246 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.94 29.84 106.80 11.67 30.40 108.79 4.68 37.56 46.31 2.06 39.11 46.79 coo 9.52 31.97 115.23 8.45 33.74 114.72 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 11.92 33.82 109.35 10.10 33.50 110.39 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG B 73 ARG~? 16.43 O ACT A 302 A 136 GLU B 23 GLU~? 17.74 CH3 ACT B 304 A 246 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 13.94 29.84 106.80 11.67 30.40 108.79 24.09 36.62 39.81 25.66 39.04 38.73 coo 9.52 31.97 115.23 8.45 33.74 114.72 23.16 43.48 49.34 24.66 42.52 50.51 coo 11.92 33.82 109.35 10.10 33.50 110.39 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 136 GLU C 23 GLU~? 17.30 CH3 ACT C 301 A 246 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 9.52 31.97 115.23 8.45 33.74 114.72 -12.38 56.72 51.72 -12.36 58.38 53.06 coo 11.92 33.82 109.35 10.10 33.50 110.39 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 136 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 246 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 9.52 31.97 115.23 8.45 33.74 114.72 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 11.92 33.82 109.35 10.10 33.50 110.39 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 10 3 # 10 A 45 ARG C 57 ARG^? 6.12 O ACT B 304 A 136 GLU C 89 GLU^? 9.21 CL CL C 203 A 246 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 0.41 44.01 46.89 3.20 43.89 45.69 coo 9.52 31.97 115.23 8.45 33.74 114.72 0.03 43.20 36.88 0.18 41.91 38.57 coo 11.92 33.82 109.35 10.10 33.50 110.39 -3.08 44.06 44.69 -2.35 42.14 45.23 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 10 hits 1fob_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP B 51 TRP.? 15.53 OXT ACT A 303 A 317 GLU B 52 GLU.? 22.83 CH3 ACT B 304 A 365 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 79.91 26.87 38.77 78.95 23.18 37.81 1.36 36.15 59.32 1.00 34.54 55.75 coo 85.55 26.30 41.25 85.59 24.97 39.65 7.66 37.44 62.50 7.81 38.11 64.51 coo 83.47 25.30 27.10 83.44 27.82 25.29 -5.46 44.01 56.97 -5.03 47.01 56.50 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 1 hits 1g8o_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 47 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 161 TYR A 33 TYR.? -7.37 CH3 ACT A 303s coo 37.12 18.35 73.76 37.09 16.69 72.44 4.59 21.37 51.97 2.75 21.07 50.95 coo 29.81 8.06 73.13 30.21 10.11 72.95 2.98 31.06 60.86 4.11 29.82 59.55 coo 37.29 15.56 67.90 37.37 13.79 70.08 1.04 26.01 48.23 1.29 24.82 50.73 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B 47 ASP B 50 ASP.? 15.85 OXT ACT A 303 B 161 TYR A 33 TYR.? -7.37 CH3 ACT A 303s coo 53.87 35.49 53.22 55.44 35.72 54.61 4.59 21.37 51.97 2.75 21.07 50.95 coo 63.47 43.65 53.95 61.45 43.07 54.06 2.98 31.06 60.86 4.11 29.82 59.55 coo 56.38 35.81 59.19 58.25 35.77 57.10 1.04 26.01 48.23 1.29 24.82 50.73 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 7 LYS^? -3.09 CL CL A 201s 210 ARG A 27 ARG~? 17.50 O ACT A 303 225 ARG A 73 ARG~? 20.11 O ACT A 303 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.17 30.56 34.55 -1.45 32.28 29.77 coo 24.74 11.56 73.05 25.29 14.32 71.80 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 19 LYS~? 20.51 O ACT A 303 210 ARG B 57 ARG^? 10.43 O ACT B 304 225 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.68 37.56 46.31 2.06 39.11 46.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 26 LYS~? 7.74 CH3 ACT A 303 210 ARG B 57 ARG^? 10.43 O ACT B 304 225 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -2.24 19.72 44.66 2.39 20.87 47.23 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.68 37.56 46.31 2.06 39.11 46.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 31 LYS.? 10.36 O ACT A 303 210 ARG A 57 ARG^? 9.16 OXT ACT C 301 225 ARG B 57 ARG^? 10.43 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 3.36 21.23 42.37 3.31 17.75 38.68 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 31 LYS.? 10.36 O ACT A 303 210 ARG B 57 ARG^? 10.43 O ACT B 304 225 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 3.36 21.23 42.37 3.31 17.75 38.68 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.68 37.56 46.31 2.06 39.11 46.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS B 7 LYS^? -3.05 CL CL B 202s 210 ARG A 57 ARG^? 9.16 OXT ACT C 301 225 ARG C 57 ARG^? 6.12 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 8.57 44.02 33.90 7.44 42.15 29.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS B 7 LYS^? -3.05 CL CL B 202s 210 ARG B 27 ARG~? 17.68 OXT ACT B 304 225 ARG B 73 ARG~? 16.43 O ACT A 302 coo 17.51 28.50 73.42 17.24 23.02 75.86 8.57 44.02 33.90 7.44 42.15 29.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 26.02 42.58 42.38 25.84 41.49 45.27 coo 27.81 15.44 77.10 25.66 16.50 75.19 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS B 26 LYS~? 10.63 CH3 ACT B 304 210 ARG C 57 ARG^? 6.12 O ACT B 304 225 ARG B 57 ARG^? 10.43 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 20.18 46.61 43.20 19.00 49.55 48.67 coo 24.74 11.56 73.05 25.29 14.32 71.80 0.41 44.01 46.89 3.20 43.89 45.69 coo 27.81 15.44 77.10 25.66 16.50 75.19 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS B 31 LYS.? 11.57 OXT ACT B 304 210 ARG B 57 ARG^? 10.43 O ACT B 304 225 ARG C 57 ARG^? 6.12 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 15.94 50.91 41.57 17.07 55.01 36.93 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.68 37.56 46.31 2.06 39.11 46.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS B 31 LYS.? 11.57 OXT ACT B 304 210 ARG C 57 ARG^? 6.12 O ACT B 304 225 ARG B 57 ARG^? 10.43 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 15.94 50.91 41.57 17.07 55.01 36.93 coo 24.74 11.56 73.05 25.29 14.32 71.80 0.41 44.01 46.89 3.20 43.89 45.69 coo 27.81 15.44 77.10 25.66 16.50 75.19 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS C 7 LYS^? -3.09 CL CL C 203s 210 ARG B 57 ARG^? 10.43 O ACT B 304 225 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.68 37.56 46.31 2.06 39.11 46.79 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS C 7 LYS^? -3.09 CL CL C 203s 210 ARG C 27 ARG~? 17.31 CH3 ACT C 301 225 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 27.81 15.44 77.10 25.66 16.50 75.19 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS C 31 LYS.? 9.88 CH3 ACT C 301 210 ARG A 57 ARG^? 9.16 OXT ACT C 301 225 ARG C 57 ARG^? 6.12 O ACT B 304 coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS C 31 LYS.? 9.88 CH3 ACT C 301 210 ARG C 57 ARG^? 6.12 O ACT B 304 225 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 24.74 11.56 73.05 25.29 14.32 71.80 0.41 44.01 46.89 3.20 43.89 45.69 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.96 37.09 46.95 -2.53 39.44 48.84 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 14 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 79 PHE.? 10.94 O ACT C 301 A 298 ASP C 2 ASP.? 15.16 CH3 ACT C 301 A 329 LYS C 98 LYS~? 7.72 O ACT C 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -16.37 31.43 43.34 -14.13 32.93 42.56 coo 2.59 0.29 25.55 4.65 0.18 25.07 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 79 PHE.? 10.72 CH3 ACT A 303 A 298 ASP A 2 ASP.? 6.75 OXT ACT A 302 A 329 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 16.82 28.73 40.58 14.28 29.90 40.31 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.13 27.42 32.13 14.80 25.81 31.83 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE C 79 PHE.? 11.51 CH3 ACT B 304 A 298 ASP B 2 ASP.? 15.66 OXT ACT B 304 A 329 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 2.54 59.12 41.47 2.64 56.35 41.07 coo 2.59 0.29 25.55 4.65 0.18 25.07 3.21 59.71 32.87 5.22 59.30 32.47 coo 12.42 6.10 23.27 9.95 1.57 20.16 12.25 56.30 36.89 8.12 57.51 41.12 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 79 PHE.? 10.94 O ACT C 301 B 298 ASP C 2 ASP.? 15.16 CH3 ACT C 301 B 329 LYS C 98 LYS~? 7.72 O ACT C 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -16.37 31.43 43.34 -14.13 32.93 42.56 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 79 PHE.? 10.72 CH3 ACT A 303 B 298 ASP A 2 ASP.? 6.75 OXT ACT A 302 B 329 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 16.82 28.73 40.58 14.28 29.90 40.31 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.13 27.42 32.13 14.80 25.81 31.83 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE C 79 PHE.? 11.51 CH3 ACT B 304 B 298 ASP B 2 ASP.? 15.66 OXT ACT B 304 B 329 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 2.54 59.12 41.47 2.64 56.35 41.07 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 3.21 59.71 32.87 5.22 59.30 32.47 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 12.25 56.30 36.89 8.12 57.51 41.12 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 79 PHE.? 10.94 O ACT C 301 C 298 ASP C 2 ASP.? 15.16 CH3 ACT C 301 C 329 LYS C 98 LYS~? 7.72 O ACT C 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -16.37 31.43 43.34 -14.13 32.93 42.56 coo 24.10 66.43 63.33 24.18 64.30 63.40 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 79 PHE.? 10.72 CH3 ACT A 303 C 298 ASP A 2 ASP.? 6.75 OXT ACT A 302 C 329 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 17.41 60.57 64.39 18.40 58.12 65.34 16.82 28.73 40.58 14.28 29.90 40.31 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.13 27.42 32.13 14.80 25.81 31.83 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE C 79 PHE.? 11.51 CH3 ACT B 304 C 298 ASP B 2 ASP.? 15.66 OXT ACT B 304 C 329 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 17.41 60.57 64.39 18.40 58.12 65.34 2.54 59.12 41.47 2.64 56.35 41.07 coo 24.10 66.43 63.33 24.18 64.30 63.40 3.21 59.71 32.87 5.22 59.30 32.47 coo 27.64 56.61 58.17 22.18 57.92 60.36 12.25 56.30 36.89 8.12 57.51 41.12 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 79 PHE.? 10.94 O ACT C 301 D 298 ASP C 2 ASP.? 15.16 CH3 ACT C 301 D 329 LYS C 98 LYS~? 7.72 O ACT C 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -16.37 31.43 43.34 -14.13 32.93 42.56 coo 29.72 46.46 83.60 30.79 47.36 81.99 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 79 PHE.? 10.72 CH3 ACT A 303 D 298 ASP A 2 ASP.? 6.75 OXT ACT A 302 D 329 LYS A 98 LYS~? 7.98 CH3 ACT A 303 coo 35.44 53.35 83.81 35.65 54.53 81.28 16.82 28.73 40.58 14.28 29.90 40.31 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.13 27.42 32.13 14.80 25.81 31.83 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.24 21.45 37.02 12.73 25.01 40.79 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE C 79 PHE.? 11.51 CH3 ACT B 304 D 298 ASP B 2 ASP.? 15.66 OXT ACT B 304 D 329 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 35.44 53.35 83.81 35.65 54.53 81.28 2.54 59.12 41.47 2.64 56.35 41.07 coo 29.72 46.46 83.60 30.79 47.36 81.99 3.21 59.71 32.87 5.22 59.30 32.47 coo 36.89 44.91 74.55 37.33 48.94 79.01 12.25 56.30 36.89 8.12 57.51 41.12 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN B 75 GLN~? 7.58 OXT ACT A 302 A 296 GLU B 76 GLU~? 14.44 O ACT A 302 A 383 TYR B 82 TYR.? 16.39 CH3 ACT A 303 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 19.05 29.20 35.92 18.84 29.16 33.81 coo 40.93 4.45 2.36 38.91 3.75 2.26 25.35 31.50 37.53 26.42 33.21 36.85 coo 30.54 7.22 6.23 31.38 5.79 3.97 19.70 29.01 48.72 22.05 29.62 50.09 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 1 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 50 ASP.? 19.58 O ACT C 301 A 327 GLU B 65 GLU~? 12.71 CL CL B 202 A 339 ARG B 69 ARG~? 14.94 O ACT A 302 coo 85.81 57.99 116.01 86.03 55.86 115.89 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 75.11 41.01 160.30 76.65 40.06 161.41 17.56 45.22 27.93 16.40 47.01 27.72 coo 82.23 40.35 159.87 85.09 40.67 161.01 22.62 42.29 33.58 21.65 45.19 33.32 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 1 hits 1hto_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU B 76 GLU~? 14.44 O ACT A 302 A 475 GLU B 77 GLU~? 17.82 O ACT A 302 A 477 ARG B 73 ARG~? 16.43 O ACT A 302 coo 13.27 46.15 59.96 13.96 44.19 59.76 25.35 31.50 37.53 26.42 33.21 36.85 coo 9.69 44.01 59.12 10.58 42.11 58.89 25.37 33.50 41.00 25.99 35.47 41.49 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 2 3 # 2 A 311 GLU B 77 GLU~? 17.82 O ACT A 302 A 475 GLU B 76 GLU~? 14.44 O ACT A 302 A 477 ARG B 73 ARG~? 16.43 O ACT A 302 coo 13.27 46.15 59.96 13.96 44.19 59.76 25.37 33.50 41.00 25.99 35.47 41.49 coo 9.69 44.01 59.12 10.58 42.11 58.89 25.35 31.50 37.53 26.42 33.21 36.85 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 3 3 # 3 A 311 GLU C 76 GLU~? 20.08 CL CL C 203 A 475 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 477 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 9.69 44.01 59.12 10.58 42.11 58.89 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 13.49 45.17 55.56 13.84 42.22 54.75 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 4 3 # 4 A 311 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 475 GLU C 76 GLU~? 20.08 CL CL C 203 A 477 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 13.27 46.15 59.96 13.96 44.19 59.76 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 9.69 44.01 59.12 10.58 42.11 58.89 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 13.49 45.17 55.56 13.84 42.22 54.75 -8.01 61.75 41.62 -10.44 63.15 40.34 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 4 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU B 76 GLU~? 14.44 O ACT A 302 B 475 GLU B 77 GLU~? 17.82 O ACT A 302 B 477 ARG B 73 ARG~? 16.43 O ACT A 302 coo 42.69 29.93 84.57 42.00 28.96 82.83 25.35 31.50 37.53 26.42 33.21 36.85 coo 46.14 28.45 82.89 45.10 27.86 81.15 25.37 33.50 41.00 25.99 35.47 41.49 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 2 3 # 2 B 311 GLU B 77 GLU~? 17.82 O ACT A 302 B 475 GLU B 76 GLU~? 14.44 O ACT A 302 B 477 ARG B 73 ARG~? 16.43 O ACT A 302 coo 42.69 29.93 84.57 42.00 28.96 82.83 25.37 33.50 41.00 25.99 35.47 41.49 coo 46.14 28.45 82.89 45.10 27.86 81.15 25.35 31.50 37.53 26.42 33.21 36.85 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 3 3 # 3 B 311 GLU C 76 GLU~? 20.08 CL CL C 203 B 475 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 477 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 46.14 28.45 82.89 45.10 27.86 81.15 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 42.47 25.53 85.29 42.25 23.66 82.85 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 4 3 # 4 B 311 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 475 GLU C 76 GLU~? 20.08 CL CL C 203 B 477 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 42.69 29.93 84.57 42.00 28.96 82.83 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 46.14 28.45 82.89 45.10 27.86 81.15 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 42.47 25.53 85.29 42.25 23.66 82.85 -8.01 61.75 41.62 -10.44 63.15 40.34 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 4 hits 1i19_c01 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 14 GLU^? 15.87 O ACT C 301 A 369 ARG A 20 ARG~? 20.10 O ACT A 303 A 372 TYR A 82 TYR.? 16.37 O ACT C 301 coo 16.47 7.99 31.03 17.36 6.90 32.63 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 16.01 4.58 27.39 13.82 5.38 28.94 -16.19 29.33 51.63 -16.36 27.05 53.19 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU A 89 GLU^? 9.05 CL CL A 201 A 369 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 372 TYR A 87 TYR^? 7.71 OXT ACT C 301 coo 16.47 7.99 31.03 17.36 6.90 32.63 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 16.01 4.58 27.39 13.82 5.38 28.94 -6.80 37.10 39.85 -4.98 38.28 41.61 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU B 77 GLU~? 17.82 O ACT A 302 A 369 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 372 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 16.47 7.99 31.03 17.36 6.90 32.63 25.37 33.50 41.00 25.99 35.47 41.49 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 23.59 35.51 49.80 23.38 33.40 52.03 coo 16.01 4.58 27.39 13.82 5.38 28.94 20.54 33.17 44.58 21.91 35.42 45.49 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 4 3 # 4 A 267 GLU B 89 GLU^? 9.16 CL CL B 202 A 369 ARG B 57 ARG^? 10.43 O ACT B 304 A 372 TYR B 87 TYR^? 7.07 OXT ACT A 303 coo 16.47 7.99 31.03 17.36 6.90 32.63 3.69 38.42 36.29 2.58 38.79 38.06 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 4.68 37.56 46.31 2.06 39.11 46.79 coo 16.01 4.58 27.39 13.82 5.38 28.94 6.95 34.35 38.83 5.26 35.08 40.94 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 5 3 # 5 A 267 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 369 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 372 TYR C 78 TYR~? 17.53 CH3 ACT B 304 coo 16.47 7.99 31.03 17.36 6.90 32.63 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 16.01 4.58 27.39 13.82 5.38 28.94 -2.76 60.08 45.99 -5.32 60.21 47.12 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 6 3 # 6 A 267 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 369 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 372 TYR C 78 TYR~? 17.53 CH3 ACT B 304 coo 16.47 7.99 31.03 17.36 6.90 32.63 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 16.01 4.58 27.39 13.82 5.38 28.94 -2.76 60.08 45.99 -5.32 60.21 47.12 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 6 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 49 VAL.? 24.61 O ACT C 301 A 200 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 226 LYS A 19 LYS~? 20.51 O ACT A 303 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.69 37.55 67.82 -6.78 37.50 69.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 2.98 31.06 60.86 4.11 29.82 59.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -5.86 23.51 54.21 -8.85 19.33 56.46 1i29_c03 source 1i29 CSDB : 1 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -2.24 19.72 44.66 2.39 20.87 47.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.36 21.23 42.37 3.31 17.75 38.68 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -2.24 19.72 44.66 2.39 20.87 47.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.36 21.23 42.37 3.31 17.75 38.68 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -2.24 19.72 44.66 2.39 20.87 47.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -2.24 19.72 44.66 2.39 20.87 47.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.24 21.45 37.02 12.73 25.01 40.79 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.24 21.45 37.02 12.73 25.01 40.79 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.24 21.45 37.02 12.73 25.01 40.79 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.36 21.23 42.37 3.31 17.75 38.68 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.24 21.45 37.02 12.73 25.01 40.79 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 3.36 21.23 42.37 3.31 17.75 38.68 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 20.18 46.61 43.20 19.00 49.55 48.67 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.94 50.91 41.57 17.07 55.01 36.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 20.18 46.61 43.20 19.00 49.55 48.67 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.94 50.91 41.57 17.07 55.01 36.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.18 46.61 43.20 19.00 49.55 48.67 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.18 46.61 43.20 19.00 49.55 48.67 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 12.25 56.30 36.89 8.12 57.51 41.12 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 12.25 56.30 36.89 8.12 57.51 41.12 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 12.25 56.30 36.89 8.12 57.51 41.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.94 50.91 41.57 17.07 55.01 36.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 12.25 56.30 36.89 8.12 57.51 41.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.94 50.91 41.57 17.07 55.01 36.93 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 26 LYS~? 10.00 O ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 98 LYS~? 7.72 O ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.02 51.38 31.36 -13.86 50.18 29.63 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 24 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -2.24 19.72 44.66 2.39 20.87 47.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -2.24 19.72 44.66 2.39 20.87 47.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -2.24 19.72 44.66 2.39 20.87 47.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 3.36 21.23 42.37 3.31 17.75 38.68 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -2.24 19.72 44.66 2.39 20.87 47.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 3.36 21.23 42.37 3.31 17.75 38.68 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -2.24 19.72 44.66 2.39 20.87 47.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 3.36 21.23 42.37 3.31 17.75 38.68 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.24 21.45 37.02 12.73 25.01 40.79 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 3.36 21.23 42.37 3.31 17.75 38.68 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.24 21.45 37.02 12.73 25.01 40.79 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.24 21.45 37.02 12.73 25.01 40.79 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.24 21.45 37.02 12.73 25.01 40.79 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.24 21.45 37.02 12.73 25.01 40.79 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.36 21.23 42.37 3.31 17.75 38.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.18 46.61 43.20 19.00 49.55 48.67 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.18 46.61 43.20 19.00 49.55 48.67 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.18 46.61 43.20 19.00 49.55 48.67 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.94 50.91 41.57 17.07 55.01 36.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 20.18 46.61 43.20 19.00 49.55 48.67 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.94 50.91 41.57 17.07 55.01 36.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 12.25 56.30 36.89 8.12 57.51 41.12 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.94 50.91 41.57 17.07 55.01 36.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 12.25 56.30 36.89 8.12 57.51 41.12 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 12.25 56.30 36.89 8.12 57.51 41.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 12.25 56.30 36.89 8.12 57.51 41.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 12.25 56.30 36.89 8.12 57.51 41.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.94 50.91 41.57 17.07 55.01 36.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 26 LYS~? 10.00 O ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 98 LYS~? 7.72 O ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.31 41.45 39.34 -17.64 37.26 43.62 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.31 41.45 39.34 -17.64 37.26 43.62 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.31 41.45 39.34 -17.64 37.26 43.62 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -19.31 41.45 39.34 -17.64 37.26 43.62 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.24 47.41 43.58 -19.18 48.92 39.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.02 51.38 31.36 -13.86 50.18 29.63 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 27 hits 1idt_c01 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 2 ASP.? 6.75 OXT ACT A 302 A 204 GLU A 97 GLU~? 8.23 OXT ACT A 302 A 279 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 5.85 5.60 30.32 5.00 7.49 29.88 16.13 27.42 32.13 14.80 25.81 31.83 coo 7.79 1.83 27.81 9.08 3.25 26.92 11.06 22.89 31.44 12.49 24.45 31.70 coo 8.22 7.77 18.64 7.58 8.47 21.28 6.28 25.07 38.68 7.82 26.15 40.75 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 2 ASP.? 15.66 OXT ACT B 304 A 204 GLU B 97 GLU~? 14.31 OXT ACT B 304 A 279 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 5.85 5.60 30.32 5.00 7.49 29.88 3.21 59.71 32.87 5.22 59.30 32.47 coo 7.79 1.83 27.81 9.08 3.25 26.92 9.46 57.70 31.80 7.43 57.99 32.35 coo 8.22 7.77 18.64 7.58 8.47 21.28 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP C 2 ASP.? 15.16 CH3 ACT C 301 A 204 GLU C 97 GLU~? 13.74 CH3 ACT C 301 A 279 TYR C 99 TYR~? -4.22 CH3 ACT C 301s coo 5.85 5.60 30.32 5.00 7.49 29.88 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 7.79 1.83 27.81 9.08 3.25 26.92 -19.69 38.70 34.05 -19.03 36.73 34.44 coo 8.22 7.77 18.64 7.58 8.47 21.28 -14.59 42.37 40.43 -14.19 40.56 42.54 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 3 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 77 GLU~? 21.92 O ACT C 301 A 61 GLU A 14 GLU^? 15.87 O ACT C 301 A 162 HIS A 81 HIS.? 19.43 O ACT C 301 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -16.08 22.27 46.45 -17.89 21.29 46.96 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -12.43 31.41 55.22 -14.25 31.05 56.29 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -20.82 26.38 49.60 -21.72 24.86 48.45 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 581 ARG A 44 ARG.? 19.54 O ACT C 301 A 713 ARG A 47 ARG.? 21.65 CH3 ACT B 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 1.93 40.93 64.24 4.88 41.80 64.42 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 1 hits 1jqn_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 41 GLU.? 4.97 O ACT C 301 A 56 LYS C 26 LYS~? 10.00 O ACT C 301 A 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 41 GLU.? 4.97 O ACT C 301 A 56 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 64 GLU~? 8.31 CL CL A 201 A 56 LYS A 7 LYS^? -3.09 CL CL A 201s A 258 ARG A 69 ARG~? 15.12 O ACT A 303 coo 42.33 1.56 26.99 42.38 2.91 28.66 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.17 30.56 34.55 -1.45 32.28 29.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU A 89 GLU^? 9.05 CL CL A 201 A 56 LYS A 7 LYS^? -3.09 CL CL A 201s A 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.17 30.56 34.55 -1.45 32.28 29.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU A 89 GLU^? 9.05 CL CL A 201 A 56 LYS A 7 LYS^? -3.09 CL CL A 201s A 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.17 30.56 34.55 -1.45 32.28 29.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 56 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 42.33 1.56 26.99 42.38 2.91 28.66 4.59 21.37 51.97 2.75 21.07 50.95 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -2.24 19.72 44.66 2.39 20.87 47.23 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 56 LYS A 31 LYS.? 10.36 O ACT A 303 A 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 42.33 1.56 26.99 42.38 2.91 28.66 4.59 21.37 51.97 2.75 21.07 50.95 coo 38.45 -0.44 19.89 37.36 0.90 25.90 3.36 21.23 42.37 3.31 17.75 38.68 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU B 64 GLU~? 8.32 CL CL B 202 A 56 LYS B 7 LYS^? -3.05 CL CL B 202s A 258 ARG B 69 ARG~? 14.94 O ACT A 302 coo 42.33 1.56 26.99 42.38 2.91 28.66 11.55 44.58 28.21 11.34 45.03 26.14 coo 38.45 -0.44 19.89 37.36 0.90 25.90 8.57 44.02 33.90 7.44 42.15 29.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU B 89 GLU^? 9.16 CL CL B 202 A 56 LYS A 7 LYS^? -3.09 CL CL A 201s A 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 3.69 38.42 36.29 2.58 38.79 38.06 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.17 30.56 34.55 -1.45 32.28 29.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 A 2 GLU B 89 GLU^? 9.16 CL CL B 202 A 56 LYS A 7 LYS^? -3.09 CL CL A 201s A 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 3.69 38.42 36.29 2.58 38.79 38.06 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.17 30.56 34.55 -1.45 32.28 29.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 A 2 GLU B 89 GLU^? 9.16 CL CL B 202 A 56 LYS B 7 LYS^? -3.05 CL CL B 202s A 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 3.69 38.42 36.29 2.58 38.79 38.06 coo 38.45 -0.44 19.89 37.36 0.90 25.90 8.57 44.02 33.90 7.44 42.15 29.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 A 2 GLU B 89 GLU^? 9.16 CL CL B 202 A 56 LYS B 7 LYS^? -3.05 CL CL B 202s A 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 3.69 38.42 36.29 2.58 38.79 38.06 coo 38.45 -0.44 19.89 37.36 0.90 25.90 8.57 44.02 33.90 7.44 42.15 29.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 A 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 56 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.43 50.94 51.34 17.50 52.11 49.94 coo 38.45 -0.44 19.89 37.36 0.90 25.90 20.18 46.61 43.20 19.00 49.55 48.67 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 A 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 56 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.43 50.94 51.34 17.50 52.11 49.94 coo 38.45 -0.44 19.89 37.36 0.90 25.90 15.94 50.91 41.57 17.07 55.01 36.93 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 A 2 GLU C 89 GLU^? 9.21 CL CL C 203 A 56 LYS B 7 LYS^? -3.05 CL CL B 202s A 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 0.03 43.20 36.88 0.18 41.91 38.57 coo 38.45 -0.44 19.89 37.36 0.90 25.90 8.57 44.02 33.90 7.44 42.15 29.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 A 2 GLU C 89 GLU^? 9.21 CL CL C 203 A 56 LYS B 7 LYS^? -3.05 CL CL B 202s A 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 0.03 43.20 36.88 0.18 41.91 38.57 coo 38.45 -0.44 19.89 37.36 0.90 25.90 8.57 44.02 33.90 7.44 42.15 29.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 A 2 GLU C 89 GLU^? 9.21 CL CL C 203 A 56 LYS C 7 LYS^? -3.09 CL CL C 203s A 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 0.03 43.20 36.88 0.18 41.91 38.57 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 A 2 GLU C 89 GLU^? 9.21 CL CL C 203 A 56 LYS C 7 LYS^? -3.09 CL CL C 203s A 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 0.03 43.20 36.88 0.18 41.91 38.57 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 0.41 44.01 46.89 3.20 43.89 45.69 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 18 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 41 GLU.? 4.97 O ACT C 301 B 56 LYS C 26 LYS~? 10.00 O ACT C 301 B 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 2.64 1.83 34.81 1.56 1.13 32.02 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 41 GLU.? 4.97 O ACT C 301 B 56 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 2.64 1.83 34.81 1.56 1.13 32.02 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 64 GLU~? 8.31 CL CL A 201 B 56 LYS A 7 LYS^? -3.09 CL CL A 201s B 258 ARG A 69 ARG~? 15.12 O ACT A 303 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.17 30.56 34.55 -1.45 32.28 29.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU A 89 GLU^? 9.05 CL CL A 201 B 56 LYS A 7 LYS^? -3.09 CL CL A 201s B 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.17 30.56 34.55 -1.45 32.28 29.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU A 89 GLU^? 9.05 CL CL A 201 B 56 LYS A 7 LYS^? -3.09 CL CL A 201s B 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.17 30.56 34.55 -1.45 32.28 29.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU A 89 GLU^? 9.05 CL CL A 201 B 56 LYS C 7 LYS^? -3.09 CL CL C 203s B 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU A 89 GLU^? 9.05 CL CL A 201 B 56 LYS C 7 LYS^? -3.09 CL CL C 203s B 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B 56 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.59 21.37 51.97 2.75 21.07 50.95 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -2.24 19.72 44.66 2.39 20.87 47.23 coo 2.64 1.83 34.81 1.56 1.13 32.02 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B 56 LYS A 31 LYS.? 10.36 O ACT A 303 B 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.59 21.37 51.97 2.75 21.07 50.95 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 3.36 21.23 42.37 3.31 17.75 38.68 coo 2.64 1.83 34.81 1.56 1.13 32.02 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU B 64 GLU~? 8.32 CL CL B 202 B 56 LYS B 7 LYS^? -3.05 CL CL B 202s B 258 ARG B 69 ARG~? 14.94 O ACT A 302 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 11.55 44.58 28.21 11.34 45.03 26.14 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 8.57 44.02 33.90 7.44 42.15 29.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU B 89 GLU^? 9.16 CL CL B 202 B 56 LYS A 7 LYS^? -3.09 CL CL A 201s B 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.69 38.42 36.29 2.58 38.79 38.06 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.17 30.56 34.55 -1.45 32.28 29.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU B 89 GLU^? 9.16 CL CL B 202 B 56 LYS A 7 LYS^? -3.09 CL CL A 201s B 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.69 38.42 36.29 2.58 38.79 38.06 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.17 30.56 34.55 -1.45 32.28 29.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU B 89 GLU^? 9.16 CL CL B 202 B 56 LYS B 7 LYS^? -3.05 CL CL B 202s B 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.69 38.42 36.29 2.58 38.79 38.06 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 8.57 44.02 33.90 7.44 42.15 29.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 B 2 GLU B 89 GLU^? 9.16 CL CL B 202 B 56 LYS B 7 LYS^? -3.05 CL CL B 202s B 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.69 38.42 36.29 2.58 38.79 38.06 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 8.57 44.02 33.90 7.44 42.15 29.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 B 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 B 56 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.43 50.94 51.34 17.50 52.11 49.94 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 20.18 46.61 43.20 19.00 49.55 48.67 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 B 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 B 56 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.43 50.94 51.34 17.50 52.11 49.94 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 15.94 50.91 41.57 17.07 55.01 36.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 B 2 GLU C 89 GLU^? 9.21 CL CL C 203 B 56 LYS B 7 LYS^? -3.05 CL CL B 202s B 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 0.03 43.20 36.88 0.18 41.91 38.57 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 8.57 44.02 33.90 7.44 42.15 29.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 B 2 GLU C 89 GLU^? 9.21 CL CL C 203 B 56 LYS B 7 LYS^? -3.05 CL CL B 202s B 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 0.03 43.20 36.88 0.18 41.91 38.57 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 8.57 44.02 33.90 7.44 42.15 29.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 B 2 GLU C 89 GLU^? 9.21 CL CL C 203 B 56 LYS C 7 LYS^? -3.09 CL CL C 203s B 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 0.03 43.20 36.88 0.18 41.91 38.57 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 B 2 GLU C 89 GLU^? 9.21 CL CL C 203 B 56 LYS C 7 LYS^? -3.09 CL CL C 203s B 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 0.03 43.20 36.88 0.18 41.91 38.57 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 0.41 44.01 46.89 3.20 43.89 45.69 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 20 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 41 GLU.? 4.97 O ACT C 301 C 56 LYS C 26 LYS~? 10.00 O ACT C 301 C 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 41 GLU.? 4.97 O ACT C 301 C 56 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 64 GLU~? 8.31 CL CL A 201 C 56 LYS A 7 LYS^? -3.09 CL CL A 201s C 258 ARG A 69 ARG~? 15.12 O ACT A 303 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.17 30.56 34.55 -1.45 32.28 29.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU A 89 GLU^? 9.05 CL CL A 201 C 56 LYS A 7 LYS^? -3.09 CL CL A 201s C 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.17 30.56 34.55 -1.45 32.28 29.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU A 89 GLU^? 9.05 CL CL A 201 C 56 LYS A 7 LYS^? -3.09 CL CL A 201s C 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.17 30.56 34.55 -1.45 32.28 29.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU A 89 GLU^? 9.05 CL CL A 201 C 56 LYS C 7 LYS^? -3.09 CL CL C 203s C 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU A 89 GLU^? 9.05 CL CL A 201 C 56 LYS C 7 LYS^? -3.09 CL CL C 203s C 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 C 56 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.59 21.37 51.97 2.75 21.07 50.95 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -2.24 19.72 44.66 2.39 20.87 47.23 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 C 56 LYS A 31 LYS.? 10.36 O ACT A 303 C 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.59 21.37 51.97 2.75 21.07 50.95 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 3.36 21.23 42.37 3.31 17.75 38.68 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU B 64 GLU~? 8.32 CL CL B 202 C 56 LYS B 7 LYS^? -3.05 CL CL B 202s C 258 ARG B 69 ARG~? 14.94 O ACT A 302 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 11.55 44.58 28.21 11.34 45.03 26.14 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 8.57 44.02 33.90 7.44 42.15 29.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU B 89 GLU^? 9.16 CL CL B 202 C 56 LYS A 7 LYS^? -3.09 CL CL A 201s C 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.69 38.42 36.29 2.58 38.79 38.06 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.17 30.56 34.55 -1.45 32.28 29.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU B 89 GLU^? 9.16 CL CL B 202 C 56 LYS A 7 LYS^? -3.09 CL CL A 201s C 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.69 38.42 36.29 2.58 38.79 38.06 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.17 30.56 34.55 -1.45 32.28 29.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU B 89 GLU^? 9.16 CL CL B 202 C 56 LYS B 7 LYS^? -3.05 CL CL B 202s C 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.69 38.42 36.29 2.58 38.79 38.06 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 8.57 44.02 33.90 7.44 42.15 29.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 C 2 GLU B 89 GLU^? 9.16 CL CL B 202 C 56 LYS B 7 LYS^? -3.05 CL CL B 202s C 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.69 38.42 36.29 2.58 38.79 38.06 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 8.57 44.02 33.90 7.44 42.15 29.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 C 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 C 56 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.43 50.94 51.34 17.50 52.11 49.94 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 20.18 46.61 43.20 19.00 49.55 48.67 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 C 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 C 56 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.43 50.94 51.34 17.50 52.11 49.94 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 15.94 50.91 41.57 17.07 55.01 36.93 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 C 2 GLU C 89 GLU^? 9.21 CL CL C 203 C 56 LYS B 7 LYS^? -3.05 CL CL B 202s C 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 0.03 43.20 36.88 0.18 41.91 38.57 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 8.57 44.02 33.90 7.44 42.15 29.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 C 2 GLU C 89 GLU^? 9.21 CL CL C 203 C 56 LYS B 7 LYS^? -3.05 CL CL B 202s C 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 0.03 43.20 36.88 0.18 41.91 38.57 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 8.57 44.02 33.90 7.44 42.15 29.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 C 2 GLU C 89 GLU^? 9.21 CL CL C 203 C 56 LYS C 7 LYS^? -3.09 CL CL C 203s C 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 0.03 43.20 36.88 0.18 41.91 38.57 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 C 2 GLU C 89 GLU^? 9.21 CL CL C 203 C 56 LYS C 7 LYS^? -3.09 CL CL C 203s C 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 0.03 43.20 36.88 0.18 41.91 38.57 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 0.41 44.01 46.89 3.20 43.89 45.69 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 20 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 41 GLU.? 4.97 O ACT C 301 D 56 LYS C 26 LYS~? 10.00 O ACT C 301 D 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 41 GLU.? 4.97 O ACT C 301 D 56 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 258 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 64 GLU~? 8.31 CL CL A 201 D 56 LYS A 7 LYS^? -3.09 CL CL A 201s D 258 ARG A 69 ARG~? 15.12 O ACT A 303 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.17 30.56 34.55 -1.45 32.28 29.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU A 89 GLU^? 9.05 CL CL A 201 D 56 LYS A 7 LYS^? -3.09 CL CL A 201s D 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.17 30.56 34.55 -1.45 32.28 29.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU A 89 GLU^? 9.05 CL CL A 201 D 56 LYS A 7 LYS^? -3.09 CL CL A 201s D 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.17 30.56 34.55 -1.45 32.28 29.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU A 89 GLU^? 9.05 CL CL A 201 D 56 LYS C 7 LYS^? -3.09 CL CL C 203s D 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU A 89 GLU^? 9.05 CL CL A 201 D 56 LYS C 7 LYS^? -3.09 CL CL C 203s D 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -1.24 36.58 37.23 -1.06 38.29 38.51 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 D 56 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.59 21.37 51.97 2.75 21.07 50.95 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -2.24 19.72 44.66 2.39 20.87 47.23 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU B 41 GLU.? 9.71 CH3 ACT A 303 D 56 LYS A 31 LYS.? 10.36 O ACT A 303 D 258 ARG B 39 ARG.? 13.46 OXT ACT A 303 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.59 21.37 51.97 2.75 21.07 50.95 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 3.36 21.23 42.37 3.31 17.75 38.68 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 2.53 31.11 56.62 -0.26 29.95 56.31 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU B 64 GLU~? 8.32 CL CL B 202 D 56 LYS B 7 LYS^? -3.05 CL CL B 202s D 258 ARG B 69 ARG~? 14.94 O ACT A 302 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 11.55 44.58 28.21 11.34 45.03 26.14 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 8.57 44.02 33.90 7.44 42.15 29.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU B 89 GLU^? 9.16 CL CL B 202 D 56 LYS A 7 LYS^? -3.09 CL CL A 201s D 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.69 38.42 36.29 2.58 38.79 38.06 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.17 30.56 34.55 -1.45 32.28 29.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU B 89 GLU^? 9.16 CL CL B 202 D 56 LYS A 7 LYS^? -3.09 CL CL A 201s D 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.69 38.42 36.29 2.58 38.79 38.06 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.17 30.56 34.55 -1.45 32.28 29.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU B 89 GLU^? 9.16 CL CL B 202 D 56 LYS B 7 LYS^? -3.05 CL CL B 202s D 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.69 38.42 36.29 2.58 38.79 38.06 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 8.57 44.02 33.90 7.44 42.15 29.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 D 2 GLU B 89 GLU^? 9.16 CL CL B 202 D 56 LYS B 7 LYS^? -3.05 CL CL B 202s D 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.69 38.42 36.29 2.58 38.79 38.06 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 8.57 44.02 33.90 7.44 42.15 29.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 D 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 D 56 LYS B 26 LYS~? 10.63 CH3 ACT B 304 D 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.43 50.94 51.34 17.50 52.11 49.94 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 20.18 46.61 43.20 19.00 49.55 48.67 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 D 2 GLU C 41 GLU.? 10.40 CH3 ACT B 304 D 56 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 258 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.43 50.94 51.34 17.50 52.11 49.94 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 15.94 50.91 41.57 17.07 55.01 36.93 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 D 2 GLU C 89 GLU^? 9.21 CL CL C 203 D 56 LYS B 7 LYS^? -3.05 CL CL B 202s D 258 ARG B 57 ARG^? 10.43 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 0.03 43.20 36.88 0.18 41.91 38.57 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 8.57 44.02 33.90 7.44 42.15 29.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 D 2 GLU C 89 GLU^? 9.21 CL CL C 203 D 56 LYS B 7 LYS^? -3.05 CL CL B 202s D 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 0.03 43.20 36.88 0.18 41.91 38.57 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 8.57 44.02 33.90 7.44 42.15 29.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 D 2 GLU C 89 GLU^? 9.21 CL CL C 203 D 56 LYS C 7 LYS^? -3.09 CL CL C 203s D 258 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 0.03 43.20 36.88 0.18 41.91 38.57 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 D 2 GLU C 89 GLU^? 9.21 CL CL C 203 D 56 LYS C 7 LYS^? -3.09 CL CL C 203s D 258 ARG C 57 ARG^? 6.12 O ACT B 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 0.03 43.20 36.88 0.18 41.91 38.57 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 0.41 44.01 46.89 3.20 43.89 45.69 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 20 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 24 GLU~? 16.57 O ACT A 303 A 163 ARG A 27 ARG~? 17.50 O ACT A 303 A 222 ARG A 20 ARG~? 20.10 O ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 54.85 84.16 52.60 54.26 81.23 53.34 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 24 GLU~? 16.57 O ACT A 303 A 163 ARG A 27 ARG~? 17.50 O ACT A 303 A 222 ARG A 73 ARG~? 20.11 O ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 54.85 84.16 52.60 54.26 81.23 53.34 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 24 GLU~? 16.57 O ACT A 303 A 163 ARG A 73 ARG~? 20.11 O ACT A 303 A 222 ARG A 20 ARG~? 20.10 O ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 54.85 84.16 52.60 54.26 81.23 53.34 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 24 GLU~? 16.57 O ACT A 303 A 163 ARG A 73 ARG~? 20.11 O ACT A 303 A 222 ARG A 27 ARG~? 17.50 O ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 54.85 84.16 52.60 54.26 81.23 53.34 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU A 77 GLU~? 21.92 O ACT C 301 A 163 ARG A 73 ARG~? 20.11 O ACT A 303 A 222 ARG A 20 ARG~? 20.10 O ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 48.06 78.22 50.94 48.51 78.27 53.98 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 54.85 84.16 52.60 54.26 81.23 53.34 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 163 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 222 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 51.27 81.34 48.31 51.67 80.79 50.28 22.32 38.82 44.21 23.94 38.72 42.86 coo 48.06 78.22 50.94 48.51 78.27 53.98 23.59 35.51 49.80 23.38 33.40 52.03 coo 54.85 84.16 52.60 54.26 81.23 53.34 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 163 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 222 ARG B 73 ARG~? 16.43 O ACT A 302 coo 51.27 81.34 48.31 51.67 80.79 50.28 22.32 38.82 44.21 23.94 38.72 42.86 coo 48.06 78.22 50.94 48.51 78.27 53.98 23.59 35.51 49.80 23.38 33.40 52.03 coo 54.85 84.16 52.60 54.26 81.23 53.34 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 163 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 222 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 22.32 38.82 44.21 23.94 38.72 42.86 coo 48.06 78.22 50.94 48.51 78.27 53.98 26.02 42.58 42.38 25.84 41.49 45.27 coo 54.85 84.16 52.60 54.26 81.23 53.34 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 163 ARG B 73 ARG~? 16.43 O ACT A 302 A 222 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 22.32 38.82 44.21 23.94 38.72 42.86 coo 48.06 78.22 50.94 48.51 78.27 53.98 24.09 36.62 39.81 25.66 39.04 38.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU B 59 GLU^? -6.17 O ACT B 304s A 163 ARG B 57 ARG^? 10.43 O ACT B 304 A 222 ARG C 57 ARG^? 6.12 O ACT B 304 coo 51.27 81.34 48.31 51.67 80.79 50.28 6.72 41.22 43.91 4.75 41.83 44.25 coo 48.06 78.22 50.94 48.51 78.27 53.98 4.68 37.56 46.31 2.06 39.11 46.79 coo 54.85 84.16 52.60 54.26 81.23 53.34 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 163 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 222 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 48.06 78.22 50.94 48.51 78.27 53.98 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 54.85 84.16 52.60 54.26 81.23 53.34 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 163 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 222 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 48.06 78.22 50.94 48.51 78.27 53.98 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 54.85 84.16 52.60 54.26 81.23 53.34 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 163 ARG C 57 ARG^? 6.12 O ACT B 304 A 222 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 51.27 81.34 48.31 51.67 80.79 50.28 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 48.06 78.22 50.94 48.51 78.27 53.98 0.41 44.01 46.89 3.20 43.89 45.69 coo 54.85 84.16 52.60 54.26 81.23 53.34 -1.96 37.09 46.95 -2.53 39.44 48.84 1kim_c00 source 1kim THYMIDINE KINASE : 13 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 24.97 5.82 58.78 26.79 1.97 55.46 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 24.97 5.82 58.78 26.79 1.97 55.46 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.46 3.44 61.93 23.95 1.12 60.13 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.46 3.44 61.93 23.95 1.12 60.13 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 24.97 5.82 58.78 26.79 1.97 55.46 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 24.97 5.82 58.78 26.79 1.97 55.46 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 24.97 5.82 58.78 26.79 1.97 55.46 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 26 LYS~? 10.00 O ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 98 LYS~? 7.72 O ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 24.97 5.82 58.78 26.79 1.97 55.46 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.02 51.38 31.36 -13.86 50.18 29.63 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 26 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 4.84 5.09 23.75 3.30 1.39 27.48 -2.24 19.72 44.66 2.39 20.87 47.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -2.24 19.72 44.66 2.39 20.87 47.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 -2.24 19.72 44.66 2.39 20.87 47.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 4.84 5.09 23.75 3.30 1.39 27.48 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.43 2.88 20.75 5.72 0.41 23.95 -2.24 19.72 44.66 2.39 20.87 47.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.43 2.88 20.75 5.72 0.41 23.95 -2.24 19.72 44.66 2.39 20.87 47.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.24 21.45 37.02 12.73 25.01 40.79 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.24 21.45 37.02 12.73 25.01 40.79 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.24 21.45 37.02 12.73 25.01 40.79 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.24 21.45 37.02 12.73 25.01 40.79 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.36 21.23 42.37 3.31 17.75 38.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 4.84 5.09 23.75 3.30 1.39 27.48 20.18 46.61 43.20 19.00 49.55 48.67 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 20.18 46.61 43.20 19.00 49.55 48.67 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 4.84 5.09 23.75 3.30 1.39 27.48 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 20.18 46.61 43.20 19.00 49.55 48.67 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 20.18 46.61 43.20 19.00 49.55 48.67 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 12.25 56.30 36.89 8.12 57.51 41.12 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 12.25 56.30 36.89 8.12 57.51 41.12 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 12.25 56.30 36.89 8.12 57.51 41.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 4.84 5.09 23.75 3.30 1.39 27.48 12.25 56.30 36.89 8.12 57.51 41.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.94 50.91 41.57 17.07 55.01 36.93 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 26 LYS~? 10.00 O ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 98 LYS~? 7.72 O ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 4.84 5.09 23.75 3.30 1.39 27.48 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.02 51.38 31.36 -13.86 50.18 29.63 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 25 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 74 LYS A 31 LYS.? 10.36 O ACT A 303 C 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 17.59 37.25 25.80 19.64 34.15 21.60 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 74 LYS A 31 LYS.? 10.36 O ACT A 303 C 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 74 LYS A 31 LYS.? 10.36 O ACT A 303 C 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 31 LYS.? 10.36 O ACT A 303 C 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 17.59 37.25 25.80 19.64 34.15 21.60 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 31 LYS.? 10.36 O ACT A 303 C 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS A 31 LYS.? 10.36 O ACT A 303 C 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 C 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.24 21.45 37.02 12.73 25.01 40.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS A 31 LYS.? 10.36 O ACT A 303 C 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 C 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.24 21.45 37.02 12.73 25.01 40.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 C 74 LYS A 31 LYS.? 10.36 O ACT A 303 C 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.24 21.45 37.02 12.73 25.01 40.79 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 C 74 LYS A 31 LYS.? 10.36 O ACT A 303 C 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.24 21.45 37.02 12.73 25.01 40.79 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 17.59 37.25 25.80 19.64 34.15 21.60 20.18 46.61 43.20 19.00 49.55 48.67 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.06 27.10 15.56 13.23 27.02 13.80 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 20.18 46.61 43.20 19.00 49.55 48.67 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 17.59 37.25 25.80 19.64 34.15 21.60 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 20.18 46.61 43.20 19.00 49.55 48.67 coo 12.06 27.10 15.56 13.23 27.02 13.80 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 20.18 46.61 43.20 19.00 49.55 48.67 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 C 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 12.25 56.30 36.89 8.12 57.51 41.12 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 C 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 12.25 56.30 36.89 8.12 57.51 41.12 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 C 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 12.25 56.30 36.89 8.12 57.51 41.12 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 C 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 C 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 17.59 37.25 25.80 19.64 34.15 21.60 12.25 56.30 36.89 8.12 57.51 41.12 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 12.06 27.10 15.56 13.23 27.02 13.80 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS C 26 LYS~? 10.00 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS C 26 LYS~? 10.00 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 C 14 LYS C 26 LYS~? 10.00 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 C 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 74 LYS C 26 LYS~? 10.00 O ACT C 301 C 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 12.06 27.10 15.56 13.23 27.02 13.80 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 C 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 74 LYS C 98 LYS~? 7.72 O ACT C 301 C 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 12.06 27.10 15.56 13.23 27.02 13.80 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 C 14 LYS C 98 LYS~? 7.72 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 C 14 LYS C 98 LYS~? 7.72 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 C 14 LYS C 98 LYS~? 7.72 O ACT C 301 C 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 C 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 17.59 37.25 25.80 19.64 34.15 21.60 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 -14.02 51.38 31.36 -13.86 50.18 29.63 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 25 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 74 LYS A 31 LYS.? 10.36 O ACT A 303 D 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -2.24 19.72 44.66 2.39 20.87 47.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 74 LYS A 31 LYS.? 10.36 O ACT A 303 D 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -2.24 19.72 44.66 2.39 20.87 47.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 74 LYS A 31 LYS.? 10.36 O ACT A 303 D 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -2.24 19.72 44.66 2.39 20.87 47.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 31 LYS.? 10.36 O ACT A 303 D 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -2.24 19.72 44.66 2.39 20.87 47.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 31 LYS.? 10.36 O ACT A 303 D 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 D 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -2.24 19.72 44.66 2.39 20.87 47.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 31 LYS.? 10.36 O ACT A 303 D 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 D 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.24 21.45 37.02 12.73 25.01 40.79 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS A 31 LYS.? 10.36 O ACT A 303 D 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 D 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.24 21.45 37.02 12.73 25.01 40.79 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 D 74 LYS A 31 LYS.? 10.36 O ACT A 303 D 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.24 21.45 37.02 12.73 25.01 40.79 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 D 74 LYS A 31 LYS.? 10.36 O ACT A 303 D 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.24 21.45 37.02 12.73 25.01 40.79 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.36 21.23 42.37 3.31 17.75 38.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 D 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 20.18 46.61 43.20 19.00 49.55 48.67 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 D 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 20.18 46.61 43.20 19.00 49.55 48.67 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 D 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.18 46.61 43.20 19.00 49.55 48.67 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 D 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.18 46.61 43.20 19.00 49.55 48.67 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 D 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 12.25 56.30 36.89 8.12 57.51 41.12 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 D 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 12.25 56.30 36.89 8.12 57.51 41.12 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 D 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 12.25 56.30 36.89 8.12 57.51 41.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 D 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 D 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 12.25 56.30 36.89 8.12 57.51 41.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.94 50.91 41.57 17.07 55.01 36.93 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS C 26 LYS~? 10.00 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS C 26 LYS~? 10.00 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS C 26 LYS~? 10.00 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 D 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 74 LYS C 26 LYS~? 10.00 O ACT C 301 D 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 D 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 74 LYS C 98 LYS~? 7.72 O ACT C 301 D 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 D 14 LYS C 98 LYS~? 7.72 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 D 14 LYS C 98 LYS~? 7.72 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 D 14 LYS C 98 LYS~? 7.72 O ACT C 301 D 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 D 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.02 51.38 31.36 -13.86 50.18 29.63 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 25 hits 1kqc_c03 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 31 LYS.? 10.36 O ACT A 303 166 LYS A 26 LYS~? 7.74 CH3 ACT A 303 324 SER B 15 SER.? 16.65 OXT ACT A 303 coo 25.93 8.11 25.51 26.40 7.80 19.66 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.27 1.43 25.09 29.18 5.25 22.89 -2.24 19.72 44.66 2.39 20.87 47.23 coo 46.32 14.55 19.93 45.95 12.72 21.27 13.49 35.39 54.57 12.84 34.83 56.84 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 31 LYS.? 10.36 O ACT A 303 166 LYS A 98 LYS~? 7.98 CH3 ACT A 303 324 SER B 15 SER.? 16.65 OXT ACT A 303 coo 25.93 8.11 25.51 26.40 7.80 19.66 3.36 21.23 42.37 3.31 17.75 38.68 coo 27.27 1.43 25.09 29.18 5.25 22.89 9.24 21.45 37.02 12.73 25.01 40.79 coo 46.32 14.55 19.93 45.95 12.72 21.27 13.49 35.39 54.57 12.84 34.83 56.84 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS B 31 LYS.? 11.57 OXT ACT B 304 166 LYS B 26 LYS~? 10.63 CH3 ACT B 304 324 SER C 15 SER.? 16.03 CH3 ACT B 304 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.18 46.61 43.20 19.00 49.55 48.67 coo 46.32 14.55 19.93 45.95 12.72 21.27 -0.02 52.59 55.50 0.94 52.38 57.70 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 31 LYS.? 11.57 OXT ACT B 304 166 LYS B 98 LYS~? 9.29 CH3 ACT B 304 324 SER C 15 SER.? 16.03 CH3 ACT B 304 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.94 50.91 41.57 17.07 55.01 36.93 coo 27.27 1.43 25.09 29.18 5.25 22.89 12.25 56.30 36.89 8.12 57.51 41.12 coo 46.32 14.55 19.93 45.95 12.72 21.27 -0.02 52.59 55.50 0.94 52.38 57.70 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS C 31 LYS.? 9.88 CH3 ACT C 301 166 LYS C 26 LYS~? 10.00 O ACT C 301 324 SER A 15 SER.? 17.30 O ACT C 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 46.32 14.55 19.93 45.95 12.72 21.27 -7.72 31.71 56.41 -7.84 32.30 58.77 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS C 31 LYS.? 9.88 CH3 ACT C 301 166 LYS C 98 LYS~? 7.72 O ACT C 301 324 SER A 15 SER.? 17.30 O ACT C 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 46.32 14.55 19.93 45.95 12.72 21.27 -7.72 31.71 56.41 -7.84 32.30 58.77 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS C 98 LYS~? 7.72 O ACT C 301 166 LYS C 31 LYS.? 9.88 CH3 ACT C 301 324 SER A 15 SER.? 17.30 O ACT C 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 27.27 1.43 25.09 29.18 5.25 22.89 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 46.32 14.55 19.93 45.95 12.72 21.27 -7.72 31.71 56.41 -7.84 32.30 58.77 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 7 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 29 GLY.? 10.49 O ACT A 303 A 501 ASP A 2 ASP.? 6.75 OXT ACT A 302 B 367 TYR C 99 TYR~? -4.22 CH3 ACT C 301s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.84 18.97 39.55 -1.94 19.48 40.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.13 27.42 32.13 14.80 25.81 31.83 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -14.59 42.37 40.43 -14.19 40.56 42.54 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 40 GLY.? 8.88 O ACT C 301 A 501 ASP C 2 ASP.? 15.16 CH3 ACT C 301 B 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.41 44.65 53.52 -9.78 44.04 53.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 29 GLY.? 11.23 OXT ACT B 304 A 501 ASP B 2 ASP.? 15.66 OXT ACT B 304 B 367 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 20.02 47.68 38.01 19.73 47.34 38.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.21 59.71 32.87 5.22 59.30 32.47 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 6.28 25.07 38.68 7.82 26.15 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 40 GLY.? 8.14 CH3 ACT A 303 A 501 ASP A 2 ASP.? 6.75 OXT ACT A 302 B 367 TYR C 99 TYR~? -4.22 CH3 ACT C 301s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.87 27.57 51.92 4.89 27.45 52.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.13 27.42 32.13 14.80 25.81 31.83 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -14.59 42.37 40.43 -14.19 40.56 42.54 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 40 GLY.? 8.14 CH3 ACT A 303 A 501 ASP A 50 ASP.? 19.58 O ACT C 301 B 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.87 27.57 51.92 4.89 27.45 52.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 53 GLY.? 18.15 OXT ACT A 303 A 501 ASP A 50 ASP.? 19.58 O ACT C 301 B 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 11.00 33.13 60.11 10.40 33.25 59.61 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY C 29 GLY.? 10.22 CH3 ACT C 301 A 501 ASP C 2 ASP.? 15.16 CH3 ACT C 301 B 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.67 52.79 40.33 -15.18 52.68 40.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY C 32 GLY.? -3.77 CH3 ACT C 301s A 501 ASP A 50 ASP.? 19.58 O ACT C 301 B 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.78 45.84 46.01 -13.36 46.37 45.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY C 40 GLY.? 7.10 CH3 ACT B 304 A 501 ASP B 2 ASP.? 15.66 OXT ACT B 304 B 367 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.77 48.31 51.36 10.92 48.35 52.19 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 3.21 59.71 32.87 5.22 59.30 32.47 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 6.28 25.07 38.68 7.82 26.15 40.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY C 53 GLY.? 16.29 CH3 ACT B 304 A 501 ASP A 50 ASP.? 19.58 O ACT C 301 B 367 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 5.95 53.06 59.85 5.63 52.23 59.43 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.54 33.17 44.58 21.91 35.42 45.49 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 10 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 29 GLY.? 10.49 O ACT A 303 D 501 ASP A 2 ASP.? 6.75 OXT ACT A 302 E 367 TYR C 99 TYR~? -4.22 CH3 ACT C 301s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.84 18.97 39.55 -1.94 19.48 40.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.13 27.42 32.13 14.80 25.81 31.83 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -14.59 42.37 40.43 -14.19 40.56 42.54 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 40 GLY.? 8.88 O ACT C 301 D 501 ASP C 2 ASP.? 15.16 CH3 ACT C 301 E 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.41 44.65 53.52 -9.78 44.04 53.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 29 GLY.? 11.23 OXT ACT B 304 D 501 ASP B 2 ASP.? 15.66 OXT ACT B 304 E 367 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 20.02 47.68 38.01 19.73 47.34 38.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.21 59.71 32.87 5.22 59.30 32.47 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 6.28 25.07 38.68 7.82 26.15 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 40 GLY.? 8.14 CH3 ACT A 303 D 501 ASP A 2 ASP.? 6.75 OXT ACT A 302 E 367 TYR C 99 TYR~? -4.22 CH3 ACT C 301s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.87 27.57 51.92 4.89 27.45 52.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.13 27.42 32.13 14.80 25.81 31.83 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -14.59 42.37 40.43 -14.19 40.56 42.54 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 40 GLY.? 8.14 CH3 ACT A 303 D 501 ASP A 50 ASP.? 19.58 O ACT C 301 E 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.87 27.57 51.92 4.89 27.45 52.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 53 GLY.? 18.15 OXT ACT A 303 D 501 ASP A 50 ASP.? 19.58 O ACT C 301 E 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 11.00 33.13 60.11 10.40 33.25 59.61 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY C 29 GLY.? 10.22 CH3 ACT C 301 D 501 ASP C 2 ASP.? 15.16 CH3 ACT C 301 E 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.67 52.79 40.33 -15.18 52.68 40.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY C 32 GLY.? -3.77 CH3 ACT C 301s D 501 ASP A 50 ASP.? 19.58 O ACT C 301 E 367 TYR B 99 TYR~? 4.94 OXT ACT B 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.78 45.84 46.01 -13.36 46.37 45.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 10.71 51.79 38.53 9.13 52.40 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY C 40 GLY.? 7.10 CH3 ACT B 304 D 501 ASP B 2 ASP.? 15.66 OXT ACT B 304 E 367 TYR A 99 TYR~? -4.58 CH3 ACT A 303s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.77 48.31 51.36 10.92 48.35 52.19 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 3.21 59.71 32.87 5.22 59.30 32.47 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 6.28 25.07 38.68 7.82 26.15 40.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY C 53 GLY.? 16.29 CH3 ACT B 304 D 501 ASP A 50 ASP.? 19.58 O ACT C 301 E 367 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 5.95 53.06 59.85 5.63 52.23 59.43 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.90 37.94 65.42 -11.50 37.20 64.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.54 33.17 44.58 21.91 35.42 45.49 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 10 hits 1mro_c01 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 169 LYS A 31 LYS.? 10.36 O ACT A 303 A 327 GLU A 23 GLU~? 17.46 O ACT A 303 coo 20.73 15.53 25.54 22.09 15.64 19.40 -2.24 19.72 44.66 2.39 20.87 47.23 coo 24.31 10.25 23.71 29.02 12.05 20.75 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.86 20.40 18.59 22.12 18.33 18.33 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 169 LYS A 31 LYS.? 10.36 O ACT A 303 A 327 GLU A 24 GLU~? 16.57 O ACT A 303 coo 20.73 15.53 25.54 22.09 15.64 19.40 -2.24 19.72 44.66 2.39 20.87 47.23 coo 24.31 10.25 23.71 29.02 12.05 20.75 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.86 20.40 18.59 22.12 18.33 18.33 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 169 LYS A 31 LYS.? 10.36 O ACT A 303 A 327 GLU B 41 GLU.? 9.71 CH3 ACT A 303 coo 20.73 15.53 25.54 22.09 15.64 19.40 -2.24 19.72 44.66 2.39 20.87 47.23 coo 24.31 10.25 23.71 29.02 12.05 20.75 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.86 20.40 18.59 22.12 18.33 18.33 4.59 21.37 51.97 2.75 21.07 50.95 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS A 31 LYS.? 10.36 O ACT A 303 A 169 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 327 GLU B 41 GLU.? 9.71 CH3 ACT A 303 coo 20.73 15.53 25.54 22.09 15.64 19.40 3.36 21.23 42.37 3.31 17.75 38.68 coo 24.31 10.25 23.71 29.02 12.05 20.75 -2.24 19.72 44.66 2.39 20.87 47.23 coo 21.86 20.40 18.59 22.12 18.33 18.33 4.59 21.37 51.97 2.75 21.07 50.95 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 169 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 327 GLU B 23 GLU~? 17.74 CH3 ACT B 304 coo 20.73 15.53 25.54 22.09 15.64 19.40 20.18 46.61 43.20 19.00 49.55 48.67 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.86 20.40 18.59 22.12 18.33 18.33 23.16 43.48 49.34 24.66 42.52 50.51 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 169 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 327 GLU C 41 GLU.? 10.40 CH3 ACT B 304 coo 20.73 15.53 25.54 22.09 15.64 19.40 20.18 46.61 43.20 19.00 49.55 48.67 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.86 20.40 18.59 22.12 18.33 18.33 16.43 50.94 51.34 17.50 52.11 49.94 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 169 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 327 GLU C 41 GLU.? 10.40 CH3 ACT B 304 coo 20.73 15.53 25.54 22.09 15.64 19.40 15.94 50.91 41.57 17.07 55.01 36.93 coo 24.31 10.25 23.71 29.02 12.05 20.75 20.18 46.61 43.20 19.00 49.55 48.67 coo 21.86 20.40 18.59 22.12 18.33 18.33 16.43 50.94 51.34 17.50 52.11 49.94 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS C 26 LYS~? 10.00 O ACT C 301 A 169 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 327 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 24.31 10.25 23.71 29.02 12.05 20.75 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.86 20.40 18.59 22.12 18.33 18.33 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 9 3 # 9 A 167 LYS C 26 LYS~? 10.00 O ACT C 301 A 169 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 327 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 24.31 10.25 23.71 29.02 12.05 20.75 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.86 20.40 18.59 22.12 18.33 18.33 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 10 3 # 10 A 167 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 169 LYS C 26 LYS~? 10.00 O ACT C 301 A 327 GLU A 41 GLU.? 4.97 O ACT C 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 24.31 10.25 23.71 29.02 12.05 20.75 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 21.86 20.40 18.59 22.12 18.33 18.33 -13.23 45.29 51.30 -13.91 44.10 49.69 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 10 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 169 LYS A 31 LYS.? 10.36 O ACT A 303 B 327 GLU A 23 GLU~? 17.46 O ACT A 303 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -2.24 19.72 44.66 2.39 20.87 47.23 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 3.36 21.23 42.37 3.31 17.75 38.68 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -5.54 19.06 51.41 -6.99 18.34 52.80 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 169 LYS A 31 LYS.? 10.36 O ACT A 303 B 327 GLU A 24 GLU~? 16.57 O ACT A 303 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -2.24 19.72 44.66 2.39 20.87 47.23 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 3.36 21.23 42.37 3.31 17.75 38.68 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 169 LYS A 31 LYS.? 10.36 O ACT A 303 B 327 GLU B 41 GLU.? 9.71 CH3 ACT A 303 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -2.24 19.72 44.66 2.39 20.87 47.23 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 3.36 21.23 42.37 3.31 17.75 38.68 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 4.59 21.37 51.97 2.75 21.07 50.95 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS A 31 LYS.? 10.36 O ACT A 303 B 169 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 327 GLU B 41 GLU.? 9.71 CH3 ACT A 303 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 3.36 21.23 42.37 3.31 17.75 38.68 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -2.24 19.72 44.66 2.39 20.87 47.23 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 4.59 21.37 51.97 2.75 21.07 50.95 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 169 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 327 GLU B 23 GLU~? 17.74 CH3 ACT B 304 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 20.18 46.61 43.20 19.00 49.55 48.67 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.94 50.91 41.57 17.07 55.01 36.93 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 23.16 43.48 49.34 24.66 42.52 50.51 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 169 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 327 GLU C 41 GLU.? 10.40 CH3 ACT B 304 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 20.18 46.61 43.20 19.00 49.55 48.67 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.94 50.91 41.57 17.07 55.01 36.93 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 16.43 50.94 51.34 17.50 52.11 49.94 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 169 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 327 GLU C 41 GLU.? 10.40 CH3 ACT B 304 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 15.94 50.91 41.57 17.07 55.01 36.93 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 20.18 46.61 43.20 19.00 49.55 48.67 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 16.43 50.94 51.34 17.50 52.11 49.94 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS C 26 LYS~? 10.00 O ACT C 301 B 169 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 327 GLU C 23 GLU~? 17.30 CH3 ACT C 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -12.38 56.72 51.72 -12.36 58.38 53.06 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS C 26 LYS~? 10.00 O ACT C 301 B 169 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 327 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 169 LYS C 26 LYS~? 10.00 O ACT C 301 B 327 GLU A 41 GLU.? 4.97 O ACT C 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -13.23 45.29 51.30 -13.91 44.10 49.69 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 10 hits 1muc_c01 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 48 SER.? 20.26 O ACT C 301 A 154 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 261 ARG A 47 ARG.? 21.65 CH3 ACT B 304 coo 16.10 74.10 3.11 17.18 73.52 5.20 -4.83 40.14 65.16 -7.27 40.24 64.93 coo 16.07 84.71 8.14 15.20 82.81 8.14 2.98 31.06 60.86 4.11 29.82 59.55 coo 10.59 77.85 4.81 13.09 76.36 5.76 1.93 40.93 64.24 4.88 41.80 64.42 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 1 hits 1o98_c00 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 15 SER.? 17.30 O ACT C 301 A 239 VAL A 12 VAL^? 7.88 OXT ACT C 301 A 413 ASN A 55 ASN^? 10.27 O ACT C 301 coo 80.14 40.76 52.28 77.73 40.59 51.94 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 75.67 35.37 52.30 76.00 35.96 50.23 -7.93 35.00 48.10 -7.41 37.11 48.16 coo 81.75 35.21 52.13 80.92 37.12 51.69 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER B 15 SER.? 16.65 OXT ACT A 303 A 239 VAL B 12 VAL^? 7.21 OXT ACT A 303 A 413 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 80.14 40.76 52.28 77.73 40.59 51.94 13.49 35.39 54.57 12.84 34.83 56.84 coo 75.67 35.37 52.30 76.00 35.96 50.23 10.18 33.83 46.66 8.09 33.15 46.95 coo 81.75 35.21 52.13 80.92 37.12 51.69 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER C 15 SER.? 16.03 CH3 ACT B 304 A 239 VAL C 12 VAL^? 6.88 O ACT B 304 A 413 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 80.14 40.76 52.28 77.73 40.59 51.94 -0.02 52.59 55.50 0.94 52.38 57.70 coo 75.67 35.37 52.30 76.00 35.96 50.23 1.99 50.51 47.19 3.66 49.08 47.14 coo 81.75 35.21 52.13 80.92 37.12 51.69 4.32 50.30 52.50 5.90 51.72 52.50 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 15 SER.? 17.30 O ACT C 301 B 239 VAL A 12 VAL^? 7.88 OXT ACT C 301 B 413 ASN A 55 ASN^? 10.27 O ACT C 301 coo 25.22 6.41 2.90 27.67 6.33 3.11 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 29.71 1.00 2.66 29.43 1.57 4.74 -7.93 35.00 48.10 -7.41 37.11 48.16 coo 23.72 0.88 2.95 24.56 2.79 3.34 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 15 SER.? 16.65 OXT ACT A 303 B 239 VAL B 12 VAL^? 7.21 OXT ACT A 303 B 413 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 25.22 6.41 2.90 27.67 6.33 3.11 13.49 35.39 54.57 12.84 34.83 56.84 coo 29.71 1.00 2.66 29.43 1.57 4.74 10.18 33.83 46.66 8.09 33.15 46.95 coo 23.72 0.88 2.95 24.56 2.79 3.34 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER C 15 SER.? 16.03 CH3 ACT B 304 B 239 VAL C 12 VAL^? 6.88 O ACT B 304 B 413 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 25.22 6.41 2.90 27.67 6.33 3.11 -0.02 52.59 55.50 0.94 52.38 57.70 coo 29.71 1.00 2.66 29.43 1.57 4.74 1.99 50.51 47.19 3.66 49.08 47.14 coo 23.72 0.88 2.95 24.56 2.79 3.34 4.32 50.30 52.50 5.90 51.72 52.50 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c01 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 13 ALA^? 11.55 O ACT C 301 A 126 LEU A 17 LEU~? 15.80 O ACT C 301 A 158 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -10.45 28.47 52.81 -12.30 27.97 51.84 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 13 ALA^? 11.55 O ACT C 301 A 126 LEU A 21 LEU~? 13.53 O ACT A 303 A 158 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -7.31 26.48 49.16 -8.96 27.84 48.73 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 30 ALA.? 6.19 O ACT A 303 A 126 LEU A 28 LEU~? 13.38 O ACT A 303 A 158 GLU A 24 GLU~? 16.57 O ACT A 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.10 22.02 41.09 -0.74 23.14 41.90 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -6.34 20.30 40.34 -8.49 20.16 40.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 67 ALA~? 8.12 CL CL A 201 A 126 LEU A 28 LEU~? 13.38 O ACT A 303 A 158 GLU A 24 GLU~? 16.57 O ACT A 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -4.97 26.51 35.79 -4.39 27.75 35.03 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -6.34 20.30 40.34 -8.49 20.16 40.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 67 ALA~? 8.12 CL CL A 201 A 126 LEU A 68 LEU~? 9.29 CL CL A 201 A 158 GLU A 65 GLU~? 11.46 CL CL A 201 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -4.97 26.51 35.79 -4.39 27.75 35.03 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.88 26.20 32.80 -8.85 28.16 31.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 A 126 LEU B 17 LEU~? 15.90 CH3 ACT A 303 A 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.76 32.40 49.06 14.10 32.82 48.50 coo -4.62 32.83 147.14 -5.50 32.85 149.12 17.86 34.43 50.92 19.03 32.72 50.29 coo -0.83 29.57 149.77 -0.39 31.47 148.95 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 A 126 LEU B 21 LEU~? 13.85 OXT ACT B 304 A 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.76 32.40 49.06 14.10 32.82 48.50 coo -4.62 32.83 147.14 -5.50 32.85 149.12 17.44 38.43 47.38 17.01 36.39 46.85 coo -0.83 29.57 149.77 -0.39 31.47 148.95 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 A 126 LEU B 58 LEU^? 8.24 O ACT B 304 A 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.76 32.40 49.06 14.10 32.82 48.50 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.92 39.88 46.89 12.77 41.75 46.21 coo -0.83 29.57 149.77 -0.39 31.47 148.95 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 30 ALA.? 7.02 OXT ACT B 304 A 126 LEU B 28 LEU~? 14.06 OXT ACT B 304 A 158 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 16.84 47.56 40.06 16.35 46.38 40.90 coo -4.62 32.83 147.14 -5.50 32.85 149.12 21.29 43.11 38.45 22.44 41.28 38.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 67 ALA~? 8.15 CL CL B 202 A 126 LEU B 68 LEU~? 6.22 O ACT A 302 A 158 GLU B 65 GLU~? 12.71 CL CL B 202 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.73 41.53 34.32 13.32 41.50 33.68 coo -4.62 32.83 147.14 -5.50 32.85 149.12 16.73 38.73 30.86 14.98 37.71 29.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 A 126 LEU C 17 LEU~? 15.40 CH3 ACT B 304 A 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 2.10 53.41 49.69 0.93 54.36 49.32 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.80 56.52 51.96 -1.21 58.31 50.94 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 A 126 LEU C 21 LEU~? 13.70 OXT ACT C 301 A 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 2.10 53.41 49.69 0.93 54.36 49.32 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.55 54.45 48.75 -3.64 55.19 48.06 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA C 30 ALA.? 6.12 CH3 ACT C 301 A 126 LEU C 28 LEU~? 13.47 CH3 ACT C 301 A 158 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -13.85 49.91 42.04 -12.50 49.96 42.74 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -12.28 56.16 40.57 -11.20 58.02 40.52 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA C 67 ALA~? 8.09 CL CL C 203 A 126 LEU C 28 LEU~? 13.47 CH3 ACT C 301 A 158 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -8.20 51.25 35.92 -7.51 50.04 35.22 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -12.28 56.16 40.57 -11.20 58.02 40.52 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.82 58.42 44.81 -9.22 60.41 45.38 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 14 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 13 ALA^? 11.55 O ACT C 301 B 126 LEU A 17 LEU~? 15.80 O ACT C 301 B 158 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -10.45 28.47 52.81 -12.30 27.97 51.84 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 13 ALA^? 11.55 O ACT C 301 B 126 LEU A 21 LEU~? 13.53 O ACT A 303 B 158 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -7.31 26.48 49.16 -8.96 27.84 48.73 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 30 ALA.? 6.19 O ACT A 303 B 126 LEU A 28 LEU~? 13.38 O ACT A 303 B 158 GLU A 24 GLU~? 16.57 O ACT A 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.10 22.02 41.09 -0.74 23.14 41.90 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -6.34 20.30 40.34 -8.49 20.16 40.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 67 ALA~? 8.12 CL CL A 201 B 126 LEU A 28 LEU~? 13.38 O ACT A 303 B 158 GLU A 24 GLU~? 16.57 O ACT A 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -4.97 26.51 35.79 -4.39 27.75 35.03 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -6.34 20.30 40.34 -8.49 20.16 40.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 67 ALA~? 8.12 CL CL A 201 B 126 LEU A 68 LEU~? 9.29 CL CL A 201 B 158 GLU A 65 GLU~? 11.46 CL CL A 201 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -4.97 26.51 35.79 -4.39 27.75 35.03 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.88 26.20 32.80 -8.85 28.16 31.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 B 126 LEU B 17 LEU~? 15.90 CH3 ACT A 303 B 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.76 32.40 49.06 14.10 32.82 48.50 coo -34.22 5.06 149.25 -33.65 4.24 151.15 17.86 34.43 50.92 19.03 32.72 50.29 coo -33.03 9.93 151.71 -34.98 9.38 151.11 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 B 126 LEU B 21 LEU~? 13.85 OXT ACT B 304 B 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.76 32.40 49.06 14.10 32.82 48.50 coo -34.22 5.06 149.25 -33.65 4.24 151.15 17.44 38.43 47.38 17.01 36.39 46.85 coo -33.03 9.93 151.71 -34.98 9.38 151.11 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 B 126 LEU B 58 LEU^? 8.24 O ACT B 304 B 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.76 32.40 49.06 14.10 32.82 48.50 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.92 39.88 46.89 12.77 41.75 46.21 coo -33.03 9.93 151.71 -34.98 9.38 151.11 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 30 ALA.? 7.02 OXT ACT B 304 B 126 LEU B 28 LEU~? 14.06 OXT ACT B 304 B 158 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 16.84 47.56 40.06 16.35 46.38 40.90 coo -34.22 5.06 149.25 -33.65 4.24 151.15 21.29 43.11 38.45 22.44 41.28 38.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 67 ALA~? 8.15 CL CL B 202 B 126 LEU B 68 LEU~? 6.22 O ACT A 302 B 158 GLU B 65 GLU~? 12.71 CL CL B 202 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.73 41.53 34.32 13.32 41.50 33.68 coo -34.22 5.06 149.25 -33.65 4.24 151.15 16.73 38.73 30.86 14.98 37.71 29.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 B 126 LEU C 17 LEU~? 15.40 CH3 ACT B 304 B 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 2.10 53.41 49.69 0.93 54.36 49.32 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.80 56.52 51.96 -1.21 58.31 50.94 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 B 126 LEU C 21 LEU~? 13.70 OXT ACT C 301 B 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 2.10 53.41 49.69 0.93 54.36 49.32 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.55 54.45 48.75 -3.64 55.19 48.06 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA C 30 ALA.? 6.12 CH3 ACT C 301 B 126 LEU C 28 LEU~? 13.47 CH3 ACT C 301 B 158 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -13.85 49.91 42.04 -12.50 49.96 42.74 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -12.28 56.16 40.57 -11.20 58.02 40.52 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.82 58.42 44.81 -9.22 60.41 45.38 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA C 67 ALA~? 8.09 CL CL C 203 B 126 LEU C 28 LEU~? 13.47 CH3 ACT C 301 B 158 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -8.20 51.25 35.92 -7.51 50.04 35.22 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -12.28 56.16 40.57 -11.20 58.02 40.52 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.82 58.42 44.81 -9.22 60.41 45.38 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 14 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 13 ALA^? 11.55 O ACT C 301 C 126 LEU A 17 LEU~? 15.80 O ACT C 301 C 158 GLU A 18 GLU~? 13.24 OXT ACT A 303 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -10.21 33.55 50.82 -10.49 32.11 50.39 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -10.45 28.47 52.81 -12.30 27.97 51.84 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -3.59 27.39 54.08 -2.09 28.32 55.24 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 30 ALA.? 6.19 O ACT A 303 C 126 LEU A 28 LEU~? 13.38 O ACT A 303 C 158 GLU A 24 GLU~? 16.57 O ACT A 303 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.10 22.02 41.09 -0.74 23.14 41.90 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -6.34 20.30 40.34 -8.49 20.16 40.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -9.61 21.94 45.26 -10.88 20.30 45.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 67 ALA~? 8.12 CL CL A 201 C 126 LEU A 68 LEU~? 9.29 CL CL A 201 C 158 GLU A 65 GLU~? 11.46 CL CL A 201 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -4.97 26.51 35.79 -4.39 27.75 35.03 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.88 26.20 32.80 -8.85 28.16 31.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 13 ALA^? 11.27 CH3 ACT A 303 C 126 LEU B 17 LEU~? 15.90 CH3 ACT A 303 C 158 GLU B 18 GLU~? 12.98 CH3 ACT B 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.76 32.40 49.06 14.10 32.82 48.50 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 17.86 34.43 50.92 19.03 32.72 50.29 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 15.35 40.93 52.66 14.20 41.89 54.18 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 30 ALA.? 7.02 OXT ACT B 304 C 126 LEU B 28 LEU~? 14.06 OXT ACT B 304 C 158 GLU B 24 GLU~? 17.02 OXT ACT B 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 16.84 47.56 40.06 16.35 46.38 40.90 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 21.29 43.11 38.45 22.44 41.28 38.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.32 38.82 44.21 23.94 38.72 42.86 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 67 ALA~? 8.15 CL CL B 202 C 126 LEU B 68 LEU~? 6.22 O ACT A 302 C 158 GLU B 65 GLU~? 12.71 CL CL B 202 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.73 41.53 34.32 13.32 41.50 33.68 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 16.73 38.73 30.86 14.98 37.71 29.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 C 126 LEU C 17 LEU~? 15.40 CH3 ACT B 304 C 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 2.10 53.41 49.69 0.93 54.36 49.32 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -1.80 56.52 51.96 -1.21 58.31 50.94 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA C 13 ALA^? 11.08 CH3 ACT B 304 C 126 LEU C 21 LEU~? 13.70 OXT ACT C 301 C 158 GLU C 18 GLU~? 13.25 OXT ACT C 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 2.10 53.41 49.69 0.93 54.36 49.32 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.55 54.45 48.75 -3.64 55.19 48.06 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.97 51.16 54.03 -5.89 49.54 55.41 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA C 30 ALA.? 6.12 CH3 ACT C 301 C 126 LEU C 28 LEU~? 13.47 CH3 ACT C 301 C 158 GLU C 24 GLU~? 16.74 CH3 ACT C 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -13.85 49.91 42.04 -12.50 49.96 42.74 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -12.28 56.16 40.57 -11.20 58.02 40.52 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.82 58.42 44.81 -9.22 60.41 45.38 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 9 hits 1pjh_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 54 GLN.? 18.54 OXT ACT C 301 294 GLU A 14 GLU^? 15.87 O ACT C 301 304 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 15.89 18.45 46.53 15.82 16.91 48.02 -6.26 37.47 60.50 -4.43 36.85 61.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 8.71 17.11 46.51 7.23 17.64 49.20 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 54 GLN.? 18.54 OXT ACT C 301 294 GLU A 18 GLU~? 13.24 OXT ACT A 303 304 ARG A 39 ARG.? 13.42 OXT ACT C 301 coo 15.89 18.45 46.53 15.82 16.91 48.02 -6.26 37.47 60.50 -4.43 36.85 61.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 8.71 17.11 46.51 7.23 17.64 49.20 -5.46 44.01 56.97 -5.03 47.01 56.50 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN A 72 GLN~? 16.53 CL CL A 201 294 GLU A 65 GLU~? 11.46 CL CL A 201 304 ARG A 73 ARG~? 20.11 O ACT A 303 coo 15.89 18.45 46.53 15.82 16.91 48.02 -14.65 23.69 36.26 -15.64 24.05 34.40 coo 22.84 13.44 52.91 20.84 13.18 52.38 -4.30 22.08 29.22 -2.64 23.27 28.50 coo 8.71 17.11 46.51 7.23 17.64 49.20 -13.24 21.34 42.66 -14.70 19.65 44.77 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 15 SER.? 17.30 O ACT C 301 B 69 ALA A 13 ALA^? 11.55 O ACT C 301 B 241 ASN A 55 ASN^? 10.27 O ACT C 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 -7.72 31.71 56.41 -7.84 32.30 58.77 coo 9.15 37.89 36.69 10.55 37.76 37.22 -10.21 33.55 50.82 -10.49 32.11 50.39 coo 10.91 43.03 38.47 11.81 41.82 36.93 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 43 SER.? 10.34 O ACT C 301 B 69 ALA A 38 ALA^? 9.36 OXT ACT C 301 B 241 ASN A 55 ASN^? 10.27 O ACT C 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 -10.91 41.82 57.59 -11.21 40.61 55.53 coo 9.15 37.89 36.69 10.55 37.76 37.22 -4.54 39.46 52.77 -5.17 38.67 51.64 coo 10.91 43.03 38.47 11.81 41.82 36.93 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 15 SER.? 16.65 OXT ACT A 303 B 69 ALA B 13 ALA^? 11.27 CH3 ACT A 303 B 241 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 13.24 41.94 33.13 13.08 39.54 33.17 13.49 35.39 54.57 12.84 34.83 56.84 coo 9.15 37.89 36.69 10.55 37.76 37.22 12.76 32.40 49.06 14.10 32.82 48.50 coo 10.91 43.03 38.47 11.81 41.82 36.93 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 15 SER.? 16.65 OXT ACT A 303 B 69 ALA B 38 ALA^? 9.48 OXT ACT A 303 B 241 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 13.24 41.94 33.13 13.08 39.54 33.17 13.49 35.39 54.57 12.84 34.83 56.84 coo 9.15 37.89 36.69 10.55 37.76 37.22 5.14 34.55 52.80 5.58 34.51 51.35 coo 10.91 43.03 38.47 11.81 41.82 36.93 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER C 15 SER.? 16.03 CH3 ACT B 304 B 69 ALA C 13 ALA^? 11.08 CH3 ACT B 304 B 241 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 13.24 41.94 33.13 13.08 39.54 33.17 -0.02 52.59 55.50 0.94 52.38 57.70 coo 9.15 37.89 36.69 10.55 37.76 37.22 2.10 53.41 49.69 0.93 54.36 49.32 coo 10.91 43.03 38.47 11.81 41.82 36.93 4.32 50.30 52.50 5.90 51.72 52.50 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 5 hits 1pnl_c00 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 14 GLU^? 15.87 O ACT C 301 A 67 ARG A 20 ARG~? 20.10 O ACT A 303 A 86 HIS A 81 HIS.? 19.43 O ACT C 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 21.52 6.83 26.64 21.22 5.53 23.85 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -20.82 26.38 49.60 -21.72 24.86 48.45 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 77 GLU~? 17.82 O ACT A 302 A 67 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 86 HIS B 81 HIS.? 19.26 CH3 ACT A 303 coo 18.15 3.28 18.56 20.10 2.92 19.20 25.37 33.50 41.00 25.99 35.47 41.49 coo 21.52 6.83 26.64 21.22 5.53 23.85 23.59 35.51 49.80 23.38 33.40 52.03 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 24.07 26.52 45.84 25.63 26.47 44.45 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 67 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 86 HIS C 81 HIS.? 20.24 CH3 ACT B 304 coo 18.15 3.28 18.56 20.10 2.92 19.20 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 21.52 6.83 26.64 21.22 5.53 23.85 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 1.30 66.32 47.25 0.46 68.04 46.40 1pyl_c00 source 1pyl RIBONUCLEASE : 3 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 14 GLU^? 15.87 O ACT C 301 B 67 ARG A 20 ARG~? 20.10 O ACT A 303 B 86 HIS A 81 HIS.? 19.43 O ACT C 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -20.82 26.38 49.60 -21.72 24.86 48.45 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU B 77 GLU~? 17.82 O ACT A 302 B 67 ARG B 20 ARG~? 20.55 CH3 ACT A 303 B 86 HIS B 81 HIS.? 19.26 CH3 ACT A 303 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 25.37 33.50 41.00 25.99 35.47 41.49 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 23.59 35.51 49.80 23.38 33.40 52.03 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 24.07 26.52 45.84 25.63 26.47 44.45 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 67 ARG C 20 ARG~? 20.69 CH3 ACT B 304 B 86 HIS C 81 HIS.? 20.24 CH3 ACT B 304 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 1.30 66.32 47.25 0.46 68.04 46.40 1pyl_c01 source 1pyl RIBONUCLEASE : 3 hits 1pyl_c01 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 27 ARG~? 17.50 O ACT A 303 A 581 ARG A 73 ARG~? 20.11 O ACT A 303 A 713 ARG A 20 ARG~? 20.10 O ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 27 ARG~? 17.50 O ACT A 303 A 581 ARG A 73 ARG~? 20.11 O ACT A 303 A 713 ARG A 69 ARG~? 15.12 O ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 581 ARG A 44 ARG.? 19.54 O ACT C 301 A 713 ARG A 47 ARG.? 21.65 CH3 ACT B 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 1.93 40.93 64.24 4.88 41.80 64.42 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 44 ARG.? 19.54 O ACT C 301 A 581 ARG A 39 ARG.? 13.42 OXT ACT C 301 A 713 ARG A 47 ARG.? 21.65 CH3 ACT B 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 1.93 40.93 64.24 4.88 41.80 64.42 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 73 ARG~? 20.11 O ACT A 303 A 581 ARG A 27 ARG~? 17.50 O ACT A 303 A 713 ARG A 20 ARG~? 20.10 O ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 73 ARG~? 20.11 O ACT A 303 A 581 ARG A 27 ARG~? 17.50 O ACT A 303 A 713 ARG A 69 ARG~? 15.12 O ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 581 ARG B 73 ARG~? 16.43 O ACT A 302 A 713 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 26.02 42.58 42.38 25.84 41.49 45.27 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 24.09 36.62 39.81 25.66 39.04 38.73 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 581 ARG B 73 ARG~? 16.43 O ACT A 302 A 713 ARG B 69 ARG~? 14.94 O ACT A 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 26.02 42.58 42.38 25.84 41.49 45.27 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 24.09 36.62 39.81 25.66 39.04 38.73 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG B 57 ARG^? 10.43 O ACT B 304 A 581 ARG C 57 ARG^? 6.12 O ACT B 304 A 713 ARG C 39 ARG.? 12.72 CH3 ACT B 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 4.68 37.56 46.31 2.06 39.11 46.79 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 0.41 44.01 46.89 3.20 43.89 45.69 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 9.00 43.74 55.65 11.90 42.76 55.27 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG B 73 ARG~? 16.43 O ACT A 302 A 581 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 713 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 24.09 36.62 39.81 25.66 39.04 38.73 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 26.02 42.58 42.38 25.84 41.49 45.27 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG B 73 ARG~? 16.43 O ACT A 302 A 581 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 713 ARG B 69 ARG~? 14.94 O ACT A 302 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 24.09 36.62 39.81 25.66 39.04 38.73 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 26.02 42.58 42.38 25.84 41.49 45.27 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 581 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 713 ARG C 20 ARG~? 20.69 CH3 ACT B 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -5.77 61.08 52.24 -4.57 63.14 50.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 581 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 713 ARG C 20 ARG~? 20.69 CH3 ACT B 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -5.77 61.08 52.24 -4.57 63.14 50.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 581 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 713 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -12.96 57.05 36.96 -15.23 55.68 35.39 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 14 hits 1qb4_c01 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 60 THR^? -4.49 O ACT A 303s A 182 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 186 LYS A 31 LYS.? 10.36 O ACT A 303 coo 69.38 87.38 24.64 71.11 88.47 25.40 0.42 28.72 42.47 -0.75 26.89 42.18 coo 73.61 90.42 31.12 71.36 89.66 29.64 1.04 26.01 48.23 1.29 24.82 50.73 coo 73.54 84.00 28.64 69.01 86.68 29.71 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR A 60 THR^? -4.49 O ACT A 303s A 182 TYR A 99 TYR~? -4.58 CH3 ACT A 303s A 186 LYS A 31 LYS.? 10.36 O ACT A 303 coo 69.38 87.38 24.64 71.11 88.47 25.40 0.42 28.72 42.47 -0.75 26.89 42.18 coo 73.61 90.42 31.12 71.36 89.66 29.64 6.28 25.07 38.68 7.82 26.15 40.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 3.36 21.23 42.37 3.31 17.75 38.68 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR A 60 THR^? -4.49 O ACT A 303s A 182 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 186 LYS A 7 LYS^? -3.09 CL CL A 201s coo 69.38 87.38 24.64 71.11 88.47 25.40 0.42 28.72 42.47 -0.75 26.89 42.18 coo 73.61 90.42 31.12 71.36 89.66 29.64 6.95 34.35 38.83 5.26 35.08 40.94 coo 73.54 84.00 28.64 69.01 86.68 29.71 0.17 30.56 34.55 -1.45 32.28 29.77 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR B 60 THR^? -4.90 OXT ACT B 304s A 182 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 186 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 69.38 87.38 24.64 71.11 88.47 25.40 10.88 44.65 41.79 13.01 44.54 41.32 coo 73.61 90.42 31.12 71.36 89.66 29.64 13.49 45.92 47.42 14.68 46.48 49.90 coo 73.54 84.00 28.64 69.01 86.68 29.71 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 3 # 5 A 145 THR B 60 THR^? -4.90 OXT ACT B 304s A 182 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 186 LYS B 31 LYS.? 11.57 OXT ACT B 304 coo 69.38 87.38 24.64 71.11 88.47 25.40 10.88 44.65 41.79 13.01 44.54 41.32 coo 73.61 90.42 31.12 71.36 89.66 29.64 10.71 51.79 38.53 9.13 52.40 40.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 15.94 50.91 41.57 17.07 55.01 36.93 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 6 3 # 6 A 145 THR C 60 THR^? 4.85 CH3 ACT C 301 A 182 TYR C 99 TYR~? -4.22 CH3 ACT C 301s A 186 LYS C 31 LYS.? 9.88 CH3 ACT C 301 coo 69.38 87.38 24.64 71.11 88.47 25.40 -8.30 46.13 43.05 -9.25 48.08 42.71 coo 73.61 90.42 31.12 71.36 89.66 29.64 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 73.54 84.00 28.64 69.01 86.68 29.71 -16.24 47.41 43.58 -19.18 48.92 39.46 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 6 hits 1qrr_c01 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 81 HIS.? 19.43 O ACT C 301 B 80 GLU A 77 GLU~? 21.92 O ACT C 301 B 223 ARG A 47 ARG.? 21.65 CH3 ACT B 304 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.82 26.38 49.60 -21.72 24.86 48.45 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -16.08 22.27 46.45 -17.89 21.29 46.96 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 1.93 40.93 64.24 4.88 41.80 64.42 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 1 hits 1t0u_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 64 GLU~? 8.31 CL CL A 201 A 126 LYS A 7 LYS^? -3.09 CL CL A 201s A 171 ALA A 67 ALA~? 8.12 CL CL A 201 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 0.17 30.56 34.55 -1.45 32.28 29.77 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -4.97 26.51 35.79 -4.39 27.75 35.03 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 64 GLU~? 8.32 CL CL B 202 A 126 LYS B 7 LYS^? -3.05 CL CL B 202s A 171 ALA B 67 ALA~? 8.15 CL CL B 202 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 11.55 44.58 28.21 11.34 45.03 26.14 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 8.57 44.02 33.90 7.44 42.15 29.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 14.73 41.53 34.32 13.32 41.50 33.68 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU C 64 GLU~? 8.49 CL CL C 203 A 126 LYS C 7 LYS^? -3.09 CL CL C 203s A 171 ALA C 67 ALA~? 8.09 CL CL C 203 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -10.73 48.33 29.42 -10.52 47.04 27.72 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -8.20 51.25 35.92 -7.51 50.04 35.22 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU C 65 GLU~? 12.15 CL CL C 203 A 126 LYS C 7 LYS^? -3.09 CL CL C 203s A 171 ALA C 67 ALA~? 8.09 CL CL C 203 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -14.02 51.38 31.36 -13.86 50.18 29.63 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -8.20 51.25 35.92 -7.51 50.04 35.22 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 4 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 64 GLU~? 8.31 CL CL A 201 B 126 LYS A 7 LYS^? -3.09 CL CL A 201s B 171 ALA A 67 ALA~? 8.12 CL CL A 201 coo 20.47 87.42 16.54 20.16 87.17 14.45 -1.46 27.34 29.13 -1.37 27.31 27.02 coo 24.73 94.37 14.59 21.08 89.84 11.98 0.17 30.56 34.55 -1.45 32.28 29.77 coo 24.38 86.32 12.71 22.88 86.54 12.71 -4.97 26.51 35.79 -4.39 27.75 35.03 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 64 GLU~? 8.32 CL CL B 202 B 126 LYS B 7 LYS^? -3.05 CL CL B 202s B 171 ALA B 67 ALA~? 8.15 CL CL B 202 coo 20.47 87.42 16.54 20.16 87.17 14.45 11.55 44.58 28.21 11.34 45.03 26.14 coo 24.73 94.37 14.59 21.08 89.84 11.98 8.57 44.02 33.90 7.44 42.15 29.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 14.73 41.53 34.32 13.32 41.50 33.68 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU C 64 GLU~? 8.49 CL CL C 203 B 126 LYS C 7 LYS^? -3.09 CL CL C 203s B 171 ALA C 67 ALA~? 8.09 CL CL C 203 coo 20.47 87.42 16.54 20.16 87.17 14.45 -10.73 48.33 29.42 -10.52 47.04 27.72 coo 24.73 94.37 14.59 21.08 89.84 11.98 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 -8.20 51.25 35.92 -7.51 50.04 35.22 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU C 65 GLU~? 12.15 CL CL C 203 B 126 LYS C 7 LYS^? -3.09 CL CL C 203s B 171 ALA C 67 ALA~? 8.09 CL CL C 203 coo 20.47 87.42 16.54 20.16 87.17 14.45 -14.02 51.38 31.36 -13.86 50.18 29.63 coo 24.73 94.37 14.59 21.08 89.84 11.98 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 -8.20 51.25 35.92 -7.51 50.04 35.22 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 4 hits 1uf7_c01 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 24 GLU~? 16.57 O ACT A 303 A 596 ARG A 27 ARG~? 17.50 O ACT A 303 A 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 69.13 32.20 28.58 68.39 32.96 30.44 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 66.09 40.54 34.70 66.92 37.69 35.49 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 24 GLU~? 16.57 O ACT A 303 A 596 ARG A 73 ARG~? 20.11 O ACT A 303 A 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 69.13 32.20 28.58 68.39 32.96 30.44 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 70.89 37.31 29.70 69.54 36.29 32.39 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 66.09 40.54 34.70 66.92 37.69 35.49 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 -0.06 34.24 44.69 1.54 35.69 44.88 coo 70.89 37.31 29.70 69.54 36.29 32.39 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 66.09 40.54 34.70 66.92 37.69 35.49 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 596 ARG B 57 ARG^? 10.43 O ACT B 304 A 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 -0.06 34.24 44.69 1.54 35.69 44.88 coo 70.89 37.31 29.70 69.54 36.29 32.39 4.68 37.56 46.31 2.06 39.11 46.79 coo 66.09 40.54 34.70 66.92 37.69 35.49 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU A 76 GLU~? 20.19 CL CL A 201 A 596 ARG A 73 ARG~? 20.11 O ACT A 303 A 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 69.13 32.20 28.58 68.39 32.96 30.44 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 70.89 37.31 29.70 69.54 36.29 32.39 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 66.09 40.54 34.70 66.92 37.69 35.49 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU A 77 GLU~? 21.92 O ACT C 301 A 596 ARG A 73 ARG~? 20.11 O ACT A 303 A 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo 69.13 32.20 28.58 68.39 32.96 30.44 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 70.89 37.31 29.70 69.54 36.29 32.39 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 66.09 40.54 34.70 66.92 37.69 35.49 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 22.32 38.82 44.21 23.94 38.72 42.86 coo 70.89 37.31 29.70 69.54 36.29 32.39 26.02 42.58 42.38 25.84 41.49 45.27 coo 66.09 40.54 34.70 66.92 37.69 35.49 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 A 596 ARG B 73 ARG~? 16.43 O ACT A 302 A 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 22.32 38.82 44.21 23.94 38.72 42.86 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.09 36.62 39.81 25.66 39.04 38.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU B 59 GLU^? -6.17 O ACT B 304s A 596 ARG B 57 ARG^? 10.43 O ACT B 304 A 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 6.72 41.22 43.91 4.75 41.83 44.25 coo 70.89 37.31 29.70 69.54 36.29 32.39 4.68 37.56 46.31 2.06 39.11 46.79 coo 66.09 40.54 34.70 66.92 37.69 35.49 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 10 3 # 10 A 581 GLU B 76 GLU~? 14.44 O ACT A 302 A 596 ARG B 73 ARG~? 16.43 O ACT A 302 A 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 25.35 31.50 37.53 26.42 33.21 36.85 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.09 36.62 39.81 25.66 39.04 38.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 11 3 # 11 A 581 GLU B 76 GLU~? 14.44 O ACT A 302 A 596 ARG B 73 ARG~? 16.43 O ACT A 302 A 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 25.35 31.50 37.53 26.42 33.21 36.85 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.09 36.62 39.81 25.66 39.04 38.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 12 3 # 12 A 581 GLU B 77 GLU~? 17.82 O ACT A 302 A 596 ARG B 73 ARG~? 16.43 O ACT A 302 A 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 25.37 33.50 41.00 25.99 35.47 41.49 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.09 36.62 39.81 25.66 39.04 38.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 13 3 # 13 A 581 GLU B 77 GLU~? 17.82 O ACT A 302 A 596 ARG B 73 ARG~? 16.43 O ACT A 302 A 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 69.13 32.20 28.58 68.39 32.96 30.44 25.37 33.50 41.00 25.99 35.47 41.49 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.09 36.62 39.81 25.66 39.04 38.73 coo 66.09 40.54 34.70 66.92 37.69 35.49 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 14 3 # 14 A 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 70.89 37.31 29.70 69.54 36.29 32.39 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 66.09 40.54 34.70 66.92 37.69 35.49 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 15 3 # 15 A 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 16 3 # 16 A 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 A 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 70.89 37.31 29.70 69.54 36.29 32.39 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 66.09 40.54 34.70 66.92 37.69 35.49 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 17 3 # 17 A 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 596 ARG C 57 ARG^? 6.12 O ACT B 304 A 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 70.89 37.31 29.70 69.54 36.29 32.39 0.41 44.01 46.89 3.20 43.89 45.69 coo 66.09 40.54 34.70 66.92 37.69 35.49 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 18 3 # 18 A 581 GLU C 76 GLU~? 20.08 CL CL C 203 A 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 19 3 # 19 A 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 20 3 # 20 A 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 A 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 20 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 24 GLU~? 16.57 O ACT A 303 B 596 ARG A 27 ARG~? 17.50 O ACT A 303 B 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 38.22 57.83 70.36 36.82 56.74 69.18 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 31.43 57.38 61.97 31.90 55.58 64.41 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 24 GLU~? 16.57 O ACT A 303 B 596 ARG A 73 ARG~? 20.11 O ACT A 303 B 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 38.22 57.83 70.36 36.82 56.74 69.18 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 34.24 60.89 68.08 33.31 57.93 67.63 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 31.43 57.38 61.97 31.90 55.58 64.41 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 B 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 -0.06 34.24 44.69 1.54 35.69 44.88 coo 34.24 60.89 68.08 33.31 57.93 67.63 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 31.43 57.38 61.97 31.90 55.58 64.41 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 596 ARG B 57 ARG^? 10.43 O ACT B 304 B 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 -0.06 34.24 44.69 1.54 35.69 44.88 coo 34.24 60.89 68.08 33.31 57.93 67.63 4.68 37.56 46.31 2.06 39.11 46.79 coo 31.43 57.38 61.97 31.90 55.58 64.41 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU A 76 GLU~? 20.19 CL CL A 201 B 596 ARG A 73 ARG~? 20.11 O ACT A 303 B 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 38.22 57.83 70.36 36.82 56.74 69.18 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 34.24 60.89 68.08 33.31 57.93 67.63 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 31.43 57.38 61.97 31.90 55.58 64.41 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU A 77 GLU~? 21.92 O ACT C 301 B 596 ARG A 73 ARG~? 20.11 O ACT A 303 B 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo 38.22 57.83 70.36 36.82 56.74 69.18 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 34.24 60.89 68.08 33.31 57.93 67.63 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 31.43 57.38 61.97 31.90 55.58 64.41 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 B 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 B 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 22.32 38.82 44.21 23.94 38.72 42.86 coo 34.24 60.89 68.08 33.31 57.93 67.63 26.02 42.58 42.38 25.84 41.49 45.27 coo 31.43 57.38 61.97 31.90 55.58 64.41 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 B 596 ARG B 73 ARG~? 16.43 O ACT A 302 B 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 22.32 38.82 44.21 23.94 38.72 42.86 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.09 36.62 39.81 25.66 39.04 38.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU B 59 GLU^? -6.17 O ACT B 304s B 596 ARG B 57 ARG^? 10.43 O ACT B 304 B 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 6.72 41.22 43.91 4.75 41.83 44.25 coo 34.24 60.89 68.08 33.31 57.93 67.63 4.68 37.56 46.31 2.06 39.11 46.79 coo 31.43 57.38 61.97 31.90 55.58 64.41 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 10 3 # 10 B 581 GLU B 76 GLU~? 14.44 O ACT A 302 B 596 ARG B 73 ARG~? 16.43 O ACT A 302 B 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 25.35 31.50 37.53 26.42 33.21 36.85 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.09 36.62 39.81 25.66 39.04 38.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 11 3 # 11 B 581 GLU B 76 GLU~? 14.44 O ACT A 302 B 596 ARG B 73 ARG~? 16.43 O ACT A 302 B 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 25.35 31.50 37.53 26.42 33.21 36.85 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.09 36.62 39.81 25.66 39.04 38.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 12 3 # 12 B 581 GLU B 77 GLU~? 17.82 O ACT A 302 B 596 ARG B 73 ARG~? 16.43 O ACT A 302 B 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 25.37 33.50 41.00 25.99 35.47 41.49 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.09 36.62 39.81 25.66 39.04 38.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 13 3 # 13 B 581 GLU B 77 GLU~? 17.82 O ACT A 302 B 596 ARG B 73 ARG~? 16.43 O ACT A 302 B 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 38.22 57.83 70.36 36.82 56.74 69.18 25.37 33.50 41.00 25.99 35.47 41.49 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.09 36.62 39.81 25.66 39.04 38.73 coo 31.43 57.38 61.97 31.90 55.58 64.41 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 14 3 # 14 B 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 B 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 B 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 34.24 60.89 68.08 33.31 57.93 67.63 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 31.43 57.38 61.97 31.90 55.58 64.41 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 15 3 # 15 B 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 B 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 B 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 16 3 # 16 B 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 B 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 34.24 60.89 68.08 33.31 57.93 67.63 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 31.43 57.38 61.97 31.90 55.58 64.41 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 17 3 # 17 B 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 596 ARG C 57 ARG^? 6.12 O ACT B 304 B 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 34.24 60.89 68.08 33.31 57.93 67.63 0.41 44.01 46.89 3.20 43.89 45.69 coo 31.43 57.38 61.97 31.90 55.58 64.41 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 18 3 # 18 B 581 GLU C 76 GLU~? 20.08 CL CL C 203 B 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 B 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 19 3 # 19 B 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 B 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 20 3 # 20 B 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 B 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 20 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 24 GLU~? 16.57 O ACT A 303 C 596 ARG A 27 ARG~? 17.50 O ACT A 303 C 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 11.31 31.26 27.00 13.31 30.71 26.58 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 21.00 33.35 22.82 19.83 30.82 24.09 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 24 GLU~? 16.57 O ACT A 303 C 596 ARG A 73 ARG~? 20.11 O ACT A 303 C 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 11.31 31.26 27.00 13.31 30.71 26.58 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 13.44 32.78 22.07 15.56 30.91 23.37 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 21.00 33.35 22.82 19.83 30.82 24.09 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 C 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 -0.06 34.24 44.69 1.54 35.69 44.88 coo 13.44 32.78 22.07 15.56 30.91 23.37 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 21.00 33.35 22.82 19.83 30.82 24.09 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 596 ARG B 57 ARG^? 10.43 O ACT B 304 C 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 -0.06 34.24 44.69 1.54 35.69 44.88 coo 13.44 32.78 22.07 15.56 30.91 23.37 4.68 37.56 46.31 2.06 39.11 46.79 coo 21.00 33.35 22.82 19.83 30.82 24.09 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU A 76 GLU~? 20.19 CL CL A 201 C 596 ARG A 73 ARG~? 20.11 O ACT A 303 C 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 11.31 31.26 27.00 13.31 30.71 26.58 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 13.44 32.78 22.07 15.56 30.91 23.37 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 21.00 33.35 22.82 19.83 30.82 24.09 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU A 77 GLU~? 21.92 O ACT C 301 C 596 ARG A 73 ARG~? 20.11 O ACT A 303 C 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo 11.31 31.26 27.00 13.31 30.71 26.58 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 13.44 32.78 22.07 15.56 30.91 23.37 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 21.00 33.35 22.82 19.83 30.82 24.09 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU B 23 GLU~? 17.74 CH3 ACT B 304 C 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 C 647 ARG B 73 ARG~? 16.43 O ACT A 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 23.16 43.48 49.34 24.66 42.52 50.51 coo 13.44 32.78 22.07 15.56 30.91 23.37 26.02 42.58 42.38 25.84 41.49 45.27 coo 21.00 33.35 22.82 19.83 30.82 24.09 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 C 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 C 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 22.32 38.82 44.21 23.94 38.72 42.86 coo 13.44 32.78 22.07 15.56 30.91 23.37 26.02 42.58 42.38 25.84 41.49 45.27 coo 21.00 33.35 22.82 19.83 30.82 24.09 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 C 596 ARG B 73 ARG~? 16.43 O ACT A 302 C 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 22.32 38.82 44.21 23.94 38.72 42.86 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.09 36.62 39.81 25.66 39.04 38.73 coo 21.00 33.35 22.82 19.83 30.82 24.09 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU B 59 GLU^? -6.17 O ACT B 304s C 596 ARG B 57 ARG^? 10.43 O ACT B 304 C 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.72 41.22 43.91 4.75 41.83 44.25 coo 13.44 32.78 22.07 15.56 30.91 23.37 4.68 37.56 46.31 2.06 39.11 46.79 coo 21.00 33.35 22.82 19.83 30.82 24.09 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 11 3 # 11 C 581 GLU B 59 GLU^? -6.17 O ACT B 304s C 596 ARG C 57 ARG^? 6.12 O ACT B 304 C 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 6.72 41.22 43.91 4.75 41.83 44.25 coo 13.44 32.78 22.07 15.56 30.91 23.37 0.41 44.01 46.89 3.20 43.89 45.69 coo 21.00 33.35 22.82 19.83 30.82 24.09 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 12 3 # 12 C 581 GLU B 76 GLU~? 14.44 O ACT A 302 C 596 ARG B 73 ARG~? 16.43 O ACT A 302 C 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 25.35 31.50 37.53 26.42 33.21 36.85 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.09 36.62 39.81 25.66 39.04 38.73 coo 21.00 33.35 22.82 19.83 30.82 24.09 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 13 3 # 13 C 581 GLU B 76 GLU~? 14.44 O ACT A 302 C 596 ARG B 73 ARG~? 16.43 O ACT A 302 C 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 11.31 31.26 27.00 13.31 30.71 26.58 25.35 31.50 37.53 26.42 33.21 36.85 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.09 36.62 39.81 25.66 39.04 38.73 coo 21.00 33.35 22.82 19.83 30.82 24.09 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 14 3 # 14 C 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 C 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 C 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 13.44 32.78 22.07 15.56 30.91 23.37 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 21.00 33.35 22.82 19.83 30.82 24.09 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 15 3 # 15 C 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 C 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 C 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 16 3 # 16 C 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 C 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 13.44 32.78 22.07 15.56 30.91 23.37 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 21.00 33.35 22.82 19.83 30.82 24.09 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 17 3 # 17 C 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 596 ARG C 57 ARG^? 6.12 O ACT B 304 C 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 13.44 32.78 22.07 15.56 30.91 23.37 0.41 44.01 46.89 3.20 43.89 45.69 coo 21.00 33.35 22.82 19.83 30.82 24.09 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 18 3 # 18 C 581 GLU C 76 GLU~? 20.08 CL CL C 203 C 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 C 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 19 3 # 19 C 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 C 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 C 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 20 3 # 20 C 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 C 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 C 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 20 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 24 GLU~? 16.57 O ACT A 303 D 596 ARG A 27 ARG~? 17.50 O ACT A 303 D 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -9.61 21.94 45.26 -10.88 20.30 45.74 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.48 15.97 44.91 -10.41 17.08 42.79 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 24 GLU~? 16.57 O ACT A 303 D 596 ARG A 73 ARG~? 20.11 O ACT A 303 D 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -9.61 21.94 45.26 -10.88 20.30 45.74 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 D 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 D 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -0.06 34.24 44.69 1.54 35.69 44.88 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 D 596 ARG B 57 ARG^? 10.43 O ACT B 304 D 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -0.06 34.24 44.69 1.54 35.69 44.88 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 4.68 37.56 46.31 2.06 39.11 46.79 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU A 76 GLU~? 20.19 CL CL A 201 D 596 ARG A 73 ARG~? 20.11 O ACT A 303 D 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -18.07 23.62 39.12 -17.25 21.90 38.18 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU A 77 GLU~? 21.92 O ACT C 301 D 596 ARG A 73 ARG~? 20.11 O ACT A 303 D 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -16.08 22.27 46.45 -17.89 21.29 46.96 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 D 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 D 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 22.32 38.82 44.21 23.94 38.72 42.86 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 26.02 42.58 42.38 25.84 41.49 45.27 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 D 596 ARG B 73 ARG~? 16.43 O ACT A 302 D 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 22.32 38.82 44.21 23.94 38.72 42.86 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.09 36.62 39.81 25.66 39.04 38.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU B 59 GLU^? -6.17 O ACT B 304s D 596 ARG B 57 ARG^? 10.43 O ACT B 304 D 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 6.72 41.22 43.91 4.75 41.83 44.25 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 4.68 37.56 46.31 2.06 39.11 46.79 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 10 3 # 10 D 581 GLU B 76 GLU~? 14.44 O ACT A 302 D 596 ARG B 73 ARG~? 16.43 O ACT A 302 D 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 25.35 31.50 37.53 26.42 33.21 36.85 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.09 36.62 39.81 25.66 39.04 38.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 11 3 # 11 D 581 GLU B 76 GLU~? 14.44 O ACT A 302 D 596 ARG B 73 ARG~? 16.43 O ACT A 302 D 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 25.35 31.50 37.53 26.42 33.21 36.85 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.09 36.62 39.81 25.66 39.04 38.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 12 3 # 12 D 581 GLU B 77 GLU~? 17.82 O ACT A 302 D 596 ARG B 73 ARG~? 16.43 O ACT A 302 D 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 25.37 33.50 41.00 25.99 35.47 41.49 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.09 36.62 39.81 25.66 39.04 38.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 13 3 # 13 D 581 GLU B 77 GLU~? 17.82 O ACT A 302 D 596 ARG B 73 ARG~? 16.43 O ACT A 302 D 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 25.37 33.50 41.00 25.99 35.47 41.49 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.09 36.62 39.81 25.66 39.04 38.73 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 14 3 # 14 D 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 D 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 D 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -8.82 58.42 44.81 -9.22 60.41 45.38 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -14.39 60.44 44.96 -12.57 61.21 42.61 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 15 3 # 15 D 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 D 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 D 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -8.82 58.42 44.81 -9.22 60.41 45.38 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 16 3 # 16 D 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 D 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 D 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -3.08 44.06 44.69 -2.35 42.14 45.23 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 17 3 # 17 D 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 D 596 ARG C 57 ARG^? 6.12 O ACT B 304 D 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -3.08 44.06 44.69 -2.35 42.14 45.23 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 0.41 44.01 46.89 3.20 43.89 45.69 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 18 3 # 18 D 581 GLU C 76 GLU~? 20.08 CL CL C 203 D 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 D 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -3.98 63.92 37.70 -6.01 64.18 37.13 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 19 3 # 19 D 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 D 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 D 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -5.84 64.35 43.42 -7.71 63.68 44.17 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 20 3 # 20 D 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 D 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 D 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -5.84 64.35 43.42 -7.71 63.68 44.17 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 20 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 24 GLU~? 16.57 O ACT A 303 E 596 ARG A 27 ARG~? 17.50 O ACT A 303 E 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 24 GLU~? 16.57 O ACT A 303 E 596 ARG A 73 ARG~? 20.11 O ACT A 303 E 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 E 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 E 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -0.06 34.24 44.69 1.54 35.69 44.88 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 E 596 ARG B 57 ARG^? 10.43 O ACT B 304 E 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -0.06 34.24 44.69 1.54 35.69 44.88 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 4.68 37.56 46.31 2.06 39.11 46.79 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU A 76 GLU~? 20.19 CL CL A 201 E 596 ARG A 73 ARG~? 20.11 O ACT A 303 E 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -18.07 23.62 39.12 -17.25 21.90 38.18 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU A 77 GLU~? 21.92 O ACT C 301 E 596 ARG A 73 ARG~? 20.11 O ACT A 303 E 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -13.24 21.34 42.66 -14.70 19.65 44.77 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 E 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 E 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 22.32 38.82 44.21 23.94 38.72 42.86 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 26.02 42.58 42.38 25.84 41.49 45.27 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 E 596 ARG B 73 ARG~? 16.43 O ACT A 302 E 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 22.32 38.82 44.21 23.94 38.72 42.86 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.09 36.62 39.81 25.66 39.04 38.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU B 59 GLU^? -6.17 O ACT B 304s E 596 ARG B 57 ARG^? 10.43 O ACT B 304 E 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 6.72 41.22 43.91 4.75 41.83 44.25 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 4.68 37.56 46.31 2.06 39.11 46.79 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU B 76 GLU~? 14.44 O ACT A 302 E 596 ARG B 73 ARG~? 16.43 O ACT A 302 E 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 25.35 31.50 37.53 26.42 33.21 36.85 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.09 36.62 39.81 25.66 39.04 38.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU B 76 GLU~? 14.44 O ACT A 302 E 596 ARG B 73 ARG~? 16.43 O ACT A 302 E 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 25.35 31.50 37.53 26.42 33.21 36.85 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.09 36.62 39.81 25.66 39.04 38.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 12 3 # 12 E 581 GLU B 77 GLU~? 17.82 O ACT A 302 E 596 ARG B 73 ARG~? 16.43 O ACT A 302 E 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 25.37 33.50 41.00 25.99 35.47 41.49 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.09 36.62 39.81 25.66 39.04 38.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 13 3 # 13 E 581 GLU B 77 GLU~? 17.82 O ACT A 302 E 596 ARG B 73 ARG~? 16.43 O ACT A 302 E 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 25.37 33.50 41.00 25.99 35.47 41.49 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.09 36.62 39.81 25.66 39.04 38.73 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 14 3 # 14 E 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 E 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 E 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 15 3 # 15 E 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 E 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 E 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 16 3 # 16 E 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 E 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 E 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 17 3 # 17 E 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 E 596 ARG C 57 ARG^? 6.12 O ACT B 304 E 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 0.41 44.01 46.89 3.20 43.89 45.69 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 18 3 # 18 E 581 GLU C 76 GLU~? 20.08 CL CL C 203 E 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 E 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -3.98 63.92 37.70 -6.01 64.18 37.13 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 19 3 # 19 E 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 E 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 E 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 20 3 # 20 E 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 E 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 E 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.01 61.75 41.62 -10.44 63.15 40.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 20 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 24 GLU~? 16.57 O ACT A 303 F 596 ARG A 27 ARG~? 17.50 O ACT A 303 F 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -9.61 21.94 45.26 -10.88 20.30 45.74 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.48 15.97 44.91 -10.41 17.08 42.79 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 24 GLU~? 16.57 O ACT A 303 F 596 ARG A 73 ARG~? 20.11 O ACT A 303 F 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -9.61 21.94 45.26 -10.88 20.30 45.74 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 F 596 ARG A 57 ARG^? 9.16 OXT ACT C 301 F 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -0.06 34.24 44.69 1.54 35.69 44.88 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU A 59 GLU^? 7.35 OXT ACT A 303 F 596 ARG B 57 ARG^? 10.43 O ACT B 304 F 647 ARG C 57 ARG^? 6.12 O ACT B 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -0.06 34.24 44.69 1.54 35.69 44.88 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 4.68 37.56 46.31 2.06 39.11 46.79 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU A 76 GLU~? 20.19 CL CL A 201 F 596 ARG A 73 ARG~? 20.11 O ACT A 303 F 647 ARG A 69 ARG~? 15.12 O ACT A 303 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -18.07 23.62 39.12 -17.25 21.90 38.18 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU A 77 GLU~? 21.92 O ACT C 301 F 596 ARG A 73 ARG~? 20.11 O ACT A 303 F 647 ARG A 27 ARG~? 17.50 O ACT A 303 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -16.08 22.27 46.45 -17.89 21.29 46.96 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -13.24 21.34 42.66 -14.70 19.65 44.77 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 F 596 ARG B 27 ARG~? 17.68 OXT ACT B 304 F 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 22.32 38.82 44.21 23.94 38.72 42.86 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 26.02 42.58 42.38 25.84 41.49 45.27 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU B 24 GLU~? 17.02 OXT ACT B 304 F 596 ARG B 73 ARG~? 16.43 O ACT A 302 F 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 22.32 38.82 44.21 23.94 38.72 42.86 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.09 36.62 39.81 25.66 39.04 38.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU B 59 GLU^? -6.17 O ACT B 304s F 596 ARG B 57 ARG^? 10.43 O ACT B 304 F 647 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 6.72 41.22 43.91 4.75 41.83 44.25 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 4.68 37.56 46.31 2.06 39.11 46.79 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 10 3 # 10 F 581 GLU B 76 GLU~? 14.44 O ACT A 302 F 596 ARG B 73 ARG~? 16.43 O ACT A 302 F 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 25.35 31.50 37.53 26.42 33.21 36.85 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.09 36.62 39.81 25.66 39.04 38.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 11 3 # 11 F 581 GLU B 76 GLU~? 14.44 O ACT A 302 F 596 ARG B 73 ARG~? 16.43 O ACT A 302 F 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 25.35 31.50 37.53 26.42 33.21 36.85 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.09 36.62 39.81 25.66 39.04 38.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 12 3 # 12 F 581 GLU B 77 GLU~? 17.82 O ACT A 302 F 596 ARG B 73 ARG~? 16.43 O ACT A 302 F 647 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 25.37 33.50 41.00 25.99 35.47 41.49 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.09 36.62 39.81 25.66 39.04 38.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 13 3 # 13 F 581 GLU B 77 GLU~? 17.82 O ACT A 302 F 596 ARG B 73 ARG~? 16.43 O ACT A 302 F 647 ARG B 69 ARG~? 14.94 O ACT A 302 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 25.37 33.50 41.00 25.99 35.47 41.49 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.09 36.62 39.81 25.66 39.04 38.73 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 14 3 # 14 F 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 F 596 ARG C 27 ARG~? 17.31 CH3 ACT C 301 F 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -8.82 58.42 44.81 -9.22 60.41 45.38 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -14.39 60.44 44.96 -12.57 61.21 42.61 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 15 3 # 15 F 581 GLU C 24 GLU~? 16.74 CH3 ACT C 301 F 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 F 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -8.82 58.42 44.81 -9.22 60.41 45.38 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 16 3 # 16 F 581 GLU C 59 GLU^? 7.72 OXT ACT C 301 F 596 ARG C 57 ARG^? 6.12 O ACT B 304 F 647 ARG B 57 ARG^? 10.43 O ACT B 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -3.08 44.06 44.69 -2.35 42.14 45.23 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 0.41 44.01 46.89 3.20 43.89 45.69 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 17 3 # 17 F 581 GLU C 76 GLU~? 20.08 CL CL C 203 F 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 F 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -3.98 63.92 37.70 -6.01 64.18 37.13 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -12.96 57.05 36.96 -15.23 55.68 35.39 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 18 3 # 18 F 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 F 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 F 647 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -5.84 64.35 43.42 -7.71 63.68 44.17 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 19 3 # 19 F 581 GLU C 77 GLU~? 20.13 CH3 ACT C 301 F 596 ARG C 73 ARG~? 19.49 CH3 ACT C 301 F 647 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -5.84 64.35 43.42 -7.71 63.68 44.17 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.01 61.75 41.62 -10.44 63.15 40.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -12.96 57.05 36.96 -15.23 55.68 35.39 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 19 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 55 ASN^? 10.27 O ACT C 301 457 GLY A 40 GLY.? 8.88 O ACT C 301 459 GLU A 41 GLU.? 4.97 O ACT C 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -9.41 44.65 53.52 -9.78 44.04 53.98 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.23 45.29 51.30 -13.91 44.10 49.69 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 55 ASN^? 10.27 O ACT C 301 457 GLY A 42 GLY.? 12.48 O ACT C 301 459 GLU A 41 GLU.? 4.97 O ACT C 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -13.24 44.86 57.56 -12.65 44.58 57.16 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.23 45.29 51.30 -13.91 44.10 49.69 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN A 55 ASN^? 10.27 O ACT C 301 457 GLY A 53 GLY.? 16.08 O ACT C 301 459 GLU A 52 GLU.? 20.44 O ACT C 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -11.39 37.01 60.51 -10.69 36.62 60.44 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.35 32.78 61.59 -14.92 31.80 62.64 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN C 55 ASN^? 9.16 CH3 ACT B 304 457 GLY C 53 GLY.? 16.29 CH3 ACT B 304 459 GLU C 52 GLU.? 17.63 CH3 ACT B 304 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 4.32 50.30 52.50 5.90 51.72 52.50 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 5.95 53.06 59.85 5.63 52.23 59.43 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 2.90 48.54 61.44 4.21 46.86 61.22 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 317 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 365 ARG A 27 ARG~? 17.50 O ACT A 303 coo 1.77 6.56 57.05 3.05 7.44 59.37 1.04 26.01 48.23 1.29 24.82 50.73 coo 3.06 2.85 52.79 4.83 3.89 53.24 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 3.82 17.09 49.56 4.09 14.32 50.84 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 317 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 365 ARG B 57 ARG^? 10.43 O ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 1.04 26.01 48.23 1.29 24.82 50.73 coo 3.06 2.85 52.79 4.83 3.89 53.24 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 3.82 17.09 49.56 4.09 14.32 50.84 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s A 317 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 365 ARG A 27 ARG~? 17.50 O ACT A 303 coo 1.77 6.56 57.05 3.05 7.44 59.37 1.04 26.01 48.23 1.29 24.82 50.73 coo 3.06 2.85 52.79 4.83 3.89 53.24 4.59 21.37 51.97 2.75 21.07 50.95 coo 3.82 17.09 49.56 4.09 14.32 50.84 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR A 78 TYR~? 17.62 O ACT C 301 A 317 GLU A 24 GLU~? 16.57 O ACT A 303 A 365 ARG C 95 ARG.? 16.43 O ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 3.06 2.85 52.79 4.83 3.89 53.24 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 3.82 17.09 49.56 4.09 14.32 50.84 -19.41 33.29 38.70 -21.06 30.88 37.75 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR A 78 TYR~? 17.62 O ACT C 301 A 317 GLU A 77 GLU~? 21.92 O ACT C 301 A 365 ARG A 69 ARG~? 15.12 O ACT A 303 coo 1.77 6.56 57.05 3.05 7.44 59.37 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 3.06 2.85 52.79 4.83 3.89 53.24 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 3.82 17.09 49.56 4.09 14.32 50.84 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR A 78 TYR~? 17.62 O ACT C 301 A 317 GLU A 77 GLU~? 21.92 O ACT C 301 A 365 ARG C 95 ARG.? 16.43 O ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 3.06 2.85 52.79 4.83 3.89 53.24 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 3.82 17.09 49.56 4.09 14.32 50.84 -19.41 33.29 38.70 -21.06 30.88 37.75 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR A 82 TYR.? 16.37 O ACT C 301 A 317 GLU A 14 GLU^? 15.87 O ACT C 301 A 365 ARG A 73 ARG~? 20.11 O ACT A 303 coo 1.77 6.56 57.05 3.05 7.44 59.37 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 3.06 2.85 52.79 4.83 3.89 53.24 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 1vzx_c02 2.04.01.0087 user 8 3 # 8 A 314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 365 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 13.49 45.92 47.42 14.68 46.48 49.90 coo 3.06 2.85 52.79 4.83 3.89 53.24 15.35 40.93 52.66 14.20 41.89 54.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1vzx_c02 2.04.01.0087 user 9 3 # 9 A 314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 365 ARG B 57 ARG^? 10.43 O ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 13.49 45.92 47.42 14.68 46.48 49.90 coo 3.06 2.85 52.79 4.83 3.89 53.24 15.35 40.93 52.66 14.20 41.89 54.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1vzx_c02 2.04.01.0087 user 10 3 # 10 A 314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 365 ARG C 57 ARG^? 6.12 O ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 13.49 45.92 47.42 14.68 46.48 49.90 coo 3.06 2.85 52.79 4.83 3.89 53.24 15.35 40.93 52.66 14.20 41.89 54.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1vzx_c02 2.04.01.0087 user 11 3 # 11 A 314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s A 317 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 365 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 13.49 45.92 47.42 14.68 46.48 49.90 coo 3.06 2.85 52.79 4.83 3.89 53.24 16.43 50.94 51.34 17.50 52.11 49.94 coo 3.82 17.09 49.56 4.09 14.32 50.84 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1vzx_c02 2.04.01.0087 user 12 3 # 12 A 314 TYR B 78 TYR~? 17.24 CH3 ACT A 303 A 317 GLU B 77 GLU~? 17.82 O ACT A 302 A 365 ARG A 95 ARG.? 9.56 OXT ACT A 302 coo 1.77 6.56 57.05 3.05 7.44 59.37 20.54 33.17 44.58 21.91 35.42 45.49 coo 3.06 2.85 52.79 4.83 3.89 53.24 25.37 33.50 41.00 25.99 35.47 41.49 coo 3.82 17.09 49.56 4.09 14.32 50.84 16.24 25.45 35.76 18.96 25.41 34.33 ULMN 3 1vzx_c02 2.04.01.0087 user 13 3 # 13 A 314 TYR C 33 TYR.? -7.29 C ACT C 301s A 317 GLU A 41 GLU.? 4.97 O ACT C 301 A 365 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 3.06 2.85 52.79 4.83 3.89 53.24 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 3.82 17.09 49.56 4.09 14.32 50.84 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1vzx_c02 2.04.01.0087 user 14 3 # 14 A 314 TYR C 33 TYR.? -7.29 C ACT C 301s A 317 GLU A 41 GLU.? 4.97 O ACT C 301 A 365 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 3.06 2.85 52.79 4.83 3.89 53.24 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 3.82 17.09 49.56 4.09 14.32 50.84 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1vzx_c02 2.04.01.0087 user 15 3 # 15 A 314 TYR C 33 TYR.? -7.29 C ACT C 301s A 317 GLU A 41 GLU.? 4.97 O ACT C 301 A 365 ARG C 57 ARG^? 6.12 O ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 3.06 2.85 52.79 4.83 3.89 53.24 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 3.82 17.09 49.56 4.09 14.32 50.84 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1vzx_c02 2.04.01.0087 user 16 3 # 16 A 314 TYR C 33 TYR.? -7.29 C ACT C 301s A 317 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 365 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 3.06 2.85 52.79 4.83 3.89 53.24 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 3.82 17.09 49.56 4.09 14.32 50.84 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1vzx_c02 2.04.01.0087 user 17 3 # 17 A 314 TYR C 33 TYR.? -7.29 C ACT C 301s A 317 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 365 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 1.77 6.56 57.05 3.05 7.44 59.37 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 3.06 2.85 52.79 4.83 3.89 53.24 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 3.82 17.09 49.56 4.09 14.32 50.84 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1vzx_c02 2.04.01.0087 user 18 3 # 18 A 314 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 317 GLU C 24 GLU~? 16.74 CH3 ACT C 301 A 365 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 3.06 2.85 52.79 4.83 3.89 53.24 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 3.82 17.09 49.56 4.09 14.32 50.84 5.02 60.48 36.40 3.75 63.08 35.35 ULMN 3 1vzx_c02 2.04.01.0087 user 19 3 # 19 A 314 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 317 GLU C 77 GLU~? 20.13 CH3 ACT C 301 A 365 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 1.77 6.56 57.05 3.05 7.44 59.37 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 3.06 2.85 52.79 4.83 3.89 53.24 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 3.82 17.09 49.56 4.09 14.32 50.84 5.02 60.48 36.40 3.75 63.08 35.35 1vzx_c02 source 1vzx 2.04.01.0087 : 19 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s B1317 GLU A 18 GLU~? 13.24 OXT ACT A 303 B1365 ARG A 27 ARG~? 17.50 O ACT A 303 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 1.04 26.01 48.23 1.29 24.82 50.73 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s B1317 GLU A 18 GLU~? 13.24 OXT ACT A 303 B1365 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 1.04 26.01 48.23 1.29 24.82 50.73 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR A 33 TYR.? -7.37 CH3 ACT A 303s B1317 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B1365 ARG A 27 ARG~? 17.50 O ACT A 303 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 1.04 26.01 48.23 1.29 24.82 50.73 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 4.59 21.37 51.97 2.75 21.07 50.95 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -8.48 15.97 44.91 -10.41 17.08 42.79 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR A 78 TYR~? 17.62 O ACT C 301 B1317 GLU A 24 GLU~? 16.57 O ACT A 303 B1365 ARG C 95 ARG.? 16.43 O ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -9.61 21.94 45.26 -10.88 20.30 45.74 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -19.41 33.29 38.70 -21.06 30.88 37.75 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR A 78 TYR~? 17.62 O ACT C 301 B1317 GLU A 77 GLU~? 21.92 O ACT C 301 B1365 ARG A 69 ARG~? 15.12 O ACT A 303 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR A 78 TYR~? 17.62 O ACT C 301 B1317 GLU A 77 GLU~? 21.92 O ACT C 301 B1365 ARG C 95 ARG.? 16.43 O ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -16.08 22.27 46.45 -17.89 21.29 46.96 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -19.41 33.29 38.70 -21.06 30.88 37.75 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR A 82 TYR.? 16.37 O ACT C 301 B1317 GLU A 14 GLU^? 15.87 O ACT C 301 B1365 ARG A 73 ARG~? 20.11 O ACT A 303 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -12.43 31.41 55.22 -14.25 31.05 56.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s B1317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B1365 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 13.49 45.92 47.42 14.68 46.48 49.90 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 15.35 40.93 52.66 14.20 41.89 54.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1vzx_c03 2.04.01.0087 user 9 3 # 9 B1314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s B1317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B1365 ARG B 57 ARG^? 10.43 O ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 13.49 45.92 47.42 14.68 46.48 49.90 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 15.35 40.93 52.66 14.20 41.89 54.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 1vzx_c03 2.04.01.0087 user 10 3 # 10 B1314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s B1317 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B1365 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 13.49 45.92 47.42 14.68 46.48 49.90 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 15.35 40.93 52.66 14.20 41.89 54.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1vzx_c03 2.04.01.0087 user 11 3 # 11 B1314 TYR B 33 TYR.? -6.95 CH3 ACT B 304s B1317 GLU C 41 GLU.? 10.40 CH3 ACT B 304 B1365 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 13.49 45.92 47.42 14.68 46.48 49.90 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 16.43 50.94 51.34 17.50 52.11 49.94 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 26.02 42.58 42.38 25.84 41.49 45.27 ULMN 3 1vzx_c03 2.04.01.0087 user 12 3 # 12 B1314 TYR B 78 TYR~? 17.24 CH3 ACT A 303 B1317 GLU B 77 GLU~? 17.82 O ACT A 302 B1365 ARG A 95 ARG.? 9.56 OXT ACT A 302 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 20.54 33.17 44.58 21.91 35.42 45.49 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 25.37 33.50 41.00 25.99 35.47 41.49 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 16.24 25.45 35.76 18.96 25.41 34.33 ULMN 3 1vzx_c03 2.04.01.0087 user 13 3 # 13 B1314 TYR C 33 TYR.? -7.29 C ACT C 301s B1317 GLU A 41 GLU.? 4.97 O ACT C 301 B1365 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1vzx_c03 2.04.01.0087 user 14 3 # 14 B1314 TYR C 33 TYR.? -7.29 C ACT C 301s B1317 GLU A 41 GLU.? 4.97 O ACT C 301 B1365 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1vzx_c03 2.04.01.0087 user 15 3 # 15 B1314 TYR C 33 TYR.? -7.29 C ACT C 301s B1317 GLU A 41 GLU.? 4.97 O ACT C 301 B1365 ARG C 57 ARG^? 6.12 O ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -13.23 45.29 51.30 -13.91 44.10 49.69 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 1vzx_c03 2.04.01.0087 user 16 3 # 16 B1314 TYR C 33 TYR.? -7.29 C ACT C 301s B1317 GLU C 18 GLU~? 13.25 OXT ACT C 301 B1365 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 1vzx_c03 2.04.01.0087 user 17 3 # 17 B1314 TYR C 33 TYR.? -7.29 C ACT C 301s B1317 GLU C 18 GLU~? 13.25 OXT ACT C 301 B1365 ARG C 27 ARG~? 17.31 CH3 ACT C 301 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -10.17 47.49 48.78 -10.97 48.02 51.40 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -14.39 60.44 44.96 -12.57 61.21 42.61 ULMN 3 1vzx_c03 2.04.01.0087 user 18 3 # 18 B1314 TYR C 78 TYR~? 17.53 CH3 ACT B 304 B1317 GLU C 24 GLU~? 16.74 CH3 ACT C 301 B1365 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -8.82 58.42 44.81 -9.22 60.41 45.38 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 5.02 60.48 36.40 3.75 63.08 35.35 ULMN 3 1vzx_c03 2.04.01.0087 user 19 3 # 19 B1314 TYR C 78 TYR~? 17.53 CH3 ACT B 304 B1317 GLU C 77 GLU~? 20.13 CH3 ACT C 301 B1365 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -5.84 64.35 43.42 -7.71 63.68 44.17 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 5.02 60.48 36.40 3.75 63.08 35.35 1vzx_c03 source 1vzx 2.04.01.0087 : 19 hits 1vzx_c03 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 38 ALA^? 9.36 OXT ACT C 301 B 182 GLY A 42 GLY.? 12.48 O ACT C 301 B 183 GLY A 40 GLY.? 8.88 O ACT C 301 coo 38.36-101.47-135.52 39.62-101.29-136.35 -4.54 39.46 52.77 -5.17 38.67 51.64 coo 41.93-102.35-126.87 41.52-101.89-126.30 -13.24 44.86 57.56 -12.65 44.58 57.16 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.41 44.65 53.52 -9.78 44.04 53.98 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 1 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA C 13 ALA^? 11.08 CH3 ACT B 304 B 126 ARG C 57 ARG^? 6.12 O ACT B 304 B 138 GLU C 14 GLU^? 15.65 CH3 ACT B 304 coo 2.11 4.00 19.31 3.14 4.86 19.99 2.10 53.41 49.69 0.93 54.36 49.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 0.41 44.01 46.89 3.20 43.89 45.69 coo 6.10 2.00 25.24 6.12 1.84 23.13 3.23 56.16 55.11 3.39 58.23 55.56 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 13 ALA^? 11.55 O ACT C 301 C 126 ARG A 57 ARG^? 9.16 OXT ACT C 301 C 138 GLU A 14 GLU^? 15.87 O ACT C 301 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 13 ALA^? 11.27 CH3 ACT A 303 C 126 ARG B 57 ARG^? 10.43 O ACT B 304 C 138 GLU B 14 GLU^? 14.83 CH3 ACT A 303 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 12.76 32.40 49.06 14.10 32.82 48.50 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 4.68 37.56 46.31 2.06 39.11 46.79 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 14.26 29.69 53.47 14.81 28.86 55.34 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA C 13 ALA^? 11.08 CH3 ACT B 304 C 126 ARG C 57 ARG^? 6.12 O ACT B 304 C 138 GLU C 14 GLU^? 15.65 CH3 ACT B 304 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 2.10 53.41 49.69 0.93 54.36 49.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 0.41 44.01 46.89 3.20 43.89 45.69 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 3.23 56.16 55.11 3.39 58.23 55.56 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA C 13 ALA^? 11.08 CH3 ACT B 304 D 126 ARG C 57 ARG^? 6.12 O ACT B 304 D 138 GLU C 14 GLU^? 15.65 CH3 ACT B 304 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 2.10 53.41 49.69 0.93 54.36 49.32 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 0.41 44.01 46.89 3.20 43.89 45.69 coo 6.23 0.50 57.10 5.93 0.72 59.19 3.23 56.16 55.11 3.39 58.23 55.56 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA C 13 ALA^? 11.08 CH3 ACT B 304 E 126 ARG C 57 ARG^? 6.12 O ACT B 304 E 138 GLU C 14 GLU^? 15.65 CH3 ACT B 304 coo -4.56 10.03 62.36 -4.38 11.31 61.55 2.10 53.41 49.69 0.93 54.36 49.32 coo -3.02 12.00 70.07 -1.94 13.84 67.82 0.41 44.01 46.89 3.20 43.89 45.69 coo -8.67 12.22 56.54 -8.68 12.09 58.65 3.23 56.16 55.11 3.39 58.23 55.56 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 13 ALA^? 11.55 O ACT C 301 F 126 ARG A 57 ARG^? 9.16 OXT ACT C 301 F 138 GLU A 14 GLU^? 15.87 O ACT C 301 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -10.21 33.55 50.82 -10.49 32.11 50.39 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -12.43 31.41 55.22 -14.25 31.05 56.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 13 ALA^? 11.27 CH3 ACT A 303 F 126 ARG B 57 ARG^? 10.43 O ACT B 304 F 138 GLU B 14 GLU^? 14.83 CH3 ACT A 303 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 12.76 32.40 49.06 14.10 32.82 48.50 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 4.68 37.56 46.31 2.06 39.11 46.79 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 14.26 29.69 53.47 14.81 28.86 55.34 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA C 13 ALA^? 11.08 CH3 ACT B 304 F 126 ARG C 57 ARG^? 6.12 O ACT B 304 F 138 GLU C 14 GLU^? 15.65 CH3 ACT B 304 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 2.10 53.41 49.69 0.93 54.36 49.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 0.41 44.01 46.89 3.20 43.89 45.69 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 3.23 56.16 55.11 3.39 58.23 55.56 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 42 GLY.? 12.48 O ACT C 301 B 175 ARG A 39 ARG.? 13.42 OXT ACT C 301 B 242 TYR C 33 TYR.? -7.29 C ACT C 301s coo 99.45 58.28 3.33 99.57 58.61 4.10 -13.24 44.86 57.56 -12.65 44.58 57.16 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 100.93 69.04 4.38 99.52 68.48 2.09 -10.17 47.49 48.78 -10.97 48.02 51.40 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 42 GLY.? 12.96 CH3 ACT A 303 B 175 ARG B 39 ARG.? 13.46 OXT ACT A 303 B 242 TYR A 33 TYR.? -7.37 CH3 ACT A 303s coo 99.45 58.28 3.33 99.57 58.61 4.10 5.11 23.74 56.37 5.08 24.43 55.92 coo 106.37 63.53 0.89 108.02 63.40 -1.62 2.53 31.11 56.62 -0.26 29.95 56.31 coo 100.93 69.04 4.38 99.52 68.48 2.09 1.04 26.01 48.23 1.29 24.82 50.73 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY C 42 GLY.? 12.37 CH3 ACT B 304 B 175 ARG C 39 ARG.? 12.72 CH3 ACT B 304 B 242 TYR B 33 TYR.? -6.95 CH3 ACT B 304s coo 99.45 58.28 3.33 99.57 58.61 4.10 14.74 50.71 55.40 14.32 50.00 55.21 coo 106.37 63.53 0.89 108.02 63.40 -1.62 9.00 43.74 55.65 11.90 42.76 55.27 coo 100.93 69.04 4.38 99.52 68.48 2.09 13.49 45.92 47.42 14.68 46.48 49.90 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 3 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 18.28 7.83 36.39 22.82 8.75 39.52 -2.24 19.72 44.66 2.39 20.87 47.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.36 21.23 42.37 3.31 17.75 38.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -2.24 19.72 44.66 2.39 20.87 47.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.36 21.23 42.37 3.31 17.75 38.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 -2.24 19.72 44.66 2.39 20.87 47.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.36 21.23 42.37 3.31 17.75 38.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 18.28 7.83 36.39 22.82 8.75 39.52 3.36 21.23 42.37 3.31 17.75 38.68 coo 14.16 13.09 37.03 20.00 12.44 37.49 -2.24 19.72 44.66 2.39 20.87 47.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 3.36 21.23 42.37 3.31 17.75 38.68 coo 14.16 13.09 37.03 20.00 12.44 37.49 -2.24 19.72 44.66 2.39 20.87 47.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 3.36 21.23 42.37 3.31 17.75 38.68 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.24 21.45 37.02 12.73 25.01 40.79 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 31 LYS.? 10.36 O ACT A 303 A 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 3.36 21.23 42.37 3.31 17.75 38.68 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.24 21.45 37.02 12.73 25.01 40.79 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.24 21.45 37.02 12.73 25.01 40.79 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.36 21.23 42.37 3.31 17.75 38.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 74 LYS A 31 LYS.? 10.36 O ACT A 303 A 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.24 21.45 37.02 12.73 25.01 40.79 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.36 21.23 42.37 3.31 17.75 38.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 18.28 7.83 36.39 22.82 8.75 39.52 20.18 46.61 43.20 19.00 49.55 48.67 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.94 50.91 41.57 17.07 55.01 36.93 coo 22.22 16.06 48.76 23.94 15.33 49.78 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 20.18 46.61 43.20 19.00 49.55 48.67 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.94 50.91 41.57 17.07 55.01 36.93 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 18.28 7.83 36.39 22.82 8.75 39.52 15.94 50.91 41.57 17.07 55.01 36.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 20.18 46.61 43.20 19.00 49.55 48.67 coo 22.22 16.06 48.76 23.94 15.33 49.78 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.94 50.91 41.57 17.07 55.01 36.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 20.18 46.61 43.20 19.00 49.55 48.67 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.94 50.91 41.57 17.07 55.01 36.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 12.25 56.30 36.89 8.12 57.51 41.12 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.94 50.91 41.57 17.07 55.01 36.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 12.25 56.30 36.89 8.12 57.51 41.12 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 12.25 56.30 36.89 8.12 57.51 41.12 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.94 50.91 41.57 17.07 55.01 36.93 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 18.28 7.83 36.39 22.82 8.75 39.52 12.25 56.30 36.89 8.12 57.51 41.12 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.94 50.91 41.57 17.07 55.01 36.93 coo 22.22 16.06 48.76 23.94 15.33 49.78 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS C 26 LYS~? 10.00 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 26 LYS~? 10.00 O ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 22.22 16.06 48.76 23.94 15.33 49.78 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 74 LYS C 98 LYS~? 7.72 O ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 22.22 16.06 48.76 23.94 15.33 49.78 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS C 98 LYS~? 7.72 O ACT C 301 A 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 A 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 18.28 7.83 36.39 22.82 8.75 39.52 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.02 51.38 31.36 -13.86 50.18 29.63 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 25 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.51 0.92 76.10 12.98 6.13 74.68 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.89 -0.55 76.51 17.10 4.32 77.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 -2.24 19.72 44.66 2.39 20.87 47.23 coo 19.89 -0.55 76.51 17.10 4.32 77.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 59 GLU^? 7.35 OXT ACT A 303 coo 13.51 0.92 76.10 12.98 6.13 74.68 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -2.24 19.72 44.66 2.39 20.87 47.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.06 34.24 44.69 1.54 35.69 44.88 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 26 LYS~? 7.74 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -2.24 19.72 44.66 2.39 20.87 47.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.24 21.45 37.02 12.73 25.01 40.79 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 31 LYS.? 10.36 O ACT A 303 B 74 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 3.36 21.23 42.37 3.31 17.75 38.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.24 21.45 37.02 12.73 25.01 40.79 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 64 GLU~? 8.31 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.89 -0.55 76.51 17.10 4.32 77.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.46 27.34 29.13 -1.37 27.31 27.02 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 98 LYS~? 7.98 CH3 ACT A 303 B 74 LYS A 31 LYS.? 10.36 O ACT A 303 B 165 GLU A 65 GLU~? 11.46 CL CL A 201 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.24 21.45 37.02 12.73 25.01 40.79 coo 19.89 -0.55 76.51 17.10 4.32 77.43 3.36 21.23 42.37 3.31 17.75 38.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.30 22.08 29.22 -2.64 23.27 28.50 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 13.51 0.92 76.10 12.98 6.13 74.68 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.39 11.56 68.52 20.24 13.13 67.73 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 20.18 46.61 43.20 19.00 49.55 48.67 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 165 GLU B 59 GLU^? -6.17 O ACT B 304s coo 13.51 0.92 76.10 12.98 6.13 74.68 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 20.18 46.61 43.20 19.00 49.55 48.67 coo 21.39 11.56 68.52 20.24 13.13 67.73 6.72 41.22 43.91 4.75 41.83 44.25 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 20.18 46.61 43.20 19.00 49.55 48.67 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 12.25 56.30 36.89 8.12 57.51 41.12 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 74 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.94 50.91 41.57 17.07 55.01 36.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 12.25 56.30 36.89 8.12 57.51 41.12 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 64 GLU~? 8.32 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.55 44.58 28.21 11.34 45.03 26.14 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 98 LYS~? 9.29 CH3 ACT B 304 B 74 LYS B 31 LYS.? 11.57 OXT ACT B 304 B 165 GLU B 65 GLU~? 12.71 CL CL B 202 coo 13.51 0.92 76.10 12.98 6.13 74.68 12.25 56.30 36.89 8.12 57.51 41.12 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.94 50.91 41.57 17.07 55.01 36.93 coo 21.39 11.56 68.52 20.24 13.13 67.73 17.56 45.22 27.93 16.40 47.01 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS C 26 LYS~? 10.00 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 26 LYS~? 10.00 O ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 21.39 11.56 68.52 20.24 13.13 67.73 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 74 LYS C 98 LYS~? 7.72 O ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 21.39 11.56 68.52 20.24 13.13 67.73 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 59 GLU^? 7.72 OXT ACT C 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -3.08 44.06 44.69 -2.35 42.14 45.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 64 GLU~? 8.49 CL CL C 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -10.73 48.33 29.42 -10.52 47.04 27.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS C 98 LYS~? 7.72 O ACT C 301 B 74 LYS C 31 LYS.? 9.88 CH3 ACT C 301 B 165 GLU C 65 GLU~? 12.15 CL CL C 203 coo 13.51 0.92 76.10 12.98 6.13 74.68 -19.31 41.45 39.34 -17.64 37.26 43.62 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.24 47.41 43.58 -19.18 48.92 39.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.02 51.38 31.36 -13.86 50.18 29.63 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 24 hits 1ylu_c01 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 51 TRP.? 23.81 O ACT C 301 223 ASP B 50 ASP.? 15.85 OXT ACT A 303 258 ALA A 38 ALA^? 9.36 OXT ACT C 301 coo 128.40 33.01 26.67 128.12 36.28 28.81 -5.11 34.35 64.95 -3.63 31.02 66.43 coo 127.91 41.73 23.55 129.18 40.35 24.44 2.98 31.06 60.86 4.11 29.82 59.55 coo 141.00 37.49 25.74 139.80 37.53 24.78 -4.54 39.46 52.77 -5.17 38.67 51.64 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 1 hits 2aat_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 156 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 4.59 21.37 51.97 2.75 21.07 50.95 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 156 GLU B 59 GLU^? -6.17 O ACT B 304s A 194 ASN A 90 ASN^? -5.08 CL CL A 201s coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 156 GLU B 59 GLU^? -6.17 O ACT B 304s A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 156 GLU B 59 GLU^? -6.17 O ACT B 304s A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 15.35 40.93 52.66 14.20 41.89 54.18 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 156 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 15.35 40.93 52.66 14.20 41.89 54.18 coo 67.47 20.07 1.34 65.99 20.06 2.88 16.43 50.94 51.34 17.50 52.11 49.94 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU B 41 GLU.? 9.71 CH3 ACT A 303 A 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 4.59 21.37 51.97 2.75 21.07 50.95 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU B 59 GLU^? -6.17 O ACT B 304s A 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 74.14 15.91 8.55 72.08 15.36 8.63 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.44 25.26 13.91 67.54 23.65 15.28 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU B 59 GLU^? -6.17 O ACT B 304s A 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 15.35 40.93 52.66 14.20 41.89 54.18 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU B 59 GLU^? -6.17 O ACT B 304s A 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c00 CHITINASE C user 15 3 # 15 A 147 GLU C 41 GLU.? 10.40 CH3 ACT B 304 A 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.43 50.94 51.34 17.50 52.11 49.94 coo 67.47 20.07 1.34 65.99 20.06 2.88 15.35 40.93 52.66 14.20 41.89 54.18 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 16 3 # 16 A 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 A 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.06 34.24 44.69 1.54 35.69 44.88 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c00 CHITINASE C user 17 3 # 17 A 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 156 GLU B 59 GLU^? -6.17 O ACT B 304s A 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.72 41.22 43.91 4.75 41.83 44.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c00 CHITINASE C user 18 3 # 18 A 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 A 156 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.33 37.03 53.83 -10.36 37.52 54.24 2dbt_c00 source 2dbt CHITINASE C : 18 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 156 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.59 21.37 51.97 2.75 21.07 50.95 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.06 34.24 44.69 1.54 35.69 44.88 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 156 GLU B 59 GLU^? -6.17 O ACT B 304s B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.06 34.24 44.69 1.54 35.69 44.88 coo 54.43 67.89 19.82 55.62 67.90 18.07 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.06 34.24 44.69 1.54 35.69 44.88 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 156 GLU B 59 GLU^? -6.17 O ACT B 304s B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 15.35 40.93 52.66 14.20 41.89 54.18 coo 54.43 67.89 19.82 55.62 67.90 18.07 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 156 GLU C 41 GLU.? 10.40 CH3 ACT B 304 B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 15.35 40.93 52.66 14.20 41.89 54.18 coo 54.43 67.89 19.82 55.62 67.90 18.07 16.43 50.94 51.34 17.50 52.11 49.94 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 41 GLU.? 9.71 CH3 ACT A 303 B 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 4.59 21.37 51.97 2.75 21.07 50.95 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 59 GLU^? -6.17 O ACT B 304s B 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.72 41.22 43.91 4.75 41.83 44.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.79 70.75 7.78 50.10 68.90 6.86 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU B 59 GLU^? -6.17 O ACT B 304s B 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.72 41.22 43.91 4.75 41.83 44.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 15.35 40.93 52.66 14.20 41.89 54.18 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU B 59 GLU^? -6.17 O ACT B 304s B 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.72 41.22 43.91 4.75 41.83 44.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU C 41 GLU.? 10.40 CH3 ACT B 304 B 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 16.43 50.94 51.34 17.50 52.11 49.94 coo 54.43 67.89 19.82 55.62 67.90 18.07 15.35 40.93 52.66 14.20 41.89 54.18 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 B 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 156 GLU B 59 GLU^? -6.17 O ACT B 304s B 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 54.43 67.89 19.82 55.62 67.90 18.07 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c01 CHITINASE C user 16 3 # 16 B 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 B 156 GLU C 18 GLU~? 13.25 OXT ACT C 301 B 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 54.43 67.89 19.82 55.62 67.90 18.07 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.33 37.03 53.83 -10.36 37.52 54.24 2dbt_c01 source 2dbt CHITINASE C : 16 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 156 GLU B 41 GLU.? 9.71 CH3 ACT A 303 C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 4.59 21.37 51.97 2.75 21.07 50.95 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.06 34.24 44.69 1.54 35.69 44.88 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 156 GLU B 59 GLU^? -6.17 O ACT B 304s C 194 ASN A 90 ASN^? -5.08 CL CL A 201s coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.06 34.24 44.69 1.54 35.69 44.88 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 156 GLU B 59 GLU^? -6.17 O ACT B 304s C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.06 34.24 44.69 1.54 35.69 44.88 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.06 34.24 44.69 1.54 35.69 44.88 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 156 GLU B 59 GLU^? -6.17 O ACT B 304s C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 15.35 40.93 52.66 14.20 41.89 54.18 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 156 GLU C 41 GLU.? 10.40 CH3 ACT B 304 C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 15.35 40.93 52.66 14.20 41.89 54.18 coo 44.75 23.09 5.51 46.77 22.91 6.12 16.43 50.94 51.34 17.50 52.11 49.94 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU B 41 GLU.? 9.71 CH3 ACT A 303 C 156 GLU A 18 GLU~? 13.24 OXT ACT A 303 C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 4.59 21.37 51.97 2.75 21.07 50.95 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.59 27.39 54.08 -2.09 28.32 55.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU B 59 GLU^? -6.17 O ACT B 304s C 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 194 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.72 41.22 43.91 4.75 41.83 44.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.75 21.00 18.12 50.45 23.02 18.26 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU B 59 GLU^? -6.17 O ACT B 304s C 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.72 41.22 43.91 4.75 41.83 44.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 15.35 40.93 52.66 14.20 41.89 54.18 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU B 59 GLU^? -6.17 O ACT B 304s C 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.72 41.22 43.91 4.75 41.83 44.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU C 18 GLU~? 13.25 OXT ACT C 301 C 156 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU C 41 GLU.? 10.40 CH3 ACT B 304 C 156 GLU B 18 GLU~? 12.98 CH3 ACT B 304 C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.43 50.94 51.34 17.50 52.11 49.94 coo 44.75 23.09 5.51 46.77 22.91 6.12 15.35 40.93 52.66 14.20 41.89 54.18 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 156 GLU A 59 GLU^? 7.35 OXT ACT A 303 C 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.06 34.24 44.69 1.54 35.69 44.88 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 3 2dbt_c02 CHITINASE C user 16 3 # 16 C 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 156 GLU B 59 GLU^? -6.17 O ACT B 304s C 194 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.72 41.22 43.91 4.75 41.83 44.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 3 2dbt_c02 CHITINASE C user 17 3 # 17 C 147 GLU C 59 GLU^? 7.72 OXT ACT C 301 C 156 GLU C 18 GLU~? 13.25 OXT ACT C 301 C 194 ASN A 55 ASN^? 10.27 O ACT C 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.08 44.06 44.69 -2.35 42.14 45.23 coo 44.75 23.09 5.51 46.77 22.91 6.12 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.33 37.03 53.83 -10.36 37.52 54.24 2dbt_c02 source 2dbt CHITINASE C : 17 hits 2dbt_c02 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 79 PHE.? 10.94 O ACT C 301 B 263 ASP C 2 ASP.? 15.16 CH3 ACT C 301 B 292 LYS C 98 LYS~? 7.72 O ACT C 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -16.37 31.43 43.34 -14.13 32.93 42.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -18.15 32.16 34.90 -18.94 34.09 34.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 -19.31 41.45 39.34 -17.64 37.26 43.62 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE C 79 PHE.? 11.51 CH3 ACT B 304 B 263 ASP B 2 ASP.? 15.66 OXT ACT B 304 B 292 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo 49.99 26.05 6.28 51.46 26.87 8.49 2.54 59.12 41.47 2.64 56.35 41.07 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 3.21 59.71 32.87 5.22 59.30 32.47 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.25 56.30 36.89 8.12 57.51 41.12 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c04 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP B 51 TRP.? 15.53 OXT ACT A 303 A 263 ASP B 50 ASP.? 15.85 OXT ACT A 303 A 292 LYS A 19 LYS~? 20.51 O ACT A 303 coo 48.96 45.07 19.49 48.62 41.39 18.16 1.36 36.15 59.32 1.00 34.54 55.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 2.98 31.06 60.86 4.11 29.82 59.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -5.86 23.51 54.21 -8.85 19.33 56.46 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP B 51 TRP.? 15.53 OXT ACT A 303 B 263 ASP B 50 ASP.? 15.85 OXT ACT A 303 B 292 LYS A 19 LYS~? 20.51 O ACT A 303 coo 45.83 31.15 4.65 45.88 34.74 6.24 1.36 36.15 59.32 1.00 34.54 55.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 2.98 31.06 60.86 4.11 29.82 59.55 coo 60.53 31.67 0.97 57.79 27.51 3.63 -5.86 23.51 54.21 -8.85 19.33 56.46 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP B 51 TRP.? 15.53 OXT ACT A 303 C 263 ASP B 50 ASP.? 15.85 OXT ACT A 303 C 292 LYS A 19 LYS~? 20.51 O ACT A 303 coo 20.52 16.65 4.15 17.32 18.91 4.39 1.36 36.15 59.32 1.00 34.54 55.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 2.98 31.06 60.86 4.11 29.82 59.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -5.86 23.51 54.21 -8.85 19.33 56.46 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c08 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP B 2 ASP.? 15.66 OXT ACT B 304 166 GLY B 32 GLY.? 4.31 CH3 ACT B 304 169 GLU C 41 GLU.? 10.40 CH3 ACT B 304 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.21 59.71 32.87 5.22 59.30 32.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 13.51 49.65 44.20 13.73 48.98 43.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 16.43 50.94 51.34 17.50 52.11 49.94 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 1 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 78 TYR~? 17.62 O ACT C 301 A 172 HIS A 81 HIS.? 19.43 O ACT C 301 A 174 TYR A 82 TYR.? 16.37 O ACT C 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 24.73 15.69 1.93 26.72 14.32 3.31 -16.19 29.33 51.63 -16.36 27.05 53.19 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 82 TYR.? 16.37 O ACT C 301 A 172 HIS A 81 HIS.? 19.43 O ACT C 301 A 174 TYR A 78 TYR~? 17.62 O ACT C 301 coo 26.78 20.44 0.03 28.51 18.26 0.09 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 24.73 15.69 1.93 26.72 14.32 3.31 -13.80 26.13 47.19 -12.59 23.74 48.01 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 78 TYR~? 17.24 CH3 ACT A 303 A 172 HIS B 81 HIS.? 19.26 CH3 ACT A 303 A 174 TYR B 82 TYR.? 16.39 CH3 ACT A 303 coo 26.78 20.44 0.03 28.51 18.26 0.09 20.54 33.17 44.58 21.91 35.42 45.49 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 24.07 26.52 45.84 25.63 26.47 44.45 coo 24.73 15.69 1.93 26.72 14.32 3.31 19.70 29.01 48.72 22.05 29.62 50.09 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 82 TYR.? 16.39 CH3 ACT A 303 A 172 HIS B 81 HIS.? 19.26 CH3 ACT A 303 A 174 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 26.78 20.44 0.03 28.51 18.26 0.09 19.70 29.01 48.72 22.05 29.62 50.09 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 24.07 26.52 45.84 25.63 26.47 44.45 coo 24.73 15.69 1.93 26.72 14.32 3.31 20.54 33.17 44.58 21.91 35.42 45.49 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 A 169 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 172 HIS C 81 HIS.? 20.24 CH3 ACT B 304 A 174 TYR C 82 TYR.? 16.78 CH3 ACT B 304 coo 26.78 20.44 0.03 28.51 18.26 0.09 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 1.30 66.32 47.25 0.46 68.04 46.40 coo 24.73 15.69 1.93 26.72 14.32 3.31 1.46 61.13 49.70 -0.36 62.80 51.06 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 A 169 TYR C 82 TYR.? 16.78 CH3 ACT B 304 A 172 HIS C 81 HIS.? 20.24 CH3 ACT B 304 A 174 TYR C 78 TYR~? 17.53 CH3 ACT B 304 coo 26.78 20.44 0.03 28.51 18.26 0.09 1.46 61.13 49.70 -0.36 62.80 51.06 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 1.30 66.32 47.25 0.46 68.04 46.40 coo 24.73 15.69 1.93 26.72 14.32 3.31 -2.76 60.08 45.99 -5.32 60.21 47.12 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 6 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 78 TYR~? 17.62 O ACT C 301 B 172 HIS A 81 HIS.? 19.43 O ACT C 301 B 174 TYR A 82 TYR.? 16.37 O ACT C 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 45.95 0.11 28.25 43.87 0.82 26.55 -16.19 29.33 51.63 -16.36 27.05 53.19 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 82 TYR.? 16.37 O ACT C 301 B 172 HIS A 81 HIS.? 19.43 O ACT C 301 B 174 TYR A 78 TYR~? 17.62 O ACT C 301 coo 44.86 1.98 33.27 42.75 1.12 31.67 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -20.82 26.38 49.60 -21.72 24.86 48.45 coo 45.95 0.11 28.25 43.87 0.82 26.55 -13.80 26.13 47.19 -12.59 23.74 48.01 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 78 TYR~? 17.24 CH3 ACT A 303 B 172 HIS B 81 HIS.? 19.26 CH3 ACT A 303 B 174 TYR B 82 TYR.? 16.39 CH3 ACT A 303 coo 44.86 1.98 33.27 42.75 1.12 31.67 20.54 33.17 44.58 21.91 35.42 45.49 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 24.07 26.52 45.84 25.63 26.47 44.45 coo 45.95 0.11 28.25 43.87 0.82 26.55 19.70 29.01 48.72 22.05 29.62 50.09 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 82 TYR.? 16.39 CH3 ACT A 303 B 172 HIS B 81 HIS.? 19.26 CH3 ACT A 303 B 174 TYR B 78 TYR~? 17.24 CH3 ACT A 303 coo 44.86 1.98 33.27 42.75 1.12 31.67 19.70 29.01 48.72 22.05 29.62 50.09 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 24.07 26.52 45.84 25.63 26.47 44.45 coo 45.95 0.11 28.25 43.87 0.82 26.55 20.54 33.17 44.58 21.91 35.42 45.49 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 B 169 TYR C 78 TYR~? 17.53 CH3 ACT B 304 B 172 HIS C 81 HIS.? 20.24 CH3 ACT B 304 B 174 TYR C 82 TYR.? 16.78 CH3 ACT B 304 coo 44.86 1.98 33.27 42.75 1.12 31.67 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 1.30 66.32 47.25 0.46 68.04 46.40 coo 45.95 0.11 28.25 43.87 0.82 26.55 1.46 61.13 49.70 -0.36 62.80 51.06 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 B 169 TYR C 82 TYR.? 16.78 CH3 ACT B 304 B 172 HIS C 81 HIS.? 20.24 CH3 ACT B 304 B 174 TYR C 78 TYR~? 17.53 CH3 ACT B 304 coo 44.86 1.98 33.27 42.75 1.12 31.67 1.46 61.13 49.70 -0.36 62.80 51.06 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 1.30 66.32 47.25 0.46 68.04 46.40 coo 45.95 0.11 28.25 43.87 0.82 26.55 -2.76 60.08 45.99 -5.32 60.21 47.12 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 6 hits 2tmd_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 39 ARG.? 13.42 OXT ACT C 301 127 ARG A 44 ARG.? 19.54 O ACT C 301 270 GLU C 52 GLU.? 17.63 CH3 ACT B 304 coo -1.14 25.72 1.64 0.76 28.10 1.50 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -9.80 41.84 63.03 -12.20 41.46 64.90 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 2.90 48.54 61.44 4.21 46.86 61.22 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 57 ARG^? 9.16 OXT ACT C 301 127 ARG B 57 ARG^? 10.43 O ACT B 304 270 GLU C 89 GLU^? 9.21 CL CL C 203 coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.68 37.56 46.31 2.06 39.11 46.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 57 ARG^? 9.16 OXT ACT C 301 127 ARG C 57 ARG^? 6.12 O ACT B 304 270 GLU B 89 GLU^? 9.16 CL CL B 202 coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 0.41 44.01 46.89 3.20 43.89 45.69 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG B 57 ARG^? 10.43 O ACT B 304 127 ARG A 57 ARG^? 9.16 OXT ACT C 301 270 GLU C 89 GLU^? 9.21 CL CL C 203 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.68 37.56 46.31 2.06 39.11 46.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG B 57 ARG^? 10.43 O ACT B 304 127 ARG C 57 ARG^? 6.12 O ACT B 304 270 GLU A 89 GLU^? 9.05 CL CL A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.68 37.56 46.31 2.06 39.11 46.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 0.41 44.01 46.89 3.20 43.89 45.69 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG C 57 ARG^? 6.12 O ACT B 304 127 ARG A 57 ARG^? 9.16 OXT ACT C 301 270 GLU B 89 GLU^? 9.16 CL CL B 202 coo -1.14 25.72 1.64 0.76 28.10 1.50 0.41 44.01 46.89 3.20 43.89 45.69 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.96 37.09 46.95 -2.53 39.44 48.84 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG C 57 ARG^? 6.12 O ACT B 304 127 ARG B 57 ARG^? 10.43 O ACT B 304 270 GLU A 89 GLU^? 9.05 CL CL A 201 coo -1.14 25.72 1.64 0.76 28.10 1.50 0.41 44.01 46.89 3.20 43.89 45.69 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.68 37.56 46.31 2.06 39.11 46.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -1.24 36.58 37.23 -1.06 38.29 38.51 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 7 hits 5cpa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 55 ASN^? 10.27 O ACT C 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.33 37.03 53.83 -10.36 37.52 54.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 90 ASN^? -5.08 CL CL A 201s coo 5.80 63.03 55.85 5.52 65.03 56.45 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 55 ASN^? 9.91 CH3 ACT A 303 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.14 32.38 52.24 9.69 30.32 52.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 90 ASN^? -5.08 CL CL B 202s coo 5.80 63.03 55.85 5.52 65.03 56.45 3.80 42.08 30.71 3.97 43.74 29.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN C 55 ASN^? 9.16 CH3 ACT B 304 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.32 50.30 52.50 5.90 51.72 52.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN C 90 ASN^? -5.08 CL CL C 203s coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.57 41.72 31.30 -5.19 41.10 30.13 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 6 hits 1kbk_p00 naa= 1 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 108 ASN A 90 ASN^? -5.08 CL CL A 201s A 135 ASN C 90 ASN^? -5.08 CL CL C 203s coo 17.59 4.66 17.88 15.38 5.96 18.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 12.36 16.24 15.27 12.06 14.29 16.05 0.36 35.53 30.95 1.55 34.49 29.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 -3.57 41.72 31.30 -5.19 41.10 30.13 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 108 ASN B 90 ASN^? -5.08 CL CL B 202s A 135 ASN C 90 ASN^? -5.08 CL CL C 203s coo 17.59 4.66 17.88 15.38 5.96 18.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 12.36 16.24 15.27 12.06 14.29 16.05 3.80 42.08 30.71 3.97 43.74 29.40 coo 18.05 11.56 12.71 17.57 10.75 14.60 -3.57 41.72 31.30 -5.19 41.10 30.13 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 108 ASN B 90 ASN^? -5.08 CL CL B 202s A 135 ASN A 90 ASN^? -5.08 CL CL A 201s coo 17.59 4.66 17.88 15.38 5.96 18.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 12.36 16.24 15.27 12.06 14.29 16.05 3.80 42.08 30.71 3.97 43.74 29.40 coo 18.05 11.56 12.71 17.57 10.75 14.60 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 108 ASN C 90 ASN^? -5.08 CL CL C 203s A 135 ASN A 90 ASN^? -5.08 CL CL A 201s coo 17.59 4.66 17.88 15.38 5.96 18.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 12.36 16.24 15.27 12.06 14.29 16.05 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 18.05 11.56 12.71 17.57 10.75 14.60 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR C 87 TYR^? 6.46 O ACT B 304 A 108 ASN A 90 ASN^? -5.08 CL CL A 201s A 135 ASN B 90 ASN^? -5.08 CL CL B 202s coo 17.59 4.66 17.88 15.38 5.96 18.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 12.36 16.24 15.27 12.06 14.29 16.05 0.36 35.53 30.95 1.55 34.49 29.53 coo 18.05 11.56 12.71 17.57 10.75 14.60 3.80 42.08 30.71 3.97 43.74 29.40 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR C 87 TYR^? 6.46 O ACT B 304 A 108 ASN C 90 ASN^? -5.08 CL CL C 203s A 135 ASN B 90 ASN^? -5.08 CL CL B 202s coo 17.59 4.66 17.88 15.38 5.96 18.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 12.36 16.24 15.27 12.06 14.29 16.05 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 18.05 11.56 12.71 17.57 10.75 14.60 3.80 42.08 30.71 3.97 43.74 29.40 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 6 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 87 TYR^? 7.71 OXT ACT C 301 A 108 ASN A 90 ASN^? -5.08 CL CL A 201s A 135 ASN C 90 ASN^? -5.08 CL CL C 203s coo 17.50 4.57 17.85 15.28 5.88 18.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 12.22 15.98 15.24 11.94 14.05 16.09 0.36 35.53 30.95 1.55 34.49 29.53 coo 17.94 11.43 12.65 17.42 10.61 14.53 -3.57 41.72 31.30 -5.19 41.10 30.13 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR B 87 TYR^? 7.07 OXT ACT A 303 A 108 ASN B 90 ASN^? -5.08 CL CL B 202s A 135 ASN A 90 ASN^? -5.08 CL CL A 201s coo 17.50 4.57 17.85 15.28 5.88 18.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 12.22 15.98 15.24 11.94 14.05 16.09 3.80 42.08 30.71 3.97 43.74 29.40 coo 17.94 11.43 12.65 17.42 10.61 14.53 0.36 35.53 30.95 1.55 34.49 29.53 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR C 87 TYR^? 6.46 O ACT B 304 A 108 ASN C 90 ASN^? -5.08 CL CL C 203s A 135 ASN B 90 ASN^? -5.08 CL CL B 202s coo 17.50 4.57 17.85 15.28 5.88 18.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 12.22 15.98 15.24 11.94 14.05 16.09 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 17.94 11.43 12.65 17.42 10.61 14.53 3.80 42.08 30.71 3.97 43.74 29.40 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 3 hits 1uy4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 55 ASN^? 10.27 O ACT C 301 A 384 ASN A 90 ASN^? -5.08 CL CL A 201s A 385 GLU B 89 GLU^? 9.16 CL CL B 202 coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 0.36 35.53 30.95 1.55 34.49 29.53 coo 11.59 49.83 99.41 10.92 47.97 100.16 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 55 ASN^? 10.27 O ACT C 301 A 384 ASN B 90 ASN^? -5.08 CL CL B 202s A 385 GLU B 89 GLU^? 9.16 CL CL B 202 coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.80 42.08 30.71 3.97 43.74 29.40 coo 11.59 49.83 99.41 10.92 47.97 100.16 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 55 ASN^? 10.27 O ACT C 301 A 384 ASN B 90 ASN^? -5.08 CL CL B 202s A 385 GLU C 89 GLU^? 9.21 CL CL C 203 coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.80 42.08 30.71 3.97 43.74 29.40 coo 11.59 49.83 99.41 10.92 47.97 100.16 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 55 ASN^? 10.27 O ACT C 301 A 384 ASN C 90 ASN^? -5.08 CL CL C 203s A 385 GLU C 89 GLU^? 9.21 CL CL C 203 coo 22.28 63.17 110.61 22.47 65.06 111.53 -8.33 37.03 53.83 -10.36 37.52 54.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 11.59 49.83 99.41 10.92 47.97 100.16 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 55 ASN^? 9.91 CH3 ACT A 303 A 384 ASN A 90 ASN^? -5.08 CL CL A 201s A 385 GLU A 89 GLU^? 9.05 CL CL A 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 9.14 32.38 52.24 9.69 30.32 52.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 0.36 35.53 30.95 1.55 34.49 29.53 coo 11.59 49.83 99.41 10.92 47.97 100.16 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 55 ASN^? 9.91 CH3 ACT A 303 A 384 ASN B 90 ASN^? -5.08 CL CL B 202s A 385 GLU C 89 GLU^? 9.21 CL CL C 203 coo 22.28 63.17 110.61 22.47 65.06 111.53 9.14 32.38 52.24 9.69 30.32 52.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.80 42.08 30.71 3.97 43.74 29.40 coo 11.59 49.83 99.41 10.92 47.97 100.16 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 55 ASN^? 9.91 CH3 ACT A 303 A 384 ASN C 90 ASN^? -5.08 CL CL C 203s A 385 GLU C 89 GLU^? 9.21 CL CL C 203 coo 22.28 63.17 110.61 22.47 65.06 111.53 9.14 32.38 52.24 9.69 30.32 52.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 11.59 49.83 99.41 10.92 47.97 100.16 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN C 55 ASN^? 9.16 CH3 ACT B 304 A 384 ASN A 90 ASN^? -5.08 CL CL A 201s A 385 GLU A 89 GLU^? 9.05 CL CL A 201 coo 22.28 63.17 110.61 22.47 65.06 111.53 4.32 50.30 52.50 5.90 51.72 52.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 0.36 35.53 30.95 1.55 34.49 29.53 coo 11.59 49.83 99.41 10.92 47.97 100.16 -1.24 36.58 37.23 -1.06 38.29 38.51 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN C 55 ASN^? 9.16 CH3 ACT B 304 A 384 ASN A 90 ASN^? -5.08 CL CL A 201s A 385 GLU B 89 GLU^? 9.16 CL CL B 202 coo 22.28 63.17 110.61 22.47 65.06 111.53 4.32 50.30 52.50 5.90 51.72 52.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 0.36 35.53 30.95 1.55 34.49 29.53 coo 11.59 49.83 99.41 10.92 47.97 100.16 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN C 55 ASN^? 9.16 CH3 ACT B 304 A 384 ASN B 90 ASN^? -5.08 CL CL B 202s A 385 GLU B 89 GLU^? 9.16 CL CL B 202 coo 22.28 63.17 110.61 22.47 65.06 111.53 4.32 50.30 52.50 5.90 51.72 52.50 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.80 42.08 30.71 3.97 43.74 29.40 coo 11.59 49.83 99.41 10.92 47.97 100.16 3.69 38.42 36.29 2.58 38.79 38.06 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 10 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 39 ARG.? 13.42 OXT ACT C 301 B 6 THR C 34 THR^? 4.17 OXT ACT C 301 B 8 THR C 60 THR^? 4.85 CH3 ACT C 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 36.11 13.64 95.03 34.54 14.86 95.91 -7.63 43.78 49.13 -7.19 42.15 47.76 coo 32.72 8.05 92.39 31.25 9.11 91.35 -8.30 46.13 43.05 -9.25 48.08 42.71 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 39 ARG.? 13.42 OXT ACT C 301 B 6 THR C 36 THR^? 10.76 OXT ACT C 301 B 8 THR B 36 THR^? 10.28 O ACT B 304 coo 40.52 16.08 100.90 37.97 16.41 102.60 -5.46 44.01 56.97 -5.03 47.01 56.50 coo 36.11 13.64 95.03 34.54 14.86 95.91 -1.57 43.28 52.09 -0.86 42.09 50.37 coo 32.72 8.05 92.39 31.25 9.11 91.35 5.70 40.75 51.53 3.79 40.81 50.49 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 57 ARG^? 9.16 OXT ACT C 301 B 6 THR B 36 THR^? 10.28 O ACT B 304 B 8 THR B 34 THR^? -4.05 O ACT B 304s coo 40.52 16.08 100.90 37.97 16.41 102.60 -1.96 37.09 46.95 -2.53 39.44 48.84 coo 36.11 13.64 95.03 34.54 14.86 95.91 5.70 40.75 51.53 3.79 40.81 50.49 coo 32.72 8.05 92.39 31.25 9.11 91.35 8.80 45.53 47.76 6.89 46.40 47.31 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 39 ARG.? 13.46 OXT ACT A 303 B 6 THR A 34 THR^? -4.67 OXT ACT A 303s B 8 THR A 60 THR^? -4.49 O ACT A 303s coo 40.52 16.08 100.90 37.97 16.41 102.60 2.53 31.11 56.62 -0.26 29.95 56.31 coo 36.11 13.64 95.03 34.54 14.86 95.91 2.88 30.33 48.17 4.48 31.66 47.56 coo 32.72 8.05 92.39 31.25 9.11 91.35 0.42 28.72 42.47 -0.75 26.89 42.18 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 39 ARG.? 13.46 OXT ACT A 303 B 6 THR A 36 THR^? 9.99 OXT ACT A 303 B 8 THR C 36 THR^? 10.76 OXT ACT C 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 2.53 31.11 56.62 -0.26 29.95 56.31 coo 36.11 13.64 95.03 34.54 14.86 95.91 0.70 35.56 51.71 1.36 36.35 49.79 coo 32.72 8.05 92.39 31.25 9.11 91.35 -1.57 43.28 52.09 -0.86 42.09 50.37 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG C 39 ARG.? 12.72 CH3 ACT B 304 B 6 THR B 34 THR^? -4.05 O ACT B 304s B 8 THR B 60 THR^? -4.90 OXT ACT B 304s coo 40.52 16.08 100.90 37.97 16.41 102.60 9.00 43.74 55.65 11.90 42.76 55.27 coo 36.11 13.64 95.03 34.54 14.86 95.91 8.80 45.53 47.76 6.89 46.40 47.31 coo 32.72 8.05 92.39 31.25 9.11 91.35 10.88 44.65 41.79 13.01 44.54 41.32 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG C 39 ARG.? 12.72 CH3 ACT B 304 B 6 THR B 36 THR^? 10.28 O ACT B 304 B 8 THR A 36 THR^? 9.99 OXT ACT A 303 coo 40.52 16.08 100.90 37.97 16.41 102.60 9.00 43.74 55.65 11.90 42.76 55.27 coo 36.11 13.64 95.03 34.54 14.86 95.91 5.70 40.75 51.53 3.79 40.81 50.49 coo 32.72 8.05 92.39 31.25 9.11 91.35 0.70 35.56 51.71 1.36 36.35 49.79 1b01_d00 source 1b01 GENE REGULATION/DNA : 7 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 78 TYR~? 17.62 O ACT C 301 I 306 VAL A 84 VAL.? 9.71 O ACT C 301 I 308 VAL A 12 VAL^? 7.88 OXT ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.80 26.13 47.19 -12.59 23.74 48.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.53 33.95 47.26 -13.03 31.84 46.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 -7.93 35.00 48.10 -7.41 37.11 48.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 82 TYR.? 16.37 O ACT C 301 I 306 VAL A 84 VAL.? 9.71 O ACT C 301 I 308 VAL A 12 VAL^? 7.88 OXT ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -16.19 29.33 51.63 -16.36 27.05 53.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.53 33.95 47.26 -13.03 31.84 46.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 -7.93 35.00 48.10 -7.41 37.11 48.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 87 TYR^? 7.71 OXT ACT C 301 I 306 VAL A 12 VAL^? 7.88 OXT ACT C 301 I 308 VAL A 84 VAL.? 9.71 O ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.93 35.00 48.10 -7.41 37.11 48.16 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 33.95 47.26 -13.03 31.84 46.94 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 87 TYR^? 7.71 OXT ACT C 301 I 306 VAL C 91 VAL^? 7.59 CL CL A 201 I 308 VAL C 4 VAL^? 11.65 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.96 39.29 34.50 -5.93 40.19 36.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 37.30 32.02 -15.43 38.01 32.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 87 TYR^? 7.71 OXT ACT C 301 I 306 VAL C 93 VAL^? 9.02 CH3 ACT C 301 I 308 VAL C 4 VAL^? 11.65 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.11 36.54 36.71 -11.09 38.33 37.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 37.30 32.02 -15.43 38.01 32.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 87 TYR^? 7.71 OXT ACT C 301 I 306 VAL C 94 VAL^? 11.86 O ACT C 301 I 308 VAL C 4 VAL^? 11.65 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.80 37.10 39.85 -4.98 38.28 41.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.62 33.94 37.87 -13.43 31.96 38.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 37.30 32.02 -15.43 38.01 32.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 62 VAL^? 6.46 O ACT A 303 I 308 VAL A 9 VAL^? 8.80 O ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.77 25.79 36.87 -1.08 25.83 38.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.33 31.29 39.71 -4.75 29.67 39.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 62 VAL^? 6.46 O ACT A 303 I 308 VAL A 66 VAL~? 11.00 O ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.77 25.79 36.87 -1.08 25.83 38.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.21 22.81 35.19 -2.75 21.78 36.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 93 VAL^? 8.87 O ACT A 303 I 308 VAL A 4 VAL^? 6.48 CH3 ACT A 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.19 31.25 35.04 7.75 30.22 36.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.13 29.09 30.16 9.53 27.02 30.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 93 VAL^? 8.87 O ACT A 303 I 308 VAL A 91 VAL^? 7.63 CL CL B 202 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.19 31.25 35.04 7.75 30.22 36.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 4.04 34.52 33.71 3.46 33.89 35.75 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 93 VAL^? 8.87 O ACT A 303 I 308 VAL B 88 VAL^? 5.64 CL CL B 202 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.19 31.25 35.04 7.75 30.22 36.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 8.39 37.72 35.57 9.56 38.35 33.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 94 VAL^? 8.79 CH3 ACT A 302 I 308 VAL A 4 VAL^? 6.48 CH3 ACT A 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.80 30.30 35.79 14.52 31.40 36.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.13 29.09 30.16 9.53 27.02 30.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 94 VAL^? 8.79 CH3 ACT A 302 I 308 VAL B 88 VAL^? 5.64 CL CL B 202 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.80 30.30 35.79 14.52 31.40 36.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 8.39 37.72 35.57 9.56 38.35 33.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR A 99 TYR~? -4.58 CH3 ACT A 303s I 306 VAL A 100 VAL~? 10.83 O ACT A 303 I 308 VAL A 66 VAL~? 11.00 O ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.17 21.24 34.47 4.46 21.61 32.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.21 22.81 35.19 -2.75 21.78 36.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 78 TYR~? 17.24 CH3 ACT A 303 I 306 VAL B 84 VAL.? 9.68 CH3 ACT A 303 I 308 VAL B 12 VAL^? 7.21 OXT ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.54 33.17 44.58 21.91 35.42 45.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.81 29.71 45.14 15.45 31.14 44.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.18 33.83 46.66 8.09 33.15 46.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 82 TYR.? 16.39 CH3 ACT A 303 I 306 VAL B 84 VAL.? 9.68 CH3 ACT A 303 I 308 VAL B 12 VAL^? 7.21 OXT ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.70 29.01 48.72 22.05 29.62 50.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.81 29.71 45.14 15.45 31.14 44.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.18 33.83 46.66 8.09 33.15 46.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 87 TYR^? 7.07 OXT ACT A 303 I 306 VAL A 91 VAL^? 7.63 CL CL B 202 I 308 VAL A 4 VAL^? 6.48 CH3 ACT A 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.04 34.52 33.71 3.46 33.89 35.75 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.13 29.09 30.16 9.53 27.02 30.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 87 TYR^? 7.07 OXT ACT A 303 I 306 VAL A 93 VAL^? 8.87 O ACT A 303 I 308 VAL A 4 VAL^? 6.48 CH3 ACT A 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.19 31.25 35.04 7.75 30.22 36.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.13 29.09 30.16 9.53 27.02 30.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 87 TYR^? 7.07 OXT ACT A 303 I 306 VAL A 94 VAL^? 8.79 CH3 ACT A 302 I 308 VAL A 4 VAL^? 6.48 CH3 ACT A 302 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.80 30.30 35.79 14.52 31.40 36.61 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.13 29.09 30.16 9.53 27.02 30.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 87 TYR^? 7.07 OXT ACT A 303 I 306 VAL B 12 VAL^? 7.21 OXT ACT A 303 I 308 VAL B 84 VAL.? 9.68 CH3 ACT A 303 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.95 34.35 38.83 5.26 35.08 40.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.18 33.83 46.66 8.09 33.15 46.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.81 29.71 45.14 15.45 31.14 44.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR B 99 TYR~? 4.94 OXT ACT B 304 I 306 VAL B 62 VAL^? 7.05 OXT ACT B 304 I 308 VAL B 9 VAL^? 8.91 OXT ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.64 46.80 36.11 13.67 45.07 37.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.15 40.29 38.68 12.23 39.93 38.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR B 99 TYR~? 4.94 OXT ACT B 304 I 306 VAL B 62 VAL^? 7.05 OXT ACT B 304 I 308 VAL B 66 VAL~? 11.56 OXT ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.64 46.80 36.11 13.67 45.07 37.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 17.47 44.11 33.76 17.67 45.76 35.17 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR B 99 TYR~? 4.94 OXT ACT B 304 I 306 VAL B 93 VAL^? 8.72 OXT ACT B 304 I 308 VAL B 4 VAL^? 11.75 CL CL C 203 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.65 51.57 35.50 5.31 50.73 36.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.03 52.92 30.53 6.67 54.19 31.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR B 99 TYR~? 4.94 OXT ACT B 304 I 306 VAL B 93 VAL^? 8.72 OXT ACT B 304 I 308 VAL B 91 VAL^? 7.56 CL CL C 203 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.65 51.57 35.50 5.31 50.73 36.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.16 45.57 33.75 4.13 45.22 35.70 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR B 99 TYR~? 4.94 OXT ACT B 304 I 306 VAL B 100 VAL~? 11.45 OXT ACT B 304 I 308 VAL B 66 VAL~? 11.56 OXT ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.55 52.27 33.86 13.94 52.55 31.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 17.47 44.11 33.76 17.67 45.76 35.17 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR C 78 TYR~? 17.53 CH3 ACT B 304 I 306 VAL C 84 VAL.? 9.83 CH3 ACT B 304 I 308 VAL C 12 VAL^? 6.88 O ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.76 55.82 45.80 2.00 56.84 45.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.99 50.51 47.19 3.66 49.08 47.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR C 82 TYR.? 16.78 CH3 ACT B 304 I 306 VAL C 84 VAL.? 9.83 CH3 ACT B 304 I 308 VAL C 12 VAL^? 6.88 O ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.46 61.13 49.70 -0.36 62.80 51.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.76 55.82 45.80 2.00 56.84 45.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.99 50.51 47.19 3.66 49.08 47.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR C 87 TYR^? 6.46 O ACT B 304 I 306 VAL B 91 VAL^? 7.56 CL CL C 203 I 308 VAL B 4 VAL^? 11.75 CL CL C 203 coo 26.18 35.24 6.87 24.33 35.18 8.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.16 45.57 33.75 4.13 45.22 35.70 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.03 52.92 30.53 6.67 54.19 31.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR C 87 TYR^? 6.46 O ACT B 304 I 306 VAL B 93 VAL^? 8.72 OXT ACT B 304 I 308 VAL B 4 VAL^? 11.75 CL CL C 203 coo 26.18 35.24 6.87 24.33 35.18 8.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.65 51.57 35.50 5.31 50.73 36.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.03 52.92 30.53 6.67 54.19 31.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR C 87 TYR^? 6.46 O ACT B 304 I 306 VAL B 94 VAL^? 12.18 OXT ACT B 304 I 308 VAL B 4 VAL^? 11.75 CL CL C 203 coo 26.18 35.24 6.87 24.33 35.18 8.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.72 55.15 36.45 1.02 56.11 37.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.03 52.92 30.53 6.67 54.19 31.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR C 87 TYR^? 6.46 O ACT B 304 I 306 VAL C 12 VAL^? 6.88 O ACT B 304 I 308 VAL C 84 VAL.? 9.83 CH3 ACT B 304 coo 26.18 35.24 6.87 24.33 35.18 8.97 2.28 47.86 39.06 2.71 45.79 40.92 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.99 50.51 47.19 3.66 49.08 47.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.76 55.82 45.80 2.00 56.84 45.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 62 VAL^? 6.47 CH3 ACT C 301 I 308 VAL C 9 VAL^? 9.27 CH3 ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.54 46.76 37.77 -10.43 48.42 38.67 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.42 47.71 39.74 -5.17 49.68 39.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 62 VAL^? 6.47 CH3 ACT C 301 I 308 VAL C 66 VAL~? 10.76 CH3 ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.54 46.76 37.77 -10.43 48.42 38.67 coo 16.43 30.18 9.35 15.05 30.67 11.01 -11.84 52.33 35.67 -13.24 51.67 37.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 93 VAL^? 9.02 CH3 ACT C 301 I 308 VAL C 4 VAL^? 11.65 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.11 36.54 36.71 -11.09 38.33 37.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 37.30 32.02 -15.43 38.01 32.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 93 VAL^? 9.02 CH3 ACT C 301 I 308 VAL C 91 VAL^? 7.59 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.11 36.54 36.71 -11.09 38.33 37.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.96 39.29 34.50 -5.93 40.19 36.52 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 94 VAL^? 11.86 O ACT C 301 I 308 VAL C 4 VAL^? 11.65 CL CL A 201 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -13.62 33.94 37.87 -13.43 31.96 38.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.53 37.30 32.02 -15.43 38.01 32.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR C 99 TYR~? -4.22 CH3 ACT C 301s I 306 VAL C 100 VAL~? 10.38 CH3 ACT C 301 I 308 VAL C 66 VAL~? 10.76 CH3 ACT C 301 coo 26.18 35.24 6.87 24.33 35.18 8.97 -14.59 42.37 40.43 -14.19 40.56 42.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.51 45.83 36.32 -18.16 45.20 34.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 -11.84 52.33 35.67 -13.24 51.67 37.20 1cqt_d00 source 1cqt GENE REGULATION/DNA : 37 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 5 PRO^? 8.01 CH3 ACT A 302 A 272 LEU A 3 LEU^? -4.08 CH3 ACT A 302s A 276 ARG A 95 ARG.? 9.56 OXT ACT A 302 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 5.52 29.56 27.71 6.20 30.09 29.80 coo 10.97 0.43 16.73 11.31 2.11 18.06 12.56 32.14 30.75 12.93 33.79 32.08 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 16.24 25.45 35.76 18.96 25.41 34.33 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO B 5 PRO^? 9.68 CL CL C 203 A 272 LEU B 3 LEU^? 9.10 CL CL C 203 A 276 ARG B 95 ARG.? 17.66 OXT ACT B 304 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 6.09 49.73 27.73 5.50 49.87 29.92 coo 10.97 0.43 16.73 11.31 2.11 18.06 0.74 54.40 31.61 -0.64 53.60 33.02 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 5.02 60.48 36.40 3.75 63.08 35.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO C 5 PRO^? 9.51 CL CL A 201 A 272 LEU C 3 LEU^? -8.99 CL CL A 201s A 276 ARG C 95 ARG.? 16.43 O ACT C 301 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -11.58 39.93 29.12 -11.24 39.30 31.24 coo 10.97 0.43 16.73 11.31 2.11 18.06 -12.60 32.82 32.76 -10.89 32.07 33.80 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -19.41 33.29 38.70 -21.06 30.88 37.75 1emh_d00 source 1emh HYDROLASE/DNA : 3 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 27 ARG~? 17.50 O ACT A 303 C 71 LYS A 26 LYS~? 7.74 CH3 ACT A 303 C 72 VAL A 25 VAL~? 9.11 O ACT A 303 coo 23.89 33.54 29.21 26.59 34.86 28.68 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 25.82 26.89 29.68 23.33 22.98 25.84 -2.24 19.72 44.66 2.39 20.87 47.23 coo 28.86 29.08 30.37 28.04 31.02 29.93 -4.64 22.60 43.99 -3.98 24.55 44.79 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 27 ARG~? 17.68 OXT ACT B 304 C 71 LYS B 26 LYS~? 10.63 CH3 ACT B 304 C 72 VAL B 25 VAL~? 9.66 OXT ACT B 304 coo 23.89 33.54 29.21 26.59 34.86 28.68 26.02 42.58 42.38 25.84 41.49 45.27 coo 25.82 26.89 29.68 23.33 22.98 25.84 20.18 46.61 43.20 19.00 49.55 48.67 coo 28.86 29.08 30.37 28.04 31.02 29.93 18.86 43.15 42.35 16.92 42.70 43.28 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG C 27 ARG~? 17.31 CH3 ACT C 301 C 71 LYS C 26 LYS~? 10.00 O ACT C 301 C 72 VAL C 25 VAL~? 9.18 CH3 ACT C 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 25.82 26.89 29.68 23.33 22.98 25.84 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 28.86 29.08 30.37 28.04 31.02 29.93 -10.82 53.67 44.28 -9.42 52.18 45.09 1hwt_d00 source 1hwt GENE REGULATION/DNA : 3 hits 1hwt_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 564 VAL B 25 VAL~? 9.66 OXT ACT B 304 A 568 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -6.60 80.79 55.64 -8.55 79.48 61.01 20.18 46.61 43.20 19.00 49.55 48.67 coo -9.25 78.14 55.31 -11.11 77.94 56.39 18.86 43.15 42.35 16.92 42.70 43.28 coo -12.31 74.86 52.32 -13.99 74.91 54.92 26.02 42.58 42.38 25.84 41.49 45.27 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 4 1r4o_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 461 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 462 VAL B 25 VAL~? 9.66 OXT ACT B 304 A 466 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 511 LYS B 98 LYS~? 9.29 CH3 ACT B 304 coo -5.66 13.16 26.70 -4.75 8.81 29.44 20.18 46.61 43.20 19.00 49.55 48.67 coo -4.44 10.22 24.56 -5.83 8.69 23.87 18.86 43.15 42.35 16.92 42.70 43.28 coo -1.96 7.90 20.67 -4.06 5.76 20.87 26.02 42.58 42.38 25.84 41.49 45.27 coo -3.55 13.28 40.04 -1.35 8.66 38.23 12.25 56.30 36.89 8.12 57.51 41.12 1r4o_d00 source 1r4o TRANSCRIPTION/DNA : 1 hits 1r4o_d00 naa= 4 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 7 LYS^? -3.09 CL CL A 201s A1294 ASN A 90 ASN^? -5.08 CL CL A 201s A1297 GLU B 89 GLU^? 9.16 CL CL B 202 coo 39.24 18.84-161.99 36.62 21.47-165.99 0.17 30.56 34.55 -1.45 32.28 29.77 coo 33.53 17.37-161.81 34.31 17.81-163.76 0.36 35.53 30.95 1.55 34.49 29.53 coo 29.78 23.31-161.30 31.23 23.66-162.84 3.69 38.42 36.29 2.58 38.79 38.06 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 7 LYS^? -3.05 CL CL B 202s A1294 ASN B 90 ASN^? -5.08 CL CL B 202s A1297 GLU C 89 GLU^? 9.21 CL CL C 203 coo 39.24 18.84-161.99 36.62 21.47-165.99 8.57 44.02 33.90 7.44 42.15 29.05 coo 33.53 17.37-161.81 34.31 17.81-163.76 3.80 42.08 30.71 3.97 43.74 29.40 coo 29.78 23.31-161.30 31.23 23.66-162.84 0.03 43.20 36.88 0.18 41.91 38.57 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS C 7 LYS^? -3.09 CL CL C 203s A1294 ASN C 90 ASN^? -5.08 CL CL C 203s A1297 GLU A 89 GLU^? 9.05 CL CL A 201 coo 39.24 18.84-161.99 36.62 21.47-165.99 -7.36 44.70 35.08 -5.66 44.82 30.05 coo 33.53 17.37-161.81 34.31 17.81-163.76 -3.57 41.72 31.30 -5.19 41.10 30.13 coo 29.78 23.31-161.30 31.23 23.66-162.84 -1.24 36.58 37.23 -1.06 38.29 38.51 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 3 hits 1xpx_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 15 SER.? 17.30 O ACT C 301 E 5 VAL A 12 VAL^? 7.88 OXT ACT C 301 E 7 ARG A 57 ARG^? 9.16 OXT ACT C 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -7.72 31.71 56.41 -7.84 32.30 58.77 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -7.93 35.00 48.10 -7.41 37.11 48.16 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -1.96 37.09 46.95 -2.53 39.44 48.84 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 63 SER~? 11.49 O ACT A 303 E 5 VAL A 66 VAL~? 11.00 O ACT A 303 E 7 ARG A 69 ARG~? 15.12 O ACT A 303 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 0.23 24.84 33.21 -0.95 22.75 32.99 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.21 22.81 35.19 -2.75 21.78 36.46 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -7.70 19.34 36.48 -5.54 18.45 34.49 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER B 15 SER.? 16.65 OXT ACT A 303 E 5 VAL B 12 VAL^? 7.21 OXT ACT A 303 E 7 ARG B 57 ARG^? 10.43 O ACT B 304 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 13.49 35.39 54.57 12.84 34.83 56.84 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 10.18 33.83 46.66 8.09 33.15 46.95 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 4.68 37.56 46.31 2.06 39.11 46.79 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 63 SER~? 12.00 OXT ACT B 304 E 5 VAL B 66 VAL~? 11.56 OXT ACT B 304 E 7 ARG B 69 ARG~? 14.94 O ACT A 302 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 13.26 47.11 32.36 15.61 47.27 31.93 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 17.47 44.11 33.76 17.67 45.76 35.17 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 22.62 42.29 33.58 21.65 45.19 33.32 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER C 15 SER.? 16.03 CH3 ACT B 304 E 5 VAL C 12 VAL^? 6.88 O ACT B 304 E 7 ARG C 57 ARG^? 6.12 O ACT B 304 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -0.02 52.59 55.50 0.94 52.38 57.70 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 1.99 50.51 47.19 3.66 49.08 47.14 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 0.41 44.01 46.89 3.20 43.89 45.69 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER C 63 SER~? 11.24 CH3 ACT C 301 E 5 VAL C 66 VAL~? 10.76 CH3 ACT C 301 E 7 ARG C 69 ARG~? 14.72 CH3 ACT C 301 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -12.58 47.33 34.13 -13.90 49.38 33.94 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -11.84 52.33 35.67 -13.24 51.67 37.20 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -12.96 57.05 36.96 -15.23 55.68 35.39 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 27 ARG~? 17.50 O ACT A 303 A 32 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 46 ARG A 20 ARG~? 20.10 O ACT A 303 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -8.48 15.97 44.91 -10.41 17.08 42.79 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -2.24 19.72 44.66 2.39 20.87 47.23 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 32 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 46 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo -8.00 4.27 27.74 -7.09 2.66 30.09 26.02 42.58 42.38 25.84 41.49 45.27 coo -5.15 8.65 26.69 -4.26 5.48 32.02 20.18 46.61 43.20 19.00 49.55 48.67 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 32 LYS C 19 LYS~? 19.44 O ACT C 301 A 46 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -5.77 61.08 52.24 -4.57 63.14 50.31 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -8.10 55.24 54.21 -11.72 57.88 57.10 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 32 LYS C 26 LYS~? 10.00 O ACT C 301 A 46 ARG C 20 ARG~? 20.69 CH3 ACT B 304 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -14.39 60.44 44.96 -12.57 61.21 42.61 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -14.41 53.18 45.44 -15.58 50.04 50.81 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -5.77 61.08 52.24 -4.57 63.14 50.31 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 4 hits 2ky8_d00 naa= 3 ULMN 4 2p0j_d00 HYDROLASE/DNA user 1 4 # 1 A 46 GLU A 65 GLU~? 11.46 CL CL A 201 A 133 LYS A 31 LYS.? 10.36 O ACT A 303 A 134 TYR A 99 TYR~? -4.58 CH3 ACT A 303s A 172 SER A 63 SER~? 11.49 O ACT A 303 coo 29.36 7.53 2.81 27.47 7.30 3.73 -4.30 22.08 29.22 -2.64 23.27 28.50 coo 20.43 15.67 9.20 23.49 12.62 10.53 3.36 21.23 42.37 3.31 17.75 38.68 coo 18.60 12.45 12.36 19.78 10.10 11.41 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.78 7.59 5.40 26.01 7.14 6.26 0.23 24.84 33.21 -0.95 22.75 32.99 ULMN 4 2p0j_d00 HYDROLASE/DNA user 2 4 # 2 A 46 GLU A 65 GLU~? 11.46 CL CL A 201 A 133 LYS A 98 LYS~? 7.98 CH3 ACT A 303 A 134 TYR A 99 TYR~? -4.58 CH3 ACT A 303s A 172 SER A 63 SER~? 11.49 O ACT A 303 coo 29.36 7.53 2.81 27.47 7.30 3.73 -4.30 22.08 29.22 -2.64 23.27 28.50 coo 20.43 15.67 9.20 23.49 12.62 10.53 9.24 21.45 37.02 12.73 25.01 40.79 coo 18.60 12.45 12.36 19.78 10.10 11.41 6.28 25.07 38.68 7.82 26.15 40.75 coo 23.78 7.59 5.40 26.01 7.14 6.26 0.23 24.84 33.21 -0.95 22.75 32.99 ULMN 4 2p0j_d00 HYDROLASE/DNA user 3 4 # 3 A 46 GLU B 65 GLU~? 12.71 CL CL B 202 A 133 LYS B 31 LYS.? 11.57 OXT ACT B 304 A 134 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 172 SER B 63 SER~? 12.00 OXT ACT B 304 coo 29.36 7.53 2.81 27.47 7.30 3.73 17.56 45.22 27.93 16.40 47.01 27.72 coo 20.43 15.67 9.20 23.49 12.62 10.53 15.94 50.91 41.57 17.07 55.01 36.93 coo 18.60 12.45 12.36 19.78 10.10 11.41 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.78 7.59 5.40 26.01 7.14 6.26 13.26 47.11 32.36 15.61 47.27 31.93 ULMN 4 2p0j_d00 HYDROLASE/DNA user 4 4 # 4 A 46 GLU B 65 GLU~? 12.71 CL CL B 202 A 133 LYS B 98 LYS~? 9.29 CH3 ACT B 304 A 134 TYR B 99 TYR~? 4.94 OXT ACT B 304 A 172 SER B 63 SER~? 12.00 OXT ACT B 304 coo 29.36 7.53 2.81 27.47 7.30 3.73 17.56 45.22 27.93 16.40 47.01 27.72 coo 20.43 15.67 9.20 23.49 12.62 10.53 12.25 56.30 36.89 8.12 57.51 41.12 coo 18.60 12.45 12.36 19.78 10.10 11.41 10.71 51.79 38.53 9.13 52.40 40.75 coo 23.78 7.59 5.40 26.01 7.14 6.26 13.26 47.11 32.36 15.61 47.27 31.93 2p0j_d00 source 2p0j HYDROLASE/DNA : 4 hits 2p0j_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 15 SER.? 17.30 O ACT C 301 B 37 ASN A 55 ASN^? 10.27 O ACT C 301 B 45 THR B 36 THR^? 10.28 O ACT B 304 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -7.72 31.71 56.41 -7.84 32.30 58.77 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -8.33 37.03 53.83 -10.36 37.52 54.24 coo -30.87 34.84 80.57 -28.94 34.51 81.49 5.70 40.75 51.53 3.79 40.81 50.49 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 15 SER.? 16.65 OXT ACT A 303 B 37 ASN B 55 ASN^? 9.91 CH3 ACT A 303 B 45 THR C 36 THR^? 10.76 OXT ACT C 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 13.49 35.39 54.57 12.84 34.83 56.84 coo -23.05 39.62 69.74 -22.86 39.59 67.61 9.14 32.38 52.24 9.69 30.32 52.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -1.57 43.28 52.09 -0.86 42.09 50.37 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER C 15 SER.? 16.03 CH3 ACT B 304 B 37 ASN C 55 ASN^? 9.16 CH3 ACT B 304 B 45 THR A 36 THR^? 9.99 OXT ACT A 303 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -0.02 52.59 55.50 0.94 52.38 57.70 coo -23.05 39.62 69.74 -22.86 39.59 67.61 4.32 50.30 52.50 5.90 51.72 52.50 coo -30.87 34.84 80.57 -28.94 34.51 81.49 0.70 35.56 51.71 1.36 36.35 49.79 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 3 hits 2z3x_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 44 ARG.? 19.54 O ACT C 301 B 148 LYS A 19 LYS~? 20.51 O ACT A 303 B 151 LEU A 17 LEU~? 15.80 O ACT C 301 B 154 ILE A 56 ILE^? 13.74 OXT ACT A 303 coo 13.00 32.05 60.31 16.02 31.73 59.80 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 11.05 44.13 44.68 12.77 44.45 49.56 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 11.72 38.91 44.77 13.11 39.67 46.23 -10.45 28.47 52.81 -12.30 27.97 51.84 coo 7.03 36.97 46.99 7.83 37.90 47.52 -4.60 32.98 53.36 -4.78 31.85 53.53 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 1 hits 3odc_d00 naa= 4 ULMN 4 3osn_d00 TRANSFERASE/DNA user 1 4 # 1 A 39 TYR C 78 TYR~? 17.53 CH3 ACT B 304 A 305 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 343 ARG A 44 ARG.? 19.54 O ACT C 301 A 361 GLN A 54 GLN.? 18.54 OXT ACT C 301 coo 3.17 21.01 23.67 3.92 23.69 23.42 -2.76 60.08 45.99 -5.32 60.21 47.12 coo 2.79 34.65 27.76 1.63 34.99 26.01 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 8.01 44.91 26.07 9.43 44.33 23.46 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 10.85 48.77 26.69 11.54 47.94 24.85 -6.26 37.47 60.50 -4.43 36.85 61.43 ULMN 4 3osn_d00 TRANSFERASE/DNA user 2 4 # 2 A 39 TYR C 82 TYR.? 16.78 CH3 ACT B 304 A 305 GLU C 18 GLU~? 13.25 OXT ACT C 301 A 343 ARG A 44 ARG.? 19.54 O ACT C 301 A 361 GLN A 54 GLN.? 18.54 OXT ACT C 301 coo 3.17 21.01 23.67 3.92 23.69 23.42 1.46 61.13 49.70 -0.36 62.80 51.06 coo 2.79 34.65 27.76 1.63 34.99 26.01 -5.97 51.16 54.03 -5.89 49.54 55.41 coo 8.01 44.91 26.07 9.43 44.33 23.46 -9.80 41.84 63.03 -12.20 41.46 64.90 coo 10.85 48.77 26.69 11.54 47.94 24.85 -6.26 37.47 60.50 -4.43 36.85 61.43 3osn_d00 source 3osn TRANSFERASE/DNA : 2 hits 3osn_d00 naa= 4 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 20 ARG~? 20.10 O ACT A 303 A 82 LYS A 19 LYS~? 20.51 O ACT A 303 A 97 ARG A 73 ARG~? 20.11 O ACT A 303 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -12.34 22.00 52.71 -13.61 20.80 50.18 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -5.86 23.51 54.21 -8.85 19.33 56.46 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -13.24 21.34 42.66 -14.70 19.65 44.77 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 27 ARG~? 17.50 O ACT A 303 A 82 LYS A 26 LYS~? 7.74 CH3 ACT A 303 A 97 ARG A 20 ARG~? 20.10 O ACT A 303 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -8.48 15.97 44.91 -10.41 17.08 42.79 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -2.24 19.72 44.66 2.39 20.87 47.23 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -12.34 22.00 52.71 -13.61 20.80 50.18 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG B 20 ARG~? 20.55 CH3 ACT A 303 A 82 LYS B 19 LYS~? 19.93 CH3 ACT B 304 A 97 ARG B 73 ARG~? 16.43 O ACT A 302 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 23.59 35.51 49.80 23.38 33.40 52.03 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 19.96 40.93 52.37 24.88 43.37 55.52 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 24.09 36.62 39.81 25.66 39.04 38.73 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG B 27 ARG~? 17.68 OXT ACT B 304 A 82 LYS B 26 LYS~? 10.63 CH3 ACT B 304 A 97 ARG B 20 ARG~? 20.55 CH3 ACT A 303 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 26.02 42.58 42.38 25.84 41.49 45.27 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 20.18 46.61 43.20 19.00 49.55 48.67 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 23.59 35.51 49.80 23.38 33.40 52.03 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG C 20 ARG~? 20.69 CH3 ACT B 304 A 82 LYS C 19 LYS~? 19.44 O ACT C 301 A 97 ARG C 73 ARG~? 19.49 CH3 ACT C 301 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -5.77 61.08 52.24 -4.57 63.14 50.31 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -8.10 55.24 54.21 -11.72 57.88 57.10 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -8.01 61.75 41.62 -10.44 63.15 40.34 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 78 ARG C 27 ARG~? 17.31 CH3 ACT C 301 A 82 LYS C 26 LYS~? 10.00 O ACT C 301 A 97 ARG C 20 ARG~? 20.69 CH3 ACT B 304 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -14.39 60.44 44.96 -12.57 61.21 42.61 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -14.41 53.18 45.44 -15.58 50.04 50.81 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -5.77 61.08 52.24 -4.57 63.14 50.31 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 6 hits 4er8_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS B 26 LYS~? 10.63 CH3 ACT B 304 B 443 VAL B 25 VAL~? 9.66 OXT ACT B 304 B 447 ARG B 27 ARG~? 17.68 OXT ACT B 304 coo -11.49 8.72 29.13 -11.20 3.78 25.16 20.18 46.61 43.20 19.00 49.55 48.67 coo -11.96 6.22 31.96 -10.74 4.61 32.81 18.86 43.15 42.35 16.92 42.70 43.28 coo -14.58 4.58 36.41 -12.11 2.82 36.84 26.02 42.58 42.38 25.84 41.49 45.27 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 1 hits 4hn5_d00 naa= 3